EurekaMag PDF full texts Chapter 56,827

Sun, G-Joo.; Choi, S-Woo.; Jung, S-Hyun.; Katoch, A.; Kim, S.Sub. 2013: V-groove SnO2 nanowire sensors: fabrication and Pt-nanoparticle decoration. Nanotechnology 24(2): 025504

Rajkumar, N.; McMullin, J.N. 1995: V-groove gratings on silicon for infrared beam splitting. Applied Optics 34(14): 2556-2559

Turunen, J.; Noponen, E. 1996: V-groove gratings on silicon for infrared beam splitting: comment. Applied Optics 35(5): 807-808

Khalifeh, A.; Autorino, R.; Hillyer, S.P.; Kaouk, J.H. 2012: V-hilar suture renorrhaphy during robotic partial nephrectomy for renal hilar tumors: preliminary outcomes of a novel surgical technique. Urology 80(2): 466-471

Scheel, T.; Gursche, A.; Zacher, J.; Häupl, T.; Berek, C. 2011: V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis and Rheumatism 63(1): 63-72

MacCarthy, T.; Kalis, S.L.; Roa, S.; Pham, P.; Goodman, M.F.; Scharff, M.D.; Bergman, A. 2009: V-region mutation in vitro, in vivo, and in silico reveal the importance of the enzymatic properties of AID and the sequence environment. Proceedings of the National Academy of Sciences of the United States of America 106(21): 8629-8634

Sumita, T.; Sairyo, K.; Shibuya, I.; Kitahama, Y.; Kanamori, Y.; Matsumoto, H.; Koga, S.; Kitagawa, Y.; Dezawa, A. 2013: V-rod technique for direct repair surgery of pediatric lumbar spondylolysis combined with posterior apophyseal ring fracture. Asian Spine Journal 7(2): 115-118

Koning, A.H.J.; Rousian, M.; Verwoerd-Dikkeboom, C.M.; Goedknegt, L.; Steegers, E.A.P.; van der Spek, P.J. 2009: V-scope: design and implementation of an immersive and desktop virtual reality volume visualization system. Studies in Health Technology and Informatics 142: 136-138

Mahajan, R.; Rohit, M.K.; Talwar, K.K. 2009: V-sense episode in a biventricular pacemaker device: what is the likely mechanism?. Pacing and Clinical Electrophysiology: Pace 32(2): 245-247

Arcieri, L.; Cantinotti, M.; Pak, V.; Bernabei, M.; Assanta, N.; Murzi, B. 2014: V-shape reduction plasty to reduce the neoaortic root-ascending aorta discrepancy in children undergoing arterial switch operation. Journal of Cardiac Surgery 29(3): 410-412

Achelle, S.; Nouira, I.; Pfaffinger, B.; Ramondenc, Y.; Plé, N.; Rodríguez-López, J.án. 2009: V-shaped 4,6-bis(arylvinyl)pyrimidine oligomers: synthesis and optical properties. Journal of Organic Chemistry 74(10): 3711-3717

Tasior, M.; Poronik, Y.M.; Vakuliuk, O.; Sadowski, B.ło.; Karczewski, M.; Gryko, D.T. 2014: V-shaped bis-coumarins: synthesis and optical properties. Journal of Organic Chemistry 79(18): 8723-8732

Toll, A.í; Vincent, M.-C.; Calvas, P.; Pujol, R.M. 2007: V-shaped hyperpigmented linear lesions, patchy hypotrichosis, and teeth abnormalities in a young girl. Pediatric Dermatology 24(5): 551-554

Lee, S.H.; Lim, G.; Moon, W.; Shin, H.; Kim, C.-W. 2008: V-shaped metal-oxide-semiconductor transistor probe with nano tip for surface electric properties. Ultramicroscopy 108(10): 1094-1100

Seltmann, J.; Müller, K.; Klein, S.; Lehmann, M. 2011: V-shaped nematogens with the "magic bent angle". Chemical Communications 47(23): 6680-6682

Okamoto, T.; Mitsui, C.; Yamagishi, M.; Nakahara, K.; Soeda, J.; Hirose, Y.; Miwa, K.; Sato, H.; Yamano, A.; Matsushita, T.; Uemura, T.; Takeya, J. 2013: V-shaped organic semiconductors with solution processability, high mobility, and high thermal durability. Advanced Materials 25(44): 6392-6397

Shin, D.H.; Shim, S.-Y.; Kim, M.J.; Oh, C.S.; Lee, M.-H.; Jung, S.B.; Lee, G.I.; Chai, J.-Y.; Seo, M. 2014: V-shaped pits in regions of ancient Baekje kingdom paleoparasitologically confirmed as likely human-waste reservoirs. Korean Journal of Parasitology 52(5): 569-573

Osaka, M.; Watanabe, E.; Murata, H.; Fuwamoto, Y.; Nanba, S.; Sakai, K.; Katoh, T. 2010: V-shaped trough in autonomic activity is a possible precursor of life-threatening cardiac events. Circulation Journal: Official Journal of the Japanese Circulation Society 74(9): 1906-1915

Casey, A.K.; Schwalm, E.L.; Hays, B.N.; Frantom, P.A. 2013: V-type allosteric inhibition is described by a shift in the rate-determining step for α-isopropylmalate synthase from Mycobacterium tuberculosis. Biochemistry 52(39): 6737-6739

Granov, N.; Kacila, M.; Mujicic, E.; Hadzimehmedagic, A.; Custovic, F.; Kulic, M. 2012: V-type mini sternotomy in aortic valve replacement. Medical Archives 66(3): 213-214

Schmidt, C.; Breyer, F.; Blum, M.-M.; Thiermann, H.; Worek, F.; John, H. 2014: V-type nerve agents phosphonylate ubiquitin at biologically relevant lysine residues and induce intramolecular cyclization by an isopeptide bond. Analytical and Bioanalytical Chemistry 406(21): 5171-5185

Mehling, I.; Hessmann, M.H.; Hofmann, A.; Rommens, P.M. 2008: V-y flap for restoration of the fingertip. Operative Orthopadie und Traumatologie 20(2): 103-110

Sanders, R.D.; Absalom, A.; Sleigh, J.W. 2014: V. 'for now we see through a glass, darkly': the anaesthesia syndrome. British Journal of Anaesthesia 112(5): 790-793

Morison, R. 1903: V. a Case of Ascites due to Liver Cirrhosis treated by Operation. Annals of Surgery 38(3): 361-366

Crile, G.W. 1898: V. A Case of Complete Cross Lesion of the Spinal Cord due to a Fractured Dislocation. The Fifth Cervical Vertebra being Displaced Forward upon the Sixth. Annals of Surgery 28(5): 639-645

Perkins, G.W. 1890: V. A Case of Fracture or the Styloid Processes of the Ulna and the Radius by Indirect Violence. Annals of Surgery 12(2): 134-135

Roberts, J.B. 1897: V. a Case of Persistent Thyro-Glossal Duct or of Congenital Laryngeal Diverticulum successfully treated by Excision. Annals of Surgery 25(6): 711-715

Mayo, W.J. 1897: V. a Case of Vaginal Anus, the Result of a Hysterectomy, Cured by Ileocolostomy. Annals of Surgery 26(5): 634-636

Eliot, E. 1914: V. a Consideration of Certain Coexisting Lesions of the Gall-Bladder and Kidney. Annals of Surgery 59(5): 679-689

Jepson, W. 1898: V. a Means of Regulating Inflation of the Bladder preliminary to Suprapubic Cystotomy. Annals of Surgery 28(3): 358-365

Dunham, T. 1893: V. A Method for Obtaining a Skin-Flap from the Scalp and a Permanent Buried Vascular Pedicle for Covering Defects of the Face. Annals of Surgery 17(6): 677-679

Hadra, B.E. 1898: V. a Method for facilitating Enucleation of Tumors of the Thyroid Gland. Annals of Surgery 28(6): 737-740

Pilcher, P.M. 1909: V. a new Cystoscope for Catheterizing the Ureters by the Indirect Method. Annals of Surgery 49(2): 218-224

Bacon, J.B. 1893: V. A New Method of Treating Non-malignant Strictures of the Rectum by Transplantation of Intestine. Annals of Surgery 17(5): 576-581

Gallagher, J.R.; Brouha, L. 1943: V. a Simple Method of Evaluating Fitness in Boys: the Step Test. Yale Journal of Biology and Medicine 15(6): 769-779

Schumann, E.A. 1911: V. a Study of Carcinoma Mastitoides. Annals of Surgery 54(1): 69-77

Heo, J.; Yu, S-Young.; Yi, J.; Nam, Y-Seon.; Son, D.Thai.; Oh, J.; Lee, J-Koo. 2018: Wealth gradient-based divergence in the prevalence of underweight among women by marital status in Quoc Oai district, Vietnam. Global Health Action 11(1): 1449430

Heinik, J. 2010: V. A. Kral and the origins of benign senescent forgetfulness and mild cognitive impairment. International Psychogeriatrics 22(3): 395-402

Wilson, C. 1908: V. Acute Dilatation of the Stomach Complicating Typhoid Fever. Annals of Surgery 48(5): 678-679

Laffer, W.B. 1908: V. Acute Dilatation of the Stomach and Arterio-Mesenteric Ileus. Annals of Surgery 47(4): 532-557

Bruce, H.A. 1911: V. Acute Diverticulitis. Annals of Surgery 53(5): 682-685

Hotchkiss, L.W. 1901: V. Acute Intestinal Obstruction following Appendicitis. A Report of Three Cases Successfully Operated upon. Annals of Surgery 34(5): 660-677

Dowd, C.N. 1912: V. Acute Phlegmonous Inflammation of the Large Intestine. Annals of Surgery 56(4): 579-581

Cumston, C.G. 1896: V. Amputation of the Foot with a Dorsal Flap. Annals of Surgery 24(6): 706-712

Pedersen, V.C. 1909: V. An Irrigating Sound of the Standard and Beniqué Type: Also an Irrigating Tunnelled and Grooved Sound for the Dilatation Treatment of Stricture of the Male Urethra. Annals of Surgery 50(4): 770-781

McGraw, T.A. 1909: V. Aneurisms in Young people. Annals of Surgery 50(1): 59-65

Delatour, H.B. 1905: V. Angulation at the Sigmoid. Annals of Surgery 42(5): 678-686

Stetten, d.W. 1913: V. Angulation of the Junction of the Hepatic and Common Ducts after Cholecystostomy, Simulating Common Duct Obstruction. Annals of Surgery 57(2): 182-187

Hubbard, J.C. 1906: V. Arteriovenous Anastomosis. Annals of Surgery 44(4): 559-562

Shinohara, Y.; Yanagihara, T.; Abe, K.; Yoshimine, T.; Fujinaka, T.; Chuma, T.; Ochi, F.; Nagayama, M.; Ogawa, A.; Suzuki, N.; Katayama, Y.; Kimura, A.; Kayama, T. 2011: V. Asymptomatic cerebrovascular diseases. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 20(4 Suppl): S116-S128

Pilcher, L.S. 1910: V. Atlo - Axoid Fracture - Dislocation. Annals of Surgery 51(2): 208-211

Janeway, H.H. 1910: V. Autoplastic Transplantation of Bone. Annals of Surgery 52(2): 217-228

Lyman, C.B. 1906: V. Backward Dislocation of the Second Carpo-Metacarpal Articulation. Annals of Surgery 43(6): 905-906

Warbasse, J.P. 1892: V. Boisleux on Intraligamentous Elytrotomy. Annals of Surgery 16(6): 556-563

Wyller, V.Bruun. 2013: V. Bruun Wyller replies. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 133(15): 1553

Sherrill, J.G. 1906: V. Cancer of the Gall-Bladder and Ducts. Annals of Surgery 44(6): 866-891

Erdmann, J.F. 1906: V. Cardio Spasm: With Report of an Operative Case. Annals of Surgery 43(2): 224-230

Booth-LaForce, C.; Groh, A.M.; Burchinal, M.R.; Roisman, G.I.; Owen, M.T.; Cox, M.J. 2014: V. Caregiving and contextual sources of continuity and change in attachment security from infancy to late adolescence. Monographs of the Society for Research in Child Development 79(3): 67-84

Hopkins, W.B. 1885: V. Case of Compound Depressed Fracture of Skull, with Wound of the Longitudinal Sinus. Note on the Construction of the Trephine. Annals of Surgery 2(7): 65-70

Groner, F.J. 1885: V. Case of Fracture of Femur Complicated with Sacro-iliac Dislocation. Annals of Surgery 1(5): 463-464

Chavasse, T.F. 1896: V. Case of Interscapulo-Thoracic Amputation for Injury. Annals of Surgery 24(2): 182-187

Schwinn, J. 1896: V. Case of Operative Injury to the Thoracic Duct at the Root of the Neck. Annals of Surgery 23(5): 582-584

Beach, H.H. 1896: V. Case of Pelvic Tumor formed by a Calcified Meckel's Diverticulum uniting the Ileum and Bladder. Annals of Surgery 24(4): 484-487

McCosh, A.J. 1896: V. Case of Sternal Dislocation of Second and Third Costal Cartilages and of Clavicle, with Fracture of Fourth and Fifth Cartilages. Annals of Surgery 23(3): 279-281

Fagge, C.H. 1905: V. Cases of Intussusception in Children treated by Laparotomy. Annals of Surgery 41(3): 407-414

Mixter, S.J. 1901: V. Cases of Laceration of the Spleen and of the Kidney followed by Recovery after Removal of the Injured Organ. Annals of Surgery 33(6): 713-714

Carnett, J.B. 1910: V. Cervical Subcutaneous Cavernous Haemangeioma: With Report of Two Cases. Annals of Surgery 51(1): 65-75

Caddy, A. 1899: V. Chondrocarcinoma of the Testicle. Annals of Surgery 30(2): 210-212

Loux, H.R.; Coplin, W.M. 1902: V. Chronic Phagedaena due to Mixed Infection. Annals of Surgery 35(5): 586-597

Mayo, W.J.; Mayo, C.H. 1895: V. Clinical Report.-I. Complete Section of the Vas Deferens, End-to-End Union; II. Acute Suppuration of Knee-Joint: Open Treatment; III. Gastro-Enterostomy by the Murphy Button: Anastomoses by this Method. Annals of Surgery 21(1): 35-44

Rosengren, K.S.; Gutiérrez, I.T.; Schein, S.S. 2014: V. Cognitive models of death. Monographs of the Society for Research in Child Development 79(1): 83-96

Curl, H.C. 1905: V. Combined Volvulus and Hernia through a recent Mesenteric Slit: Resection of Five and One-Half Feet of Intestine; Death on Ninth Day. Annals of Surgery 42(2): 207-208.1

Perkins, J.W. 1893: V. Complete Dislocation of Patella, Reduced by Arthrotomy After Six Years. Annals of Surgery 18(6): 654-657

Winslow, R. 1900: V. Complete External Dislocation at the Elbow. Annals of Surgery 31(5): 595-599

Fowler, G.R. 1885: V. Compound Comminuted Fracture of the Patella: Wire Sutures: Necrosis of Upper Fragment: Final Recovery with Useful Limb. Annals of Surgery 2(9): 246-250

Freiberg, A.H. 1899: V. Congenital Deformity due to Malposition of the Scapula. Annals of Surgery 29(5): 584-592

Hammond, L.J. 1911: V. Considerations Relating to the Pathogenesis and Diagnosis of Surgical Diseases of the Pancreas. Annals of Surgery 54(6): 798-805

Rixford, E. 1912: V. Contribution to the Etiology of Congenital Dislocation of the Hip. Annals of Surgery 56(6): 854-866

Marcy, H.O. 1897: V. Contribution to the History of Operative Interference for the Relief of Obstruction of the Common Choledoch Duct by Biliary Calculi. Annals of Surgery 25(1): 80-85

Maclaren, A. 1896: V. Contribution to the Statistics of Foreign Bodies in the Peritoneal Cavity. Annals of Surgery 24(3): 365-370.1

Binnie, J.F. 1898: V. Contribution to the Study of Appendicitis Obliterans. Annals of Surgery 27(5): 618-625

Wainwright, J.M. 1903: V. Contribution to the Subject of Perineal Prostatectomy. Annals of Surgery 37(5): 711-715

Niemack, J. 1905: V. Contribution to the Surgery of Gastric Ulcer. Annals of Surgery 41(1): 44-50

Kawai, M.; Yamagami, Y. 2013: V. Current status of chemotherapy for carcinoma of the ampulla open Vater. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(10): 1314-1317

Shober, J.B. 1909: V. Cystitis and Ulceration of the Bladder in Women. Annals of Surgery 49(6): 777-784

Bayne, J.K. 1946: V. D. Medical Bulletin. United States. Army. Forces in the European Theater. Office of the Theater Chief Surgeon 1(1): 13-16

Anonymous 1944: V. D. education in the factory. British Journal of Venereal Diseases 20(4): 173

Weil, R. 1913: V. Desensitization: its Theoretical and Practical Significance. Journal of Medical Research 29(2): 233-249

Smith, E.A. 1909: V. Diagnosis and Treatment of Carcinoma of the Caecum: With a Report of Two Cases Treated by Resection of the Caecum. Annals of Surgery 50(3): 562-570

Sonuga-Barke, E.J.; Schlotz, W.; Kreppner, J. 2010: V. Differentiating developmental trajectories for conduct, emotion, and peer problems following early deprivation. Monographs of the Society for Research in Child Development 75(1): 102-124

North, N.L. 1887: V. Digital Amputations under Cocaine. Annals of Surgery 5(5): 417-418

McBurney, C. 1897: V. Direct Intra-Abdominal Finger-Compression of the Common Iliac Artery during Amputation at the Hip-Joint. Annals of Surgery 25(5): 610-613

Twenhofel, W.H. 1933: V. Division of Geology and Geography. Science 77(2009): 618-620

Summers, J.E. 1901: V. Double Ureter. Report of a Nephrectomy done upon a Young Child with this Condition Present. Annals of Surgery 33(1): 39-41

Deaderick, C. 1890: V. Downward Dislocation of the Patella. Annals of Surgery 11(2): 102-103

Gaskoin, G. 1879: A Case of Morphœa. Medico-Chirurgical Transactions 62: 169-175

Cotton, F.J. 1902: V. Elbow Fractures in Children. Fractures of the Lower End of the Humerus; Lesions and End Results, and their Bearing upon Treatment. Annals of Surgery 35(2): 242-269

Cobb, F. 1912: V. Epigastric Hernia, a Cause of Chronic Diarrhoea: With Report of a Case. Annals of Surgery 55(1): 66-70

Torrance, G. 1908: V. Excision of the Whole Left Lobe of the Liver for Sarcoma. Annals of Surgery 47(1): 33-36

Horsley, J.S.; Coleman, C.C. 1913: V. Experimental Devascularization of Intestine with and without Mechanical Obstruction. Annals of Surgery 57(4): 506-510

Watson, B.A. 1893: V. Expert Examinations and Testimony in Railway Cases. Annals of Surgery 17(1): 41-56

Byford, H.T. 1896: V. Extirpation of the Rectum per Vaginam, with Utilization of the Vagina to replace the lost Rectal Tissue. Annals of Surgery 24(5): 631-633

Faust, L.; Yaya, S.; Ekholuenetale, M. 2017: Wealth inequality as a predictor of HIV-related knowledge in Nigeria. Bmj Global Health 2(4): E000461

Gage, H.; Beal, H.W. 1908: V. Fibrinous Calculi in the Kidney. Annals of Surgery 48(3): 378-387

Walton, G.L. 1904: V. Fracture of the Base of the Skull: a Contribution Based on the Clinical and Pathological Records of Fifty Cases. Annals of Surgery 40(5): 654-668

Joy, H.M. 1896: V. Fracture of the Os Calcis, with Report of a Case of Comminuted Fracture with an Unique Method of Treatment. Annals of Surgery 24(1): 39-41

Fønnebø, V. 2014: V. Fønnebø replies. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(16): 1546

Hotchkiss, L.W. 1894: V. Gangrenous Cholecystitis. Annals of Surgery 19(2): 197-205

Cannon, W.B.; Blake, J.B. 1905: V. Gastro-enterostomy and Pyloroplasty: An Experimental Study by Means of the Röntgen Rays. Annals of Surgery 41(5): 686-711

Woolsey, G. 1896: V. Gunshot Wound of the Intestines, with Sixteen Perforations; Enterorrhaphy; Use of the Murphy Button; Recovery. Annals of Surgery 23(4): 423-426

Davis, B.B. 1895: V. Hernia in the Linea Alba. Annals of Surgery 21(4): 464-467

Jopson, J.H. 1904: V. Hernia of the Uterus through the Inguinal Canal. Annals of Surgery 40(1): 98-106

Wilkinson, L.R.; Ferraro, K.F.; Mustillo, S.A. 2019: Wealth in Middle and Later Life: Examining the Life Course Timing of Women's Health Limitations. Gerontologist 59(5): 902-911

Perkins, G.W. 1895: V. I. Case of Inguino-Labial Hernia; Ovary, Fallopian Tube, and Cornu of Uterus in Sac. II. Case of Hydronephrosis, of Thirty Years' Duration, with Calcification of the Inner Portion of the Wall of the Cyst. Annals of Surgery 21(6): 691-705

Mirskiĭ, M.B.; Gedroĭ, V.Ignat'evna. 2007: V. I. Gedreitz as the professor of surgery and the writer. Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 2007(6): 50-55

Bereziuk, N.M.; Dzhunkovskiĭ, V.Ia. 2010: V. Ia. Dzhunkovskiĭ--the first historian of the national medicine. Likars'ka Sprava 2010(7-8): 129-134

Steele, D.A. 1901: V. Ileus due to Mechanical Obstruction to the Faecal Current. Annals of Surgery 33(4): 449-456

Cumston, C.G. 1897: V. Incision of the Kidney in Cases of Uncomplicated Nephrolithiasis. Annals of Surgery 26(3): 320-328

Dudgeon, L.S.; Ross, A. 1910: V. Infections of the Urinary Tract due to Bacillus Coli and Allied Organisms: Further Observations on the Treatment of Acute and Chronic Conditions. Annals of Surgery 51(3): 355-361

Hawkes, F. 1899: V. Inflammation of the Bursa Gastrocnemio-Semimembranosa, with a Report of Four Cases of Enlargement and Distention of this Bursa treated by Excision. Annals of Surgery 30(1): 61-78

Halstead, A.E. 1906: V. Inguino-Properitoneal Hernia; Inguino-Interstitial Hernia: Report of Cases with Remarks. Annals of Surgery 43(5): 704-716

Ballman, A.A.; Byer, R.L.; Eimerl, D.; Feigelson, R.S.; Feldman, B.J.; Goldberg, L.S.; Menyuk, N.; Tang, C.L. 1987: V. Inorganic nonlinear materials for frequency conversion. Applied Optics 26(2): 224-227

Robinson, B. 1899: V. Inspection of the Abdominal Cavity and its Viscera in Post-Mortems. Annals of Surgery 29(6): 731-740

Schaefer, F.C. 1903: V. Instrument to Protect the Brain while doing Craniotomy with Gigli Saw. Annals of Surgery 37(4): 505-509

Thompson, J.E. 1898: V. Intestinal Obstruction caused by Meckel's Diverticulum. Annals of Surgery 27(4): 448-458

Bloodgood, J.C. 1903: V. Intestinal Obstruction following Operation for Reducible Left Inguinal Hernia due to a Loop of Small Intestine caught in Treitz's Fossa. Annals of Surgery 38(6): 806-811

Lamson, O.F. 1914: V. Intrathoracic Goitre: Report of Two Cases with Marked Displacement of Trachea. Annals of Surgery 59(2): 191-194

Husson, F.C. 1890: V. Jaffé on the Therapy of Habitual Scoliosis. Annals of Surgery 11(5): 364-369

Baldwin, J.F. 1903: V. Knife-blade Removed from Lung. Annals of Surgery 37(3): 360-361

Moynihan, B.G. 1908: V. Late Results after Operations for Benign Diseases of Stomach and Duodenum. Annals of Surgery 47(6): 873-884

Gillette, W.J. 1908: V. Ligation of the Left Common Iliac Artery, with Report of a Recent Case. Annals of Surgery 48(1): 22-24

Mayo, W.J. 1900: V. Malignant Diseases of the Stomach and Pylorus. Annals of Surgery 32(2): 251-277

Sawyer, P.E. 1912: V. Malignant Tumors of the Mesentery: With Report of a Case. Annals of Surgery 56(5): 694-696.1

Bullitt, J.B. 1900: V. Mammoth Ovarian Tumors. Annals of Surgery 31(1): 87-96

Frank, J. 1902: V. Mechanical versus Suture Methods for Intestinal Approximation. Annals of Surgery 35(1): 36-41

Hubbard, J.C. 1902: V. Meckel's Diverticulum Patent at the Navel. Annals of Surgery 35(4): 495-502

Satoh, T.; Shikama, A.; Nakamura, Y.; Akiyama, A.; Yoshikawa, H. 2013: V. Minimal invasiveness treatment for young women with ovarian cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(2): 182-185

Foxworthy, F.W. 1904: V. Modern Bullet Wounds. Annals of Surgery 40(6): 834-855

Bergsagel, P.L.; Chesi, M. 2013: V. Molecular classification and risk stratification of myeloma. Hematological Oncology 31(Suppl 1): 38-41

Vartanian, I.A. 2007: V. N. Chernigovsky and organisation of physiological investigations in the USSR. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 93(2): 211-213

Tulsky, D.S.; Carlozzi, N.E.; Chevalier, N.; Espy, K.A.; Beaumont, J.L.; Mungas, D. 2013: V. NIH Toolbox Cognition Battery (CB): measuring working memory. Monographs of the Society for Research in Child Development 78(4): 70-87

Corson, E.R. 1907: V. Narath's Modification of Talma's Operation for Hepatic Cirrhosis. Annals of Surgery 46(6): 831-840

Lilienthal, H. 1911: V. Nephroureterectomy: Description of a Simple and Improved Method. Annals of Surgery 53(4): 521-524

Babcock, W.W. 1907: V. Nerve Disassociation; A New Method for the Surgical Relief of Certain Painful or Paralytic Affections of Nerve Trunks. Annals of Surgery 46(5): 686-693

Miller, A.H. 1899: V. Nitrous Oxide and Ether Anaesthesia by the Open Method. Annals of Surgery 30(6): 709-714

Powers, C.A. 1906: V. Non-Parasitic Cysts of the Spleen. Annals of Surgery 43(1): 48-60

Ware, M.W. 1911: V. Non-Prostatic Urinary Retention of the Senile Bladder. Annals of Surgery 53(1): 57-66

Wilcox, S.F. 1891: V. Note on Bromide of Ethyl as an Anaesthetic. Annals of Surgery 14(4): 294-295

Branch, J.R. 1911: V. Note on Penetrating Wounds of the Abdomen: Report of Cases Treated at the Macon, Ga., Hospital. Annals of Surgery 54(2): 164-166

Baldwin, J.F. 1902: V. Note on Synchronous Ligation of Both Internal Jugular Veins. Annals of Surgery 36(3): 394-396

Maclaren, A. 1908: V. Note on Syphilis of the Liver: With a Report of Three Cases in which Operation was Resorted to. Annals of Surgery 48(2): 186-191

Shepherd, F.J. 1892: V. Note on the Dissection of a Case of Lumbar Hernia. Annals of Surgery 16(2): 137

Hagner, F.R. 1910: V. Note on the Removal of Carcinoma of the Fundus of the Urinary Bladder. Annals of Surgery 52(5): 654-656

Boothby, W.M. 1912: V. Note on the Transplantation of Fresh Venous Segments. Annals of Surgery 56(3): 409-410

Pringle, J.H. 1908: V. Notes on the Arrest of Hepatic Hemorrhage Due to Trauma. Annals of Surgery 48(4): 541-549

Pilcher, P.M. 1912: V. Observations on the Diagnosis of Renal Tuberculosis, the Indications for Nephrectomy in its Treatment and the Technic of the Operation. Annals of Surgery 56(2): 292-304

Messer, A.I.; McLachlan, A.E. 1942: V. Observations on the Lipoid Reinforcement of Antigens in the Gonococcal Complement Fixation Test. British Journal of Venereal Diseases 18(1-2): 38-47

Robinson, B. 1897: V. Observations upon the Absorption of Fluids by the Peritoneum. Annals of Surgery 25(3): 332-350

Anonymous 1994: V. Occupational conjunctivitis (OC). Ocular Immunology and Inflammation 2 Suppl. 1: S35

Wong, R.; Palloni, A.; Soldo, B.J. 2007: Wealth in Middle and Old Age in Mexico: The Role of International Migration. International Migration Review 41(1): 127-151

Hosmer, A.J. 1904: V. on the use of an Electro-Magnet for Removal of a Foreign Body from a Bronchus. Annals of Surgery 40(3): 350-353

Abbe, R. 1902: V. on the use of the Abdominal Route for Approaching Rectal Tumors. Annals of Surgery 36(2): 222-227

Anonymous 1906: V. On the effect upon virulence of passage of B. pestis through rats by cutaneous inoculation without intermediate culture. Journal of Hygiene 6(4): 502-505

Baldwin, J.F. 1903: V. one Thousand Abdominal Closures by a new Method, without a Known Hernia. Annals of Surgery 38(5): 664-670

Haubold, H.A. 1904: V. Operative Removal of a Tumor of the Liver Report of a Case of Resection of the Liver for Gumma; Cholecystectomy. Annals of Surgery 39(2): 240-244

McGuire, H. 1895: V. Operative Treatment of Cancer of the Male Genitals. Annals of Surgery 22(4): 472-484

Hopkins, W.B. 1898: V. Osteotomoclasis: A Preliminary Note on a Modified Operation to Correct Curved Tibia. Annals of Surgery 28(1): 120-124

Noble, C.P. 1906: V. Overlapping the Aponeuroses in the Closure of Wounds of the Abdominal Wall, Including Umbilical, Ventral and Inguinal Herniae. Annals of Surgery 43(3): 349-358

Ransohoff, J. 1910: V. Pancreatic Hemorrhage and Acute Pancreatitis. Annals of Surgery 51(5): 670-681

Halsted, W.S. 1913: V. Partial Occlusion of the Thoracic and Abdominal Aortas by Bands of Fresh Aorta and of Fascia Lata. Annals of Surgery 58(2): 183-187

Mayo, W.J. 1913: V. Pathologic Data Obtained from Ulcers Excised from the Anterior Wall of the Duodenum. Annals of Surgery 57(5): 691-694

Robinson, B. 1900: V. Pathology of the Lymphatics of the Peritoneum. Annals of Surgery 31(2): 214-226

Pegram, J.C. 1905: V. Penetrating Bullet Wound of Abdomen passing through the Spleen, Stomach, Vertebra, and Spinal Cord: Laparotomy and Suture of Stomach Wounds; Recovery. Subsequent Laminectomy and Removal of Bullet from Spinal Cord; Recovery. Annals of Surgery 42(1): 83-89

Park, R. 1891: V. Peritonitis.-Tests for Antiseptics. (Fifth Mütter Lecture, Series of 1890-91). Annals of Surgery 14(1): 50-72

Lilienthal, H. 1910: V. Permanent Colostomy: An Improved Original Operative Method. Annals of Surgery 52(3): 384-387

Goldthwait, J.E. 1899: V. Permanent Dislocation of the Patella. The Report of a Case of Twenty Years' Duration, successfully treated by Transplantation of the Patella Tendons with the Tubercle of the Tibia. Annals of Surgery 29(1): 62-68

Whitla, W. 1895: V. Pharmaceutical Defects in the Present British Pharmacopoeia from the Medical Point of View. British Medical Journal 1(1783): 497-499

Farr, C.E. 1910: V. Preservation of the Submaxillary Branch of the Facial Nerve in Operations on the Neck. Annals of Surgery 52(4): 487-488.3

Elder, J.M. 1908: V. Primary Sarcoma of the Peritoneum. Annals of Surgery 48(6): 848-856

Rebert, M.A. 1904: V. Primary Spasm and Hypertrophy of the Pyloric Sphincter, and Resultant Enormous Dilatation of the Stomach: Relief by Pyloroplasty and Gastroplication. Annals of Surgery 40(2): 201-203

Wolf, H.E. 1905: V. Primary Urethral Calculus: With Report of a Case. Annals of Surgery 41(2): 242-248

Baran, E.; Wośko, G.; Walczyński, J.Z. 2008: V. Profiles of Polish forensic medicals-Jan Zygmunt Walczyński. Archiwum Medycyny Sadowej i Kryminologii 58(2-3): 110-116

Ransohoff, J. 1910: V. Prognosis and Operative Treatment of Fracture of the Base of the Skull: Based on an Analysis of 190 Cases. Annals of Surgery 51(6): 796-811

Squier, J.B. 1914: V. Rectovesical Echinococcus Cyst. Annals of Surgery 59(3): 396-401

Schley, W.S. 1913: V. Rectus Transplantation for Deficiency of Internal Oblique Muscle, in Certain Cases of Inguinal Hernia. Annals of Surgery 58(4): 473-478

Mayer, O.J. 1897: V. Remarks on Laminectomy, with Report of a Case done Sixteen Months after Fracture. Annals of Surgery 26(2): 207-218

Taylor, H.L. 1893: V. Remarks on the Management of Suppuration Complicating Tuberculous Disease of the Bones and Joints. Annals of Surgery 17(4): 423-429

Mynter, H. 1900: V. Remarks on the Technique of Prostatectomy, with Report of a Case. Annals of Surgery 32(4): 552-556

Pilcher, P.M. 1909: V. Renal Varix-Angiomatous Disease of the Papillae Renales. Annals of Surgery 49(5): 652-669

Alexander, E.G. 1913: V. Report of 105 Cases of Strangulated Hernia. Annals of Surgery 58(5): 639-646

Buchanan, J.J. 1897: V. Report of Cases of Circular Resection, respectively of Pylorus, Caecum with Ascending Colon, and Sigmoid Flexure. Annals of Surgery 26(6): 697-702

Weir, R.F. 1887: V. Report of Four Month's Operative Work at the New York Hospital (concluded). Annals of Surgery 6(1): 31-49

Bennett, A.L. 1900: V. Report of Results Obtained in the Treatment of Ununited Fractures with the Parkhill Clamp. Annals of Surgery 31(3): 327-331

Brown, F.T. 1896: V. Report of Two Successful Hip-Joint Amputations, the Second of which was Performed by a New Method. Annals of Surgery 23(2): 153-162.1

Montgomery, D.W. 1898: V. Report of a Case of Epithelioma of the Skin of the Face, with Unusual Course of Infection of Lymph-Nodes. Annals of Surgery 27(2): 193-198

Horwitz, O. 1895: V. Report of a Case of Impacted Urethral Calculus. Annals of Surgery 22(5): 655-660

Thorn, S.S. 1895: V. Report of a Case of Intracranial Trifacial Neurectomy. Annals of Surgery 21(3): 296-298

Cartledge, A.M.; Bullitt, J.B. 1906: V. Report of a Case of Intussusception Subjected to Operation: Colon Opened and Part of Intussusceptum Excised; Enterostomy for Fecal Drainage; Later Excision of Segment of Small Intestine and Enterorrhaphy for Suppression of Fecal Fistula; Ultimate Complete Recovery. Annals of Surgery 44(5): 674-677

Meisenbach, A.H. 1895: V. Report of a Case of Pathological Separation of the Lower Epiphysis of the Femur. Annals of Surgery 21(2): 157-165

Thomas, G.J. 1913: V. Report of a Case of Pelvic Kidney: Diagnosis Before Operation. Annals of Surgery 58(6): 809-811

Mayo, W.J. 1893: V. Report of a Case of Volvulus of the Sigmoid Flexure of the Colon Successfully Reduced after Abdominal Section. Annals of Surgery 18(1): 28-29

Peters, L. 1901: V. Resection of the Pendulous, Fat Abdominal Wall in Cases of Extreme Obesity. Annals of Surgery 33(3): 299-304

Stimson, L.A. 1896: V. Results and Methods of Surgical Operations at the New York Hospital from August 1, 1895, to January 31, 1896, and at the House of Relief from August 1, 1895, to March 10, 1896. Annals of Surgery 23(6): 717-732

Le Boutillier, W.G. 1899: V. Results and Methods of Treatment of Compound Fractures at the J. Hood Wright Memorial Hospital. Annals of Surgery 30(3): 297-316

Garceau, E. 1902: V. Results of Operations on the Kidney for Tuberculosis. Annals of Surgery 36(4): 515-527

Makins, G.H. 1911: V. Retroperitoneal and Mesenteric Cysts of a Simple Nature. Annals of Surgery 53(3): 355-363

Le Conte, R.G. 1908: V. Rupture of the Lung Without Costal Injury: With the Report of a Case. Annals of Surgery 47(3): 383-389

Hammond, L.J. 1901: V. Sacculated Aneurism of the Superior Profunda Humeri Artery. Annals of Surgery 34(3): 398-400.1

Coley, W.B. 1910: V. Sarcoma of the Clavicle: End-Results following Total Excision. Annals of Surgery 52(6): 776-796

Keenan, C.B. 1904: V. Sarcoma of the Tongue. Report of a Recent Case, with Analysis of Previously Recorded Cases. Annals of Surgery 39(6): 956-967

Wharton, H.R. 1898: V. Separation of the Upper Epiphysis of the Humerus. Annals of Surgery 28(4): 462-467

Fisher, J.M. 1906: V. Shortening of the Round Ligaments by Subperitoneal Ventro-Aponeurotic Fixation. Annals of Surgery 44(3): 404-408

Meyer, W. 1894: V. Simultaneous Ligation of Both Internal Iliac Arteries for Hypertrophy of the Prostate Gland (Bier's Method). Annals of Surgery 20(1): 44-51

Binnie, J.F. 1913: V. Snapping Hip (Hanche a Ressort; Schnellende Hufte). Annals of Surgery 58(1): 59-66

Harris, H.F. 1902: V. So-called Hypertrophic Tuberculosis of the Intestine. Annals of Surgery 36(5): 713-734

Sachs, H. 1942: V. Some Aspects of the Serology of Syphilis with Special Reference to its Theoretical and Practical Significance. British Journal of Venereal Diseases 18(3-4): 96-106

Cox, E.M. 1895: V. Some Considerations in the Operative Treatment of Fracture of the Patella, with Special Reference to Suture Material and the Use of Salt Solution. Annals of Surgery 22(6): 725-735

Freeman, L. 1897: V. Some Fractures of the Lower End of the Radius as seen by the Röntgen Rays. Annals of Surgery 25(4): 470-474

Meyer, W. 1910: V. Some Observations Regarding Thoracic Surgery on Human Beings. Annals of Surgery 52(1): 34-57

Dawbarn, R.H. 1903: V. Some Points in Ligation of Arteries. Annals of Surgery 37(1): 42-52

Dawbarn, R.H. 1897: V. Some Practical Points upon Fracture of the Thigh-Bone, especially in Babies. Annals of Surgery 26(4): 480-488

Tennant, C.E. 1911: V. Some Recent Mechanical Aids to Hollow Visceral Anastomosis. Annals of Surgery 54(4): 500-502

Rushmore, J.D. 1894: V. Some Surgical Thoughts on Appendicitis from a Clinical Stand-point. Annals of Surgery 19(5): 576-585

Bovee, J.W. 1900: V. Splenectomy for Congestive Hypertrophy. Annals of Surgery 31(6): 705-713

McCoy, J.C. 1911: V. Splenectomy for Rupture of Spleen: With Report of Four Cases. Annals of Surgery 54(5): 597-611

Park, R. 1904: V. Spontaneous Gangrene of the Hollow Viscera a Study of Mesenteric Occlusion. Annals of Surgery 39(4): 554-569

Bryan, R.C. 1909: V. Spontaneous Rupture of the Spleen in the Course of Typhoid Fever. Annals of Surgery 50(5): 856-874

Warbasse, J.P. 1894: V. Spontaneous Torsion of the Pedicle of Ovarian Tumors; with the Report of a Case of Rotated Ovarian Cyst with Extensive Intra-mural Haemorrhage. Annals of Surgery 19(4): 440-452

Walsh, J.F. 1896: V. Stretching of the Lingual Branch of the Fifth Nerve for the Relief of Neuralgia of the Tongue. Annals of Surgery 23(1): 48-53

Thompson, J.E. 1904: V. Stricture of the OEsophagus due to Typhoid Ulceration. Annals of Surgery 39(5): 683-689

Leggett, N.B.; Maury, J.W. 1907: V. Studies Upon the Function of the Pylorus and Stoma after Gastroenterostomy has been Performed. Annals of Surgery 46(4): 549-555

Monks, G.H. 1905: V. Studies in the Surgical Anatomy of the Small Intestine and its Mesentery. Annals of Surgery 42(4): 543-569

Bouffleur, A.I. 1899: V. Successful Removal of a Fibrosarcoma (Desmoid Fibroma) of the Abdominal Wall, involving the Iliac Vessels. Annals of Surgery 30(5): 587-595

Eliot, E. 1909: V. Suppurative Pericarditis. Annals of Surgery 49(1): 60-85

Mayo, C.H. 1912: V. Surgery of the Thymus Gland. Annals of Surgery 56(1): 77-82

Wolfenden, H.H. 1940: V. the Development and Characteristics of Governmental Health Insurance Plans in Europe and the British Empire: (Excluding Canada). Canadian Medical Association Journal 42(3): 276-280

Sweet, J.E. 1907: V. Technique of Blood Vessel Suture. Annals of Surgery 46(3): 350-357

Holmes, L.W. 1955: V. Telephone Tactics. Canadian Medical Association Journal 73(10): 844-845

Harrigan, A.H. 1913: V. Temporary Arrest of the Heart Beats Following Incision of the Pericardium for Suppurative Pericarditis. Annals of Surgery 57(3): 367-373

Wight, J.S. 1893: V. Ten Cases of Anchylosis of the Elbow Joint, after Treatment of Fracture of the Lower End of the Humerus, with the Fore-Arm in the Extended Position: Five Treated by Exsection, Four Treated by Infraction, and One Not Treated. Annals of Surgery 18(2): 218-226

Keen, W.W. 1897: V. The Advantages of the Trendelenburg Posture during all Operations involving directly or indirectly the Cavities of the Mouth, Nose, and the Trachea, with a Report of Two Cases of Epithelioma and Sarcoma of the Tonsil. Annals of Surgery 26(1): 96-102

Kramer, S.P. 1901: V. The Artificial Production of Connective Tissue by Means of Injection of Agar-Agar. Annals of Surgery 34(2): 273-275

Freeman, L. 1907: V. The Correction of Certain Forms of "Saddle-Nose.". Annals of Surgery 46(2): 206-209

Hemmeter, J.C. 1900: V. the Diagnosis of Cancer of the Stomach. Annals of Surgery 32(1): 96-122

Oliver, J.C. 1907: V. the End Results following Operations for Carcinoma of the Breast. Annals of Surgery 46(1): 51-56

Caulk, J.R. 1913: V. the Etiology of Kidney Cysts: Illustrated by a Cyst Due to Obstructive Calcareous Papillitis. Annals of Surgery 57(6): 840-859

Hartmann, H. 1914: V. the Function of the Gastro-Enterostomy Opening in Cases of Permeable Pylorus. Annals of Surgery 59(6): 832-840

Stratton, R.T. 1903: V. the Gradual Surgical Occlusion of Large Arteries: its Relative Advantages together with an Experimental Inquiry as to its Feasibility. Annals of Surgery 38(2): 256-264

Mayo, W.J. 1900: V. The Ileocaecal Orifice and its Bearing on Chronic Constipation, with Report of Two Cases relieved by Operation. Annals of Surgery 32(3): 364-368

Scholten, S.; Velten, J.; Neher, T.; Margraf, J.ür. 2017: Wealth, justice and freedom: Objective and subjective measures predicting poor mental health in a study across eight countries. Ssm - Population Health 3: 639-648

Bogniard, R.P.; Whipple, G.H. 1932: V. the Iron Content of Blood Free Tissues and Viscera : Variations Due to Diet, Anemia and Hemoglobin Injections. Journal of Experimental Medicine 55(4): 653-665

Brown, A.J. 1914: V. the Localization of Foreign Bodies Within the Tissues with a Description of a Method of Localization. Annals of Surgery 59(1): 65-70

Robinson, B. 1895: V. the Navel Loop. Annals of Surgery 22(3): 343-352

Fowler, G.R. 1891: V. the Operative Technique of Appendicitis. Annals of Surgery 13(4): 276-283

Cook, A.G. 1903: V. the Orbital Route for Removal of the Second Branch of the Fifth Nerve at the Foramen Rotundum. Annals of Surgery 37(6): 855-858

Fowler, G.R. 1893: V. the Present State of Knowledge as to Carcinoma. Annals of Surgery 17(4): 478-488

Fuller, E. 1905: V. The Question of Priority in the Adoption of the Method of Total Enucleation, Suprapubically, of the Hypertrophied Prostate. Annals of Surgery 41(4): 520-534

Oliver, J.C. 1903: V. The Question of Surgical Intervention in Cases of Injuries to the Spine. Annals of Surgery 37(2): 238-252

Hartwell, J.A. 1905: V. The Radical Treatment of Cancer of the Rectum: With Particular Reference to the Value of Inguinal Colostomy. Annals of Surgery 42(3): 399-444

Fuller, E. 1905: V. The Relation of Gonorrhoeal Rheumatism to Seminal Vesiculitis, and its Cure by Seminal Vesiculotomy: A Report of Four Cases. Annals of Surgery 41(6): 903-913

Schumann, E.A. 1913: V. the Relationship Between Gastric and Pancreatic Carcinoma. Annals of Surgery 58(3): 326-333

Maclaren, A. 1900: V. the Relationship between Cholecystitis, Jaundice and Gall-stones. Annals of Surgery 31(4): 443-449

Marro, A. 1911: V. the Restoration of Fecal Continence After Iliac Colostomy. Annals of Surgery 53(2): 250-267

Park, R. 1891: V. The Results of the Absorption of the Products of Wound Infection. (Fourth Mütter Lecture, Series of 1890-91). Annals of Surgery 13(6): 445-475

Beck, C. 1905: V. the Röntgen Method in Lithiasis of the Urinary Tract. Annals of Surgery 42(6): 864-873

Rogers, J. 1909: V. the Significance of Thyroidism and its Relation to Goitre. Annals of Surgery 50(6): 1025-1051

Keen, W.W. 1898: V. the Sterilization of Catgut by the Jefferson Method. Annals of Surgery 27(1): 49-52

Blake, J.A. 1902: V. the Surgical Aspects of the Status Lymphaticus. Annals of Surgery 35(6): 745-757

Elsberg, C.A. 1903: V. the Surgical Features of Perforation of the Intestine in Typhoid Fever in Children. Annals of Surgery 38(1): 71-96

O'conor, J. 1899: V. the Surgical Treatment of Acute Infective Arthritis and Cellulitis (Acute Articular Rheumatism). Annals of Surgery 29(4): 469-480

Murray, F.W. 1901: V. the Surgical Treatment of Amoebic Dysentery. Annals of Surgery 33(5): 574-581

Fowler, R.S. 1909: V. the Surgical Treatment of Internal Hydrocephalus. Annals of Surgery 49(3): 374-381

Mayo, W.J. 1906: V. the Technique of Gastrojejunostomy. Annals of Surgery 43(4): 537-542

Shepherd, F.J. 1903: V. The Treatment of Aneurism of the External Iliac Artery by Digital Compression. With Report of a Case. Annals of Surgery 38(4): 498-502

Link, G. 1911: V. the Treatment of Chronic Pancreatitis by Pancreatostomy: a new Operation. Annals of Surgery 53(6): 768-782

Gerster, A.G. 1910: V. the Treatment of Diffuse Progressive Free Peritonitis: a Study of Six Hundred and Nine Cases. Annals of Surgery 51(4): 490-515

Hotchkiss, L.W. 1906: V. the Treatment of Diffuse Suppurative Peritonitis, Following Appendicitis. Annals of Surgery 44(2): 197-208

Mason, J.M. 1908: V. The Treatment of Dislocation of the Shoulder-Joint Complicated by Fracture of the Upper Extremity of the Humerus, with an Analysis of Sixty-three Cases with Fracture at the Neck of the Humerus and Twenty-one Cases with Fracture of the Greater Tuberosity reported since 1894. Annals of Surgery 47(5): 672-705

Connell, F.G. 1904: V. The Treatment of Haematemesis by Gastro-Enterostomy: With Report of Case. Annals of Surgery 40(4): 500-509

Taylor, W.J. 1895: V. the Treatment of Tubercular Abscess. Annals of Surgery 22(1): 104-108

Macnamara, C. 1885: V. the use of Hare-Lip Pins for Fixing the Stomach in Gastrostomy. Annals of Surgery 1(4): 341-342

Hubbard, J.C. 1901: V. the Worsted Truss in Inguinal Hernia. Annals of Surgery 34(4): 523-526

Pontifex, M.B.; Kamijo, K.; Scudder, M.R.; Raine, L.B.; Khan, N.A.; Hemrick, B.; Evans, E.M.; Castelli, D.M.; Frank, K.A.; Hillman, C.H. 2014: V. The differential association of adiposity and fitness with cognitive control in preadolescent children. Monographs of the Society for Research in Child Development 79(4): 72-92

Lloyd, S. 1898: V. Total Excision of the Fibula for Sarcoma. Annals of Surgery 27(6): 741-744

Jones, R. 1916: V. Transplantation of Bone, and some Uses of the Bone Graft. British Medical Journal 2(2896): 1-5

Pilcher, P.M. 1914: V. Transvesical Prostatectomy in two Stages. Annals of Surgery 59(4): 500-543

Aldrich, C.J. 1902: V. Traumatic Rupture of the Mesenteric Arteries. Annals of Surgery 35(3): 342-344

Buchanan, J.J. 1900: V. Traumatic Rupture of the Small Intestine; Abdominal Section; Recovery. Annals of Surgery 32(5): 673-675

Eisendrath, D.N. 1902: V. Traumatic Rupture of the Spleen. Annals of Surgery 36(6): 921-926

Fauntleroy, A.M. 1913: V. Traumatic Rupture of the Spleen (Complete); Splenectomy. Annals of Surgery 57(1): 68-71

Balloch, E.A. 1902: V. Traumatic Rupture of the Spleen; Splenectomy; Death on the Sixth day. Annals of Surgery 36(1): 44-46

Andrews, E.W. 1901: V. Tuberculosis Herniosa and Appendicitis Tuberculosa. Annals of Surgery 34(6): 787-795

Winslow, R. 1895: V. two Cases of Gastrostomy for Cicatricial Stenosis of the OEsophagus. Annals of Surgery 21(5): 543-546

Horwitz, O. 1899: V. two Cases of Hypertrophy of the Penis; one due to Traumatism; the other, to Elephantiasis. Annals of Surgery 29(2): 167-174

Riggs, E.P. 1894: V. two Cases of Laminectomy for Fracture of the Vertebrae with Compression of the Cord. Annals of Surgery 19(6): 661-663

Mayo, W.J. 1911: V. Ulcer of the Stomach and Duodenum with Special Reference to the End Results. Annals of Surgery 54(3): 313-320

Freeman, L. 1904: V. Unilateral Haematuria from Chronic Nephritis. Recovery after Decapsulation of Kidney. Annals of Surgery 39(3): 370-374

Kelly, H.A. 1894: V. Uretero-Ureteral Anastomosis-Uretero-Ureterostomy. Annals of Surgery 19(1): 70-77

Manley, T.H. 1893: V. Urethrectomy, Partial or Complete, as a Method for Radical Treatment of Rupture of the Urethra, Fistula, or Organic Stricture. Annals of Surgery 17(2): 181-188

Horwitz, O. 1898: V. Value of Castration to Facilitate Detection of Stone in the Bladder, in the Presence of Prostatic Hypertrophy. Annals of Surgery 27(3): 329-332

Coley, W.B.; Chaffee, I.S. 1909: V. Volvulus of Giant Sigmoid Colon: Recurrent Attacks of Acute Obstruction; Relief by New Method. Annals of Surgery 50(2): 464-469

Wharton, H.R. 1901: V. Wounds of the Venous Sinuses of the Brain An Analysis of Seventy Cases. Annals of Surgery 34(1): 81-110

Anonymous 1938: V.-Carcinoma of Stomach. Proceedings of the Royal Society of Medicine 32(2): 72-73

James, W. 1937: V.-Fibrous Epulis between 2 and 1. Proceedings of the Royal Society of Medicine 30(10): 1249

Anonymous 1943: V.-Immunity to Viruses. Proceedings of the Royal Society of Medicine 36(9): 479-482

Niederer, P.F. 2010: V.1. Ultrasound imaging and Doppler flow velocity measurement. Studies in Health Technology and Informatics 152: 249-273

Niederer, P.F. 2010: V.2. X-ray-based medical imaging: X-ray projection technique, image subtraction method, direct digital X-ray imaging, computed tomography (CT). Studies in Health Technology and Informatics 152: 274-301

Niederer, P.F. 2010: V.3. Basic elements of nuclear magnetic resonance for use in medical diagnostics: Magnetic Resonance Imaging (MRI), magnetic resonance spectroscopy (MRS). Studies in Health Technology and Informatics 152: 302-320

Baharestani, M.; Amjad, I.; Bookout, K.; Fleck, T.; Gabriel, A.; Kaufman, D.; McCord, S.S.; Moores, D.C.; Olutoye, O.O.; Salazar, J.D.; Song, D.H.; Teich, S.; Gupta, S. 2009: V.A.C. Therapy in the management of paediatric wounds: clinical review and experience. International Wound Journal 6(Suppl 1): 1-26

Kilpadi, D.V.; Feeley, T.D.; Kiel, J.W. 2007: V.A.C. Therapy normalizes vascular response of injured tissue in full-thickness wounds in rabbits. Annals of Plastic Surgery 58(5): 555-560

Piff, P.K.; Moskowitz, J.P. 2018: Wealth, poverty, and happiness: Social class is differentially associated with positive emotions. Emotion 18(6): 902-905

García Manzanares, M.Elena.; Hidalgo Dóniga, C.; De Arriba Amado, S.; Sánchez Sánchez, D.; de la Fuente Guerrero, M.Luisa.; Pérez Consuegra, M.Magdalena.; Navarro Raya, A.; Ramón Pérez, M.Pilar.; Barrios Prieto, Mía.Mar. 2009: V.A.C. therapy application on perineum wound after a Miles operation or Miles resection. Revista de Enfermeria 32(12): 30-34

Sibbald, R.Gary.; Woo, K.Y. 2008: V.A.C. therapy in home care. International Wound Journal 5 Suppl. 2: Iii-Iiv

Leyva-Moral, J.M.; Caixal-Mata, C. 2009: Prevalence of bed sores in geriatrics nursing home residences. Revista de Enfermeria 32(1): 52-56

Mora, F.; Cassano, M.; Mora, R.; Gallina, A.M.; Ciprandi, G. 2009: V.A.S. in the follow-up of turbinectomy. Rhinology 47(4): 450-453

Shortal, H. 1947: V.D. BRIEFS: The Nurse as a Case Finder in Venereal Disease. Canadian Medical Association Journal 56(1): 85-86

Latraverse, V.; Ricard, P.M. 1944: Duodenoscopic Removal of a Bobbie-Pin Through a Gastrotomy in a Child 13 Months Old. Canadian Medical Association Journal 51(6): 560-562

Kaliman, P.A. 2007: V.N. Karazin Kharkov National University as the foundation of biochemistry in Ukraine. Ukrains'kyi Biokhimichnyi Zhurnal 79(1): 137-147

Nechaĭ, A.I.; Shamov, V.N. 2011: V.N. Shamov--famous military-field surgeon. Voenno-Meditsinskii Zhurnal 332(2): 84-86

Ritti-Dias, R.M.; Li, J.; Hollabaugh, K.M.; Stoner, J.A.; Montgomery, P.S.; Gardner, A.W. 2013: V.O2 Kinetics and clinical factors among patients with peripheral artery disease. Journal of Cardiopulmonary Rehabilitation and Prevention 33(6): 411-418

Uzbekova, D.G.; Kravkov, V.P. 2014: V.P. Kravkov as a sanitary physician of the Russian Imperial Army (to centenary of beginning of the First World War). Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 2014(4): 51-54

Chroustova, D.; Kubinyi, J.; Jansa, P.; Veprekova, L.; Trnka, J. 2011: V/P scan in diagnosis and follow-up of pulmonary embolism in 15-25-year-old females in relation to hormonal contraception use. Nuclear Medicine Review. Central and Eastern Europe 14(2): 63-67

Leblanc, M.; Paul, N. 2010: V/Q SPECT and computed tomographic pulmonary angiography. Seminars in Nuclear Medicine 40(6): 426-441

Laurence, I.J.; Redman, S.L.; Corrigan, A.J.G.; Graham, R.N.J. 2012: V/Q SPECT imaging of acute pulmonary embolus - a practical perspective. Clinical Radiology 67(10): 941-948

Roach, P. 2013: V/Q SPECT: the primary imaging test for suspected pulmonary embolism. Bmj 347: F5119

King, G.G.; Harris, B.; Mahadev, S. 2010: V/Q SPECT: utility for investigation of pulmonary physiology. Seminars in Nuclear Medicine 40(6): 467-473

Bailey, E.A.; Bailey, D.L.; Roach, P.J. 2010: V/Q imaging in 2010: a quick start guide. Seminars in Nuclear Medicine 40(6): 408-414

Roach, P.J.; Schembri, G.P.; Bailey, D.L. 2013: V/Q scanning using SPECT and SPECT/CT. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 54(9): 1588-1596

Ahmad, N.; Srinivasan, K.; Moudgil, H. 2011: V/Q scanning: a useful alternative to pulmonary CT angiography-- let's not forget it. Ajr. American Journal of Roentgenology 196(1): W107; Author Reply W108

Azdaki, N.; Maleki, M.H.; Kazemi, T.; Moezi, S.A.; Moghaddam, H.R.M. 2014: V/Q scans and computerized tomography pulmonary angiography in pulmonary emboli in pregnancy: Superiority for fetal or mother. Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences 19(7): 683-684

Freeman, L.M.; Haramati, L.B. 2009: V/Q scintigraphy: alive, well and equal to the challenge of CT angiography. European Journal of Nuclear Medicine and Molecular Imaging 36(3): 499-504

Kilding, A.E.; Jones, A.M. 2008: V02 'overshoot' during moderate-intensity exercise in endurance-trained athletes: the influence of exercise modality. Respiratory Physiology and Neurobiology 160(2): 139-146

Zhang, J.; Lanuza, G.M.; Britz, O.; Wang, Z.; Siembab, V.C.; Zhang, Y.; Velasquez, T.; Alvarez, F.J.; Frank, E.; Goulding, M. 2014: V1 and v2b interneurons secure the alternating flexor-extensor motor activity mice require for limbed locomotion. Neuron 82(1): 138-150

Sincich, L.C.; Jocson, C.M.; Horton, J.C. 2010: V1 interpatch projections to v2 thick stripes and pale stripes. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 30(20): 6963-6974

Ales, J.M.; Yates, J.L.; Norcia, A.M. 2010: V1 is not uniquely identified by polarity reversals of responses to upper and lower visual field stimuli. Neuroimage 52(4): 1401-1409

Teich, A.F.; Qian, N. 2010: V1 orientation plasticity is explained by broadly tuned feedforward inputs and intracortical sharpening. Visual Neuroscience 27(1-2): 57-73

Masuda, Y.; Dumoulin, S.O.; Nakadomari, S.; Wandell, B.A. 2008: V1 projection zone signals in human macular degeneration depend on task, not stimulus. Cerebral Cortex 18(11): 2483-2493

Qin, J.; Liu, K.; Wang, P.S.; Liu, C. 2009: V1 receptor in ENS mediates the excitatory effect of vasopressin on circular muscle strips of gastric body in vitro in rats. Regulatory Peptides 157(1-3): 32-36

Huang, X.; Paradiso, M.A. 2008: V1 response timing and surface filling-in. Journal of Neurophysiology 100(1): 539-547

Mirijello, A.; Pola, R.; Saviano, L.; Landolfi, R. 2013: V1-V2-V3-V4 T wave inversion: left or right ventricle?. BMJ Case Reports

Zhou, C.; Zhou, Y.; Wang, J.; Feng, Y.; Wang, H.; Xue, J.; Chen, Y.; Ye, R.D.; Wang, M.-W. 2013: V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins. Biochemical Journal 451(2): 245-255

Keene, T.D.; D'Alessandro, D.M.; Krämer, K.W.; Price, J.R.; Price, D.J.; Decurtins, S.; Kepert, C.J. 2012: V16O38(CN)]9–: a soluble mixed-valence redox-active building block with strong antiferromagnetic coupling. Inorganic Chemistry 51(17): 9192-9199

Wutkowski, A.; Näther, C.; Kögerler, P.; Bensch, W. 2008: V16Sb4O42(H2O){VO(C6H14N2)2}4]: a terminal expansion to a polyoxovanadate archetype. Inorganic Chemistry 47(6): 1916-1918

Mohedano-Moriano, A.; Pro-Sistiaga, P.; Ubeda-Bañon, I.; de la Rosa-Prieto, C.; Saiz-Sanchez, D.; Martinez-Marcos, A. 2008: V1R and V2R segregated vomeronasal pathways to the hypothalamus. Neuroreport 19(16): 1623-1626

Stewart, R.; Lane, R.P. 2007: V1R promoters are well conserved and exhibit common putative regulatory motifs. Bmc Genomics 8: 253

Van Haren, F.M.P.; Mitchell, I. 2012: V1a receptor agonists: the search for clean and green alternatives to vasopressin. Critical Care Medicine 40(6): 1999-2000

Wang, B.; Li, F.; Huang, C.; Yang, X.; Qian, Y.; Xie, Y.; Zhou, X. 2014: V2 of tomato yellow leaf curl virus can suppress methylation-mediated transcriptional gene silencing in plants. Journal of General Virology 95(Part 1): 225-230

Costello-Boerrigter, L.C.; Boerrigter, G.; Burnett, J.C. 2007: V2 receptor antagonism with tolvaptan in heart failure. Expert Opinion on Investigational Drugs 16(10): 1639-1647

Yi, J.-H.; Shin, H.-J.; Kim, H.-J. 2011: V2 receptor antagonist; tolvaptan. Electrolyte and Blood Pressure: e and Bp 9(2): 50-54

Takahashi, K.; Makita, N.; Manaka, K.; Hisano, M.; Akioka, Y.; Miura, K.; Takubo, N.; Iida, A.; Ueda, N.; Hashimoto, M.; Fujita, T.; Igarashi, T.; Sekine, T.; Iiri, T. 2012: V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists. Journal of Biological Chemistry 287(3): 2099-2106

Schliebe, N.; Strotmann, R.; Busse, K.; Mitschke, D.; Biebermann, H.; Schomburg, L.; Köhrle, J.; Bär, J.ör.; Römpler, H.; Wess, J.ür.; Schöneberg, T.; Sangkuhl, K. 2008: V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis. American Journal of Physiology. Renal Physiology 295(4): F1177-F1190

Decaux, G. 2007: V2-antagonists for the treatment of hyponatraemia. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 22(7): 1853-1855

Etzkorn, J.; Ade, M.; Hillebrecht, H. 2007: V2AlC, V4AlC3-x (x approximately 0.31), and V12Al3C8: synthesis, crystal growth, structure, and superstructure. Inorganic Chemistry 46(18): 7646-7653

Window, A.J.; Hentz, A.; Sheppard, D.C.; Parkinson, G.S.; Niehus, H.; Ahlbehrendt, D.; Noakes, T.C.Q.; Bailey, P.; Woodruff, D.P. 2011: V2O3(0001) surface termination: phase equilibrium. Physical Review Letters 107(1): 016105

Yan, J.; Sumboja, A.; Khoo, E.; Lee, P.S. 2011: V2O5 loaded on SnO2 nanowires for high-rate li ion batteries. Advanced Materials 23(6): 746-750

Menezes, W.G.; Reis, D.M.; Benedetti, Tânia.M.; Oliveira, M.M.; Soares, Jísa.F.; Torresi, R.M.; Zarbin, A.J.G. 2009: V2O5 nanoparticles obtained from a synthetic bariandite-like vanadium oxide: synthesis, characterization and electrochemical behavior in an ionic liquid. Journal of Colloid and Interface Science 337(2): 586-593

Sathiya, M.; Prakash, A.S.; Ramesha, K.; Tarascon, J.M.; Shukla, A.K. 2011: V2O5-anchored carbon nanotubes for enhanced electrochemical energy storage. Journal of the American Chemical Society 133(40): 16291-16299

Liu, Z.-W.; Wang, C.; Fan, W.-B.; Liu, Z.-T.; Hao, Q.-Q.; Long, X.; Lu, J.; Wang, J.-G.; Qin, Z.-F.; Su, D.S. 2011: V2O5/Ce0.6Zr0.4O2-Al2O3 as an efficient catalyst for the oxidative dehydrogenation of ethylbenzene with carbon dioxide. Chemsuschem 4(3): 341-345

Ohde, C.; Brandt, M.; Limberg, C.; Döbler, J.; Ziemer, B.; Sauer, J. 2008: V2O5/SiO2 surface inspired, silsesquioxane-derived oxovanadium complexes and their properties. Dalton Transactions 3: 326-331

Jin, W.; Chen, W.; Lu, Y.; Zhao, C.; Dai, Y. 2011: V2O5/polypyrrole core-shell nanotubes for gas sensor. Journal of Nanoscience and Nanotechnology 11(12): 10834-10838

Bichet, D.G. 2009: V2R mutations and nephrogenic diabetes insipidus. Progress in Molecular Biology and Translational Science 89: 15-29

Kimura, Y.; Satou, C.; Higashijima, S-Ichi. 2008: V2a and V2b neurons are generated by the final divisions of pair-producing progenitors in the zebrafish spinal cord. Development 135(18): 3001-3005

Berro, R.; Klasse, P.J.; Jakobsen, M.R.; Gorry, P.R.; Moore, J.P.; Sanders, R.W. 2012: V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc. Virology 427(2): 158-165

Bozek, K.; Thielen, A.; Sierra, S.; Kaiser, R.; Lengauer, T. 2009: V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV. Plos one 4(10): E7387

Montagna, C.; De Crignis, E.; Bon, I.; Re, M.C.; Mezzaroma, I.; Turriziani, O.; Graziosi, C.; Antonelli, G. 2014: V3 net charge: additional tool in HIV-1 tropism prediction. Aids Research and Human Retroviruses 30(12): 1203-1212

Monno, L.; Brindicci, G.; Saracino, A.; Punzi, G.; Cibelli, D.; Lagioia, A.; Angarano, G. 2010: V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients. Aids Research and Human Retroviruses 26(3): 365-372

Posch, A.; Kohn, J.; Oh, K.; Hammond, M.; Liu, N. 2013: V3 stain-free workflow for a practical, convenient, and reliable total protein loading control in western blotting. Journal of Visualized Experiments: Jove 82: 50948

Hernández, D.; Miquel-Serra, L.; Docampo, M.ía.-J.é; Marco-Ramell, A.; Cabrera, J.; Fabra, A.; Bassols, A. 2011: V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling. Journal of Biological Chemistry 286(2): 1475-1485

Huang, H.-T.; He, J.-L.; Zhang, B.-T.; Yang, J.-F.; Xu, J.-L.; Zuo, C.-H.; Tao, X.-T. 2010: V3+:YAG as the saturable absorber for a diode-pumped quasi-three-level dual-wavelength Nd:GGG laser. Optics Express 18(4): 3352-3357

Maeda, Y.; Terasawa, H.; Nakano, Y.; Monde, K.; Yusa, K.; Oka, S.; Takiguchi, M.; Harada, S. 2014: V3-independent competitive resistance of a dual-X4 HIV-1 to the CXCR4 inhibitor AMD3100. Plos one 9(2): E89515

Akgun, Z.; Atasoy, B.M.; Ozen, Z.; Yavuz, D.; Gulluoglu, B.; Sengoz, M.; Abacioglu, U. 2014: V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck. Radiation Oncology 9: 104

Sligte, I.G.; Scholte, H.Steven.; Lamme, V.A.F. 2009: V4 activity predicts the strength of visual short-term memory representations. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 29(23): 7432-7438

Herwig, C.; Limberg, C. 2008: V4O10: spectroscopic fingerprint of a well-defined, molecular metaloxo aggregate. Inorganic Chemistry 47(8): 2937-2939

Chen, D.; Hickner, M.A. 2013: V5+ degradation of sulfonated Radel membranes for vanadium redox flow batteries. Physical Chemistry Chemical Physics: Pccp 15(27): 11299-11305

Toshima, T.; Taketomi, A.; Ikegami, T.; Fukuhara, T.; Kayashima, H.; Yoshizumi, T.; Soejima, Y.; Shirabe, K.; Maehara, Y. 2012: V5-drainage-preserved right lobe grafts improve graft congestion for living donor liver transplantation. Transplantation 93(9): 929-935

McDonnell, K.; Betz, B.; Fullen, D.; Lao, C.D. 2011: V559A and N822i double KIT mutant melanoma with predictable response to imatinib?. Pigment Cell and Melanoma Research 24(2): 390-392

Bannykh, S.I.; Mirocha, J.; Nuno, M.; Lopategui, J.; Kandala, G. 2014: V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior. Clinical Neuropathology 33(6): 388-398

Agaimy, A.; Terracciano, L.M.; Dirnhofer, S.; Tornillo, L.; Foerster, A.; Hartmann, A.; Bihl, M.P. 2009: V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours. Journal of Clinical Pathology 62(7): 613-616

Carragher, L.A.S.; Snell, K.R.; Giblett, S.M.; Aldridge, V.S.S.; Patel, B.; Cook, S.J.; Winton, D.J.; Marais, R.; Pritchard, C.A. 2010: V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. Embo Molecular Medicine 2(11): 458-471

Peys, N.; Ling, Y.; Dewulf, D.; Gielis, S.; De Dobbelaere, C.; Cuypers, D.; Adriaensens, P.; Van Doorslaer, S.; De Gendt, S.; Hardy, A.; Van Bael, M.K. 2013: V6O13 films by control of the oxidation state from aqueous precursor to crystalline phase. Dalton Transactions 42(4): 959-968

Matsushima, S.; Ohtsuka, K.; Ohnishi, H.; Fujiwara, M.; Nakamura, H.; Morii, T.; Kishino, T.; Goto, H.; Watanabe, T. 2014: V843I, a lung cancer predisposing EGFR mutation, is responsible for resistance to EGFR tyrosine kinase inhibitors. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 9(9): 1377-1384

Yang, H.; Zhang, H.; Xing, X. 2015: V876E mutation in CACNA1S gene associated with severe hypokalemic periodic paralysis in a Chinese woman. Journal of the Formosan Medical Association 114(4): 377-378

Boger-Megiddo, I.; Weiss, N.S.; Barnett, M.J.; Goodman, G.E.; Chen, C. 2008: V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 17(2): 286-291

Tong, M.; Jin, Y.-Y.; Li, G.; Liu, S.-M.; Ji, C.-D. 2010: V89L polymorphism of the testosterone 5-alpha-reductase Ii gene and prognostic factors of prostate cancer. Zhonghua Nan Ke Xue 16(11): 990-993

Reid, L. 2011: V: valentine, violence, vagina.. Practising Midwife 14(2): 46

Aragon, B.R.; Pierce, R.A.; Jones, W.N. 2012: VA CMOPs: producing a pattern of quality and efficiency in government. Journal of the American Pharmacists Association: Japha 52(6): 810-815

Anonymous 2013: VA Dental Insurance Program--federalism. Direct final rule. Federal Register 78(204): 62441-62443

Anonymous 2014: VA Dental Insurance Program--federalism. Direct final rule; confirmation of effective date. Federal Register 79(54): 15541-15542

Anonymous 2013: VA Dental Insurance Program. Final rule. Federal Register 78(103): 32126-32131

Anonymous 2013: VA Health Professional Scholarship and Visual Impairment and Orientation and Mobility Professional Scholarship Programs. Final rule. Federal Register 78(161): 51067-51073

Anonymous 2013: VA Homeless Providers Grant and Per Diem Program. Final rule. Federal Register 78(37): 12600-12617

Holden, C. 1977: VA Hospital System Under Scrutiny. Science 198(4312): 36-37

Spratt, J.S. 1965: VA Hospitals. Science 148(3676): 1411

Segarra, J.M. 1965: VA Hospitals: Length of Stay. Science 149(3685): 708

Stelmack, J.A.; Tang, X.C.; Reda, D.J.; Stroupe, K.T.; Rinne, S.; Massof, R.W.; Stelmack, J.; Hines, E.; Massof, R.W.; Ellis, N.; Zablocki, C.J.; Rinne, S.; Hines, E.; Korwin, T.; Hines, E.; Reda, D.J.; Tang, X.Charlene.; Stroupe, K.T.; Lippe, D.; Wei, Y.; Tir, K.; Rachelle, M.; Ballinger, R.; Whitman, O.; Hurvitz, C.; Davis, S.; Morand, T.; Rogge, M.Colleen.; Swedelius, B.; Morand, T.; Thompson, C.; Joos, B.; Stelmack, J.; Rinne, S.; Korwin, T.; Houston, J.; Brahm, K.; LaCrosse, D.; Wurf, A.; Rose, K.; Ellis, N.; Seefeldt, C.; Wilcox, D.Thomas.;, 2012: VA LOVIT II: a protocol to compare low vision rehabilitation and basic low vision. Ophthalmic and Physiological Optics: the Journal of the British College of Ophthalmic Opticians 32(6): 461-471

Boone, J.T. 1953: VA Medical Care. California Medicine 78(6): 524-525

Nazi, K.M.; Turvey, C.L.; Klein, D.M.; Hogan, T.P.; Woods, S.S. 2015: VA OpenNotes: exploring the experiences of early patient adopters with access to clinical notes. Journal of the American Medical Informatics Association: Jamia 22(2): 380-389

Beck, L. 2013: VA Prosthetic and Sensory Aids Service—65 years of progress. Journal of rehabilitation research and development 50(1): xvii-xviii

Smucker Barnwell, S.V.; Juretic, M.A.; Hoerster, K.D.; Van de Plasch, R.; Felker, B.L. 2012: VA Puget Sound Telemental Health Service to rural veterans: a growing program. Psychological Services 9(2): 209-211

Holden, C. 1985: VA Re-reconsiders Twin Study. Science 227(4682): 37

Cook, J.M.; Dinnen, S.; Simiola, V.; Thompson, R.; Schnurr, P.P. 2014: VA Residential Provider Perceptions of Dissuading Factors to the Use of Two Evidence-Based PTSD Treatments. Professional Psychology Research and Practice 45(2): 136-142

Shaposhnikov, A.V. 2007: Precancerous gastric diseases. Klinicheskaia Meditsina 85(2): 4-9

Conn, J. 2010: VA bares all: Department to release internal quality dashboard, new website to public. Modern Healthcare 40(47): 14

Jameson, J.P.; Farmer, M.S.; Head, K.J.; Fortney, J.; Teal, C.R. 2011: VA community mental health service providers' utilization of and attitudes toward telemental health care: the gatekeeper's perspective. Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association 27(4): 425-432

Roberts, C. 2009: VA coordinator in the spotlight. Nephrology News and Issues 23(9): 26

Tully, P.J. 2013: Quality-of-Life measures for cardiac surgery practice and research: a review and primer. Journal of Extra-Corporeal Technology 45(1): 8-15

Rosen, G.M.; Spitzer, R.L. 2008: VA disability policies and posttraumatic morbidity. American Journal of Public Health 98(5): 775; Author Reply 775-6

Bidassie, B.; Davies, M.L.; Stark, R.; Boushon, B. 2014: VA experience in implementing Patient-Centered Medical Home using a breakthrough series collaborative. Journal of General Internal Medicine 29(Suppl 2): S563-S571

Lee, J. 2012: VA gets local for mental health. Modern Healthcare 42(37): 12

Leslie, D.L.; Goulet, J.; Skanderson, M.; Mattocks, K.; Haskell, S.; Brandt, C. 2011: VA health care utilization and costs among male and female veterans in the year after service in Afghanistan and Iraq. Military Medicine 176(3): 265-269

Gabrielian, S.; Yuan, A.H.; Andersen, R.M.; Rubenstein, L.V.; Gelberg, L. 2014: VA health service utilization for homeless and low-income Veterans: a spotlight on the VA Supportive Housing (VASH) program in greater Los Angeles. Medical Care 52(5): 454-461

Dickinson, K.C.; Sharma, R.; Duckart, J.P.; Corson, K.; Gerrity, M.S.; Dobscha, S.K. 2010: VA healthcare costs of a collaborative intervention for chronic pain in primary care. Medical Care 48(1): 38-44

Amdur, D.; Batres, A.; Belisle, J.; Brown, J.H.; Cornis-Pop, M.; Mathewson-Chapman, M.; Harms, G.; Hunt, S.C.; Kennedy, P.; Mahoney-Gleason, H.; Perez, J.; Sheets, C.; Washam, T. 2011: VA integrated post-combat care: a systemic approach to caring for returning combat veterans. Social Work in Health Care 50(7): 564-575

Mohamed, S.; Neale, M.; Rosenheck, R.A. 2009: VA intensive mental health case management in urban and rural areas: veteran characteristics and service delivery. Psychiatric Services 60(7): 914-921

Katon, J.; Reiber, G.; Rose, D.; Bean-Mayberry, B.; Zephyrin, L.; Washington, D.L.; Yano, E.M. 2013: VA location and structural factors associated with on-site availability of reproductive health services. Journal of General Internal Medicine 28(Suppl 2): S591-S597

Seal, K.H.; Maguen, S.; Cohen, B.; Gima, K.S.; Metzler, T.J.; Ren, L.; Bertenthal, D.; Marmar, C.R. 2010: VA mental health services utilization in Iraq and Afghanistan veterans in the first year of receiving new mental health diagnoses. Journal of Traumatic Stress 23(1): 5-16

Clifford, J.; Claflin, N. 2013: VA nurses: honoring and caring for America's heroes. American Nurse 45(6): 13

Lemke, S.; Schaefer, J.A. 2010: VA nursing home residents with substance use disorders: Mental health comorbidities, functioning, and problem behaviors. Aging and Mental Health 14(5): 593-602

Halford, S.; Pires, S.S.; Turton, M.; Zheng, L.; González-Menéndez, I.; Davies, W.L.; Peirson, S.N.; García-Fernández, J.é M.; Hankins, M.W.; Foster, R.G. 2009: VA opsin-based photoreceptors in the hypothalamus of birds. Current Biology: Cb 19(16): 1396-1402

Reiber, G.E.; Smith, D.G. 2010: VA paradigm shift in care of veterans with limb loss. Journal of Rehabilitation Research and Development 47(4): Vii-Vix

Traynor, K. 2014: VA pharmacy aims high for clinical practice. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(11): 888-889; 893

Traynor, K. 2007: VA pharmacy goes mobile. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(21): 2216-2218

Aspinall, S.L.; Banthin, J.S.; Good, C.B.; Miller, G.E.; Cunningham, F.E. 2009: VA pharmacy users: how they differ from other veterans. American Journal of Managed Care 15(10): 701-708

Johnson-Lawrence, V.; Zivin, K.; Szymanski, B.R.; Pfeiffer, P.N.; McCarthy, J.F. 2012: VA primary care-mental health integration: patient characteristics and receipt of mental health services, 2008-2010. Psychiatric Services 63(11): 1137-1141

Traylor, L. 2008: VA project helps families provide care. American Journal of Nursing 108(9 Suppl): 19

Lipson, L.; Eisen, S. 2011: VA research: committed to women who have "borne the battle" and beyond. Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 21(4 Suppl): S67-S69

Anonymous 2010: VA strengthens critical patient-safety procedure. Two systems replace traditional paper-based informed-consent process with an electronic time-out checklist integrated into electronic records. Health Management Technology 31(4): 28-29

Anonymous 2010: VA study shows fewer patient deaths after OR team training. Or Manager 26(12): 1 9-1,11

Godleski, L.; Nieves, J.E.; Darkins, A.; Lehmann, L. 2008: VA telemental health: suicide assessment. Behavioral Sciences and the Law 26(3): 271-286

Conn, J. 2011: VA to update VistA EHR. Modern Healthcare 41(22): 17

Thompson, C.A. 2010: VA's Clinical Research Pharmacy wins quality award. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 67(3): 174-176

Austin, E.L.; Pollio, D.E.; Holmes, S.; Schumacher, J.; White, B.; Lukas, C.V.; Kertesz, S. 2014: VA's expansion of supportive housing: successes and challenges on the path toward Housing first. Psychiatric Services 65(5): 641-647

Bossert, W.H.; Dobalian, A. 2011: VA's involvement in the aftermath of the 9/11 attacks. Disaster Medicine and Public Health Preparedness 5(Suppl 2): S167

Kuehn, B.M. 2008: VA, military seek office-based PTSD care. JAMA 299(16): 1885-1886

Occhetta, P.; Visone, R.; Russo, L.; Cipolla, L.; Moretti, M.; Rasponi, M. 2015: VA-086 methacrylate gelatine photopolymerizable hydrogels: a parametric study for highly biocompatible 3D cell embedding. Journal of Biomedical Materials Research. Part a 103(6): 2109-2117

Haggstrom, D.A.; Rosenman, M.; Myers, L.J.; Teal, E.; Doebbeling, B.N. 2010: VA-INPC: Linking Department of Veterans Affairs (VA) and Indiana Network for Patient Care (INPC) data to assess surveillance testing among veterans with colorectal cancer. AMIA .. Annual Symposium Proceedings. AMIA Symposium 2010: 266-270

Van Olden, G.D.J. 2014: VA-LCP anterior clavicle plate: the anatomically precontoured fixation system with angular stability for clavicle shaft. Musculoskeletal Surgery 98(3): 217-223

Ayers, C.; Arch, J. 2013: VA-academic partnerships: challenges and rewards for new VA mental health investigators. Community Mental Health Journal 49(6): 709-713

Morse, L.R.; Giangregorio, L.; Battaglino, R.A.; Holland, R.; Craven, B.C.; Stolzmann, K.L.; Lazzari, A.A.; Sabharwal, S.; Garshick, E. 2009: VA-based survey of osteoporosis management in spinal cord injury. Pm and R: the Journal of Injury Function and Rehabilitation 1(3): 240-244

Bates, B.; Glasberg, J.; Hughes, K.; Katz, R.; Priefer, B.; Richards, L.; Ruff, R.; Sullivan, P.; Zartman, A.L.; Cassidy, C.; Lux, L.; Viswanathan, M.; Lohr, K.; Bowles, A.; Crumpton, S.; Lambert, K.; Alexander, D.N.; Duncan, P.W.; Lutz, B.; Degenhardt, E.; Klar, A.V.; D'Erasmo, M.; Fishman, R. 2010: VA/DOD Clinical practice guideline for the management of stroke rehabilitation. Journal of Rehabilitation Research and Development 47(9): 1-43

Cifu, D.; Hurley, R.; Peterson, M.; Cornis-Pop, M.; Rikli, P.A.; Ruff, R.L.; Scott, S.G.; Sigford, B.J.; Silva, K.A.; Tortorice, K.; Vanderploeg, R.D.; Withlock, W.; Bowles, A.; Cooper, D.; Drake, A.; Engel, C.; Simmers Geckle, L.; Helmick, K.; Hoge, C.; Jaffee, M.; Labutta, R.; Ling, G.; Lowe, L.; Mims, S.; Orman, D.T.; Solomon, B.E.; Stone, J.M.; Thomas, K.; Tolbert, M.; Williams, C.S.; Francis, J.; Cassidy, C.; Klar, A.; Degenhardt, E.; Susskind, O.; Cohen, J.; Kasten, J.J.; Radcliff, S.; Schlenger, W.E.; D'Erasmo, M.; Fishman, R.; Marko, J. 2009: VA/DoD Clinical Practice Guideline for Management of Concussion/Mild Traumatic Brain Injury. Journal of Rehabilitation Research and Development 46(6): Cp1

Wałęga, P.; Romaniszyn, M.ł; Nowak, W. 2014: VAAFT: a new minimally invasive method in the diagnostics and treatment of anal fistulas--initial results. Polski Przeglad Chirurgiczny 86(1): 7-10

Hu, H.; Huff, C.D.; Moore, B.; Flygare, S.; Reese, M.G.; Yandell, M. 2013: VAAST 2.0: improved variant classification and disease-gene identification using a conservation-controlled amino acid substitution matrix. Genetic Epidemiology 37(6): 622-634

Gomi, N.; Iwase, T.; Akiyama, F. 2012: VAB (vacuum-assisted breast biopsy system). Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 302-305

Kim, H.-S.; Murakami, R.; Quintin, S.; Mori, M.; Ohkura, K.; Tamai, K.K.; Labouesse, M.; Sakamoto, H.; Nishiwaki, K. 2011: VAB-10 spectraplakin acts in cell and nuclear migration in Caenorhabditis elegans. Development 138(18): 4013-4023

Camps, I.; Arméstar, F.; Cuadrado, M.; Mesalles, E. 2009: VAC (vacuum-assisted closure) "covered" laparostomy to control abdominal compartmental syndrome in a case of emphysematous pancreatitis. Cirugia Espanola 86(4): 250-251

Wild, T.; Goetzinger, P.; Telekey, B. 2007: VAC and fistula formation. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 9(6): 572-573

Singh, S.; Mackey, S.; Soldin, M. 2008: VAC it - Some techniques on the application of VAC dressings. Annals of the Royal College of Surgeons of England 90(2): 161-162

Alvarez, F.J.; Hosoya, K.; Lara-Garcia, A.; Kisseberth, W.; Couto, G. 2013: VAC protocol for treatment of dogs with stage III hemangiosarcoma. Journal of the American Animal Hospital Association 49(6): 370-377

De Caridi, G.; Serra, R.; Massara, M.; Barone, M.; Grande, R.; Butrico, L.; Mastroroberto, P.; de Franciscis, S.; Monaco, F. 2016: VAC therapy for the treatment of complex wounds after cardio-thoracic surgery. International Wound Journal 13(5): 759-762

De Caridi, G.; Massara, M.; Greco, M.; Pipitò, N.; Spinelli, F.; Grande, R.; Butrico, L.; de Franciscis, S.; Serra, R. 2016: VAC therapy to promote wound healing after surgical revascularisation for critical lower limb ischaemia. International Wound Journal 13(3): 336-342

Henderson, A.M.; James, J.W.; White, G.A.; Briggs, W.E.; Gundrum, F.F.; Simmons, S.E. 1915: Progress or Retrogression?. California State Journal of Medicine 13(10): 377-378

Pinzón-Rondón, Ángela.María.; Cifuentes, L.B.; Zuluaga, C.; Botero, J.Carlos.; Pinzon-Caicedo, M. 2018: Wealth, Social Protection Programs, and Child Labor in Colombia: A Cross-sectional Study. International Journal of Health Services: Planning Administration Evaluation 48(3): 535-548

Poland, G.A.; Leary, M.Lowell. 2010: VACCINE in the 21st century: what's next?. Vaccine 28(6): 1437

Johnson, A.E.; Le, I.P.; Andresen, B.T.; Stodola, J.; Dewey, G.L.; Dean, S.B.; Resau, J.; Haak, P.; Ruch, T.; Sartor, A.; Lazdins, I.; Barney, C.C.; Burnatowska-Hledin, M.A. 2012: VACM-1/cul5 expression in vascular tissue in vivo is induced by water deprivation and its expression in vitro regulates aquaporin-1 concentrations. Cell and Tissue Research 349(2): 527-539

Alvarez-Pasquín, M.J.; Heijbel, H.; Yarwood, J.; Van Damme, P.; Aksakal, F.N.; Andrén, S.; Aronsson, B.; Bechini, A.; Bejersten, M.; Blennow, M.; Bergsaker, M.; Boccalini, S.; Bonanni, P.; Czumbel, I.; Fu, C.; Gerhardsen, T.I.; Grgic-Vitek, M.; Habersaat, K.; Haugen, I.L.; Kerbo, N.; Kraigher, A.; Lundin, H.; Mayer, M.A.; Muchl, R.; Netterlid, E.; Navarro, J.A.; Nökleby, H.; Pistol, A.; Muniz, H.Pors.; Robinson, M.; Stanescu, A.; Stefanoff, P.; Tuells, J.; Vladimirova, N.; Vorsters, A. 2009: VACSATC (vaccine safety: attitudes, training and communication): why such a project?. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 14(16)

Bhurtel, D.Raj.; Losa, I. 2010: VACTERL (vertebral anomalies, anal atresia or imperforate anus, cardiac anomalies, tracheoesophageal fistula, renal and limb defect) spectrum presenting with portal hypertension: a case report. Journal of Medical Case Reports 4: 128

Carli, D.; Garagnani, L.; Lando, M.; Fairplay, T.; Bernasconi, S.; Landi, A.; Percesepe, A. 2014: VACTERL (vertebral defects, anal atresia, tracheoesophageal fistula with esophageal atresia, cardiac defects, renal and limb anomalies) association: disease spectrum in 25 patients ascertained for their upper limb involvement. Journal of pediatrics 164(3): 458-62.e1-2

Pandey, D.B.; Pednekar, S.J.; Chavan, S.A.; Korivi, D.; Shah, A.Kumar.; Kulkarni, U.P. 2011: VACTERL Association. Journal of the Association of Physicians of India 59: 447-449

Chen, R.Hung.; Hung, H-Yang.; Wang, N-Lu.; Shih, S-Lin.; Hwang, H-Kwei.; Chang, T-Yao.; Chen, P.H.; Chang, J-Hsing. 2016: VACTERL Association Complicated with Right-sided Congenital Diaphragmatic Hernia. Pediatrics and Neonatology 57(4): 347-350

Brosens, E.; Eussen, H.; van Bever, Y.; van der Helm, R.M.; Ijsselstijn, H.; Zaveri, H.P.; Wijnen, R.; Scott, D.A.; Tibboel, D.; de Klein, A. 2013: VACTERL Association Etiology: The Impact of de novo and Rare Copy Number Variations. Molecular Syndromology 4(1-2): 20-26

Keckler, S.J.; St Peter, S.D.; Valusek, P.A.; Tsao, K.; Snyder, C.L.; Holcomb, G.W.; Ostlie, D.J. 2007: VACTERL anomalies in patients with esophageal atresia: an updated delineation of the spectrum and review of the literature. Pediatric Surgery International 23(4): 309-313

Solomon, B.D.; Patel, A.; Cheung, S.Wai.; Pineda-Alvarez, D.E. 2011: VACTERL association and mitochondrial dysfunction. Birth Defects Research. Part A Clinical and Molecular Teratology 91(3): 192-194

Sandal, G.; Aslan, N.; Duman, L.; Ormeci, A.R. 2014: VACTERL association with a rare vertebral anomaly (butterfly vertebra) in a case of monochorionic twin. Genetic Counseling 25(2): 231-235

Al-Farqani, A.; Panduranga, P.; Al-Maskari, S.; Thomas, E. 2013: VACTERL association with double-chambered left ventricle: A rare occurrence. Annals of Pediatric Cardiology 6(2): 200-201

Chen, C-Ping.; Chang, T-Yao.; Chen, Y-Yung.; Chern, S-Rern.; Su, J-Wei.; Wang, W. 2013: VACTERL association with hydrocephalus in a fetus conceived by in vitro fertilization and embryo transfer. Taiwanese Journal of Obstetrics and Gynecology 52(4): 575-579

Sezer, R.Gonul.; Aydemir, Gökhan.; Bozaykut, A.; Paketci, C.; Aydinoz, S. 2012: VACTERL association: a new case with biotinidase deficiency and annular pancreas. Renal Failure 34(1): 123-125

Contreras-Omaña, R.; Aguilar-Lira, J.L. 2014: VACTERL syndrome. Revista de Gastroenterologia de Mexico 79(2): 147-148

Alter, B.P.; Rosenberg, P.S. 2013: VACTERL-H Association and Fanconi Anemia. Molecular Syndromology 4(1-2): 87-93

Salinas-Torres, V.M.; Ramos-Márquez, M.E.; Angulo-Castellanos, E. 2013: VACTERL-H association with tibial agenesis. Expansion of the clinical phenotype?. Anales de Pediatria 79(2): 125-127

Dane, B.; Kayaoğlu, Z.; Dane, C.; Aksoy, F. 2011: VACTERL-H syndrome: first trimester diagnosis. Journal of the Turkish German Gynecological Association 12(4): 266-269

Solomon, B.D. 2011: VACTERL/VATER Association. Orphanet Journal of Rare Diseases 6: 56

Javed, M.; Shokrollahi, K. 2012: VACUETTE(®) for burn depth assessment--a simple and novel alternative use for a ubiquitous phlebotomy device. Burns: Journal of the International Society for Burn Injuries 38(7): 1084-1085

Schmid, S.; Azzopardi, E.; De Jaeger, X.; Prado, M.A.M.; Prado, V.F. 2011: VAChT knock-down mice show normal prepulse inhibition but disrupted long-term habituation. Genes Brain and Behavior 10(4): 457-464

Winge, R.; Berg, J.O.; Albret, R.; Krag, C. 2012: VAC® for external fixation of flail chest. Clinics and Practice 2(3): E65

Cavigelli-Brunner, A.; Schweiger, M.; Knirsch, W.; Stiasny, B.; Klingel, K.; Kretschmar, O.; Hübler, M. 2014: VAD as bridge to recovery in anthracycline-induced cardiomyopathy and HHV6 myocarditis. Pediatrics 134(3): E894-E899

Zervas, K.; Mihou, D.; Katodritou, E.; Pouli, A.; Mitsouli, C.H.; Anagnostopoulos, A.; Delibasi, S.; Kyrtsonis, M.C.; Anagnostopoulos, N.; Terpos, E.; Zikos, P.; Maniatis, A.; Dimopoulos, M.A. 2007: VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek Myeloma Study Group. Annals of Oncology: Official Journal of the European Society for Medical Oncology 18(8): 1369-1375

Steckl, P.D.; Samaritan, G.; Martinez, L.; Gregg, M.G. 2014: VAD: an under-recognized cause of stroke in the young. Journal of the Medical Association of Georgia 103(1): 16-17

Cheng, A.; Swartz, M.F.; Massey, H.T. 2013: VADoscopy: a novel intraoperative technique to evaluate HeartMate Ii left ventricular assist device inflow obstruction and thrombosis. Asaio Journal 59(6): 671-674

Nunez, C. 2013: VAE surveillance helps clinicians improve outcomes. What the CDC's new ventilator-associated event protocol means. Health Management Technology 34(8): 16-17

Mounkoro, N.; Téguété, I.; Traoré, Y.; Diarra, I.; Sissoko, S.; Diallo, F.; Traoré, M.; Dolo, A. 2005: Vaginal Hysterectomy in the Department of Obstetrics and Gynecology of the Point "g" Hospital. Le Mali medical 20(1-2): 48-50

Anonymous 1947: VAGOTOMY for peptic ulcer. California medicine 66(6): 372

Anonymous 1947: VAGUE abdominal pain and leukocytosis. Postgraduate medicine 1(1): 74

Powell, D.R.; Seemann, T. 2013: VAGUE: a graphical user interface for the Velvet assembler. Bioinformatics 29(2): 264-265

Schmidt, J.; Gröller, M.E.; Bruckner, S. 2013: VAICo: visual analysis for image comparison. IEEE Transactions on Visualization and Computer Graphics 19(12): 2090-2099

Robson, A.W. 1898: Valedictory Presidential Address on Extrauterine Gestation: Delivered before the British Gynaecological Society on January 13th, 1898. British Medical Journal 1(1935): 285-288

Landsman, T.; De MARTINO, M.F. 1947: Some areas of caution for the psychology student. American Psychologist 2(4): 145-147

Ahmed, A.; Perry, G.J.; Husain, A. 2007: VALIDD should not invalidate angiotensin-receptor blockers. Lancet 369(9579): 2053-2054

Ching, K.K.L. 2010: VALO light curing unit. Hda now 2010: 14

Amor, A.J. 1948: Nursing and the industrial environment. Nursing Times 44(7): 114

Anonymous 1948: VALUE of antenatal exercises. New Zealand Medical Journal 47(260): 378-381

Anonymous 1945: VALUE of anterior-oblique roentgenograms in diagnosis of primary atypical pneumonia. Bulletin of the U.S. Army Medical Department. United States. Army. Medical Department 4: 641

Anonymous 1945: VALUE of convalescent reconditioning. journal of military medicine in the Pacific 1(1): 34-36

Smith, L.; Trent, A.; Brewer, J. 2007: A growing problem. Imprint 54(2): 8

Finkelstein, S.M.; Speedie, S.M.; Zhou, X.; Ratner, E.; Potthoff, S. 2006: VALUE: Virtual Assisted Living Umbrella for the Elderly -- user patterns. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2006: 3294-3296

Gurdak, E.; Green, F.M.; Rakowska, P.D.; Seah, M.P.; Salter, T.L.; Gilmore, I.S. 2014: VAMAS interlaboratory study for desorption electrospray ionization mass spectrometry (DESi MS) intensity repeatability and constancy. Analytical Chemistry 86(19): 9603-9611

Ferlito, M.; Fulton, W.B.; Zauher, M.A.; Marbán, E.; Steenbergen, C.; Lowenstein, C.J. 2010: VAMP-1, VAMP-2, and syntaxin-4 regulate ANP release from cardiac myocytes. Journal of Molecular and Cellular Cardiology 49(5): 791-800

Benagiano, V.; Lorusso, L.; Flace, P.; Girolamo, F.; Rizzi, A.; Bosco, L.; Cagiano, R.; Nico, B.; Ribatti, D.; Ambrosi, G. 2011: VAMP-2, SNAP-25A/B and syntaxin-1 in glutamatergic and GABAergic synapses of the rat cerebellar cortex. Bmc Neuroscience 12: 118

Gorący, J.ła.; Gorący, I.; Kaczmarczyk, M.; Parczewski, M.ło.; Cyryłowski, L.; Brykczyński, M.ła.; Peregud-Pogorzelska, M.łg.; Ciechanowicz, A. 2011: VAMP-8 gene variant is associated with increased risk of early myocardial infarction. Archives of Medical Science: Ams 7(3): 440-443

Tiwari, N.; Wang, C-Chun.; Brochetta, C.; Ke, G.; Vita, F.; Qi, Z.; Rivera, J.; Soranzo, M.Rosa.; Zabucchi, G.; Hong, W.; Blank, U. 2008: VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways. Blood 111(7): 3665-3674

Rao, M.; Song, W.; Jiang, A.; Shyr, Y.; Lev, S.; Greenstein, D.; Brantley-Sieders, D.; Chen, J. 2012: VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity. Plos one 7(10): E46281

Lvov, A.; Chikvashvili, D.; Michaelevski, I.; Lotan, I. 2008: VAMP2 interacts directly with the N terminus of Kv2.1 to enhance channel inactivation. Pflugers Archiv: European Journal of Physiology 456(6): 1121-1136

Tajika, Y.; Murakami, T.; Sato, M.; Kubota, F.; Yorifuji, H. 2008: VAMP2 is expressed in myogenic cells during rat development. Developmental Dynamics: An Official Publication of the American Association of Anatomists 237(7): 1886-1892

Tajika, Y.; Takahashi, M.; Hino, M.; Murakami, T.; Yorifuji, H. 2010: VAMP2 marks quiescent satellite cells and myotubes, but not activated myoblasts. Acta Histochemica et Cytochemica 43(4): 107-114

Pulido, I.és.R.; Jahn, R.; Gerke, V. 2011: VAMP3 is associated with endothelial weibel-palade bodies and participates in their Ca(2+)-dependent exocytosis. Biochimica et Biophysica Acta 1813(5): 1038-1044

Kean, M.J.; Williams, K.C.; Skalski, M.; Myers, D.; Burtnik, A.; Foster, D.; Coppolino, M.G. 2009: VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion. Journal of Cell Science 122(Part 22): 4089-4098

Shitara, A.; Shibui, T.; Okayama, M.; Arakawa, T.; Mizoguchi, I.; Sakakura, Y.; Shakakura, Y.; Takuma, T. 2013: VAMP4 is required to maintain the ribbon structure of the Golgi apparatus. Molecular and Cellular Biochemistry 380(1-2): 11-21

Szalinski, C.M.; Labilloy, A.ál.; Bruns, J.R.; Weisz, O.A. 2014: VAMP7 modulates ciliary biogenesis in kidney cells. Plos one 9(1): E86425

Chen, Y.; Meng, D.; Wang, H.; Sun, R.; Wang, D.; Wang, S.; Fan, J.; Zhao, Y.; Wang, J.; Yang, S.; Huai, C.; Song, X.; Qin, R.; Xu, T.; Yun, D.; Hu, L.; Yang, J.; Zhang, X.; Chen, H.; Chen, J.; Chen, H.; Lu, D. 2015: VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells. Neuro-Oncology 17(3): 407-418

Pushparaj, P.N.; Tay, H.K.; Wang, C.-C.; Hong, W.; Melendez, A.J. 2009: VAMP8 is essential in anaphylatoxin-induced degranulation, TNF-alpha secretion, peritonitis, and systemic inflammation. Journal of Immunology 183(2): 1413-1418

Cosen-Binker, L.I.; Binker, M.G.; Wang, C.-C.; Hong, W.; Gaisano, H.Y. 2008: VAMP8 is the v-SNARE that mediates basolateral exocytosis in a mouse model of alcoholic pancreatitis. Journal of Clinical Investigation 118(7): 2535-2551

Kondkar, A.A.; Bray, M.S.; Leal, S.M.; Nagalla, S.; Liu, D.J.; Jin, Y.; Dong, J.F.; Ren, Q.; Whiteheart, S.W.; Shaw, C.; Bray, P.F. 2010: VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. Journal of Thrombosis and Haemostasis: Jth 8(2): 369-378

Perez-Rovira, A.; MacGillivray, T.; Trucco, E.; Chin, K.S.; Zutis, K.; Lupascu, C.; Tegolo, D.; Giachetti, A.; Wilson, P.J.; Doney, A.; Dhillon, B. 2011: VAMPIRE: Vessel assessment and measurement platform for images of the REtina. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2011: 3391-3394

Huse, S.M.; Mark Welch, D.B.; Voorhis, A.; Shipunova, A.; Morrison, H.G.; Eren, A.Murat.; Sogin, M.L. 2014: VAMPS: a website for visualization and analysis of microbial population structures. Bmc Bioinformatics 15: 41

Naramoto, S.; Nodzyłski, T.; Dainobu, T.; Takatsuka, H.; Okada, T.; Friml, J.ři.; Fukuda, H. 2014: VAN4 encodes a putative TRS120 that is required for normal cell growth and vein development in Arabidopsis. Plant and Cell Physiology 55(4): 750-763

Jayaswal, V.; Schramm, S.-J.; Mann, G.J.; Wilkins, M.R.; Yang, Y.H. 2013: VAN: an R package for identifying biologically perturbed networks via differential variability analysis. Bmc Research Notes 6: 430

Brinkrolf, C.; Janowski, S.J.; Kormeier, B.; Lewinski, M.; Hippe, K.; Borck, D.; Hofestädt, R. 2014: VANESA - a software application for the visualization and analysis of networks in system biology applications. Journal of Integrative Bioinformatics 11(2): 239

Sanchez-Alvarez, L.; Visanuvimol, J.; McEwan, A.; Su, A.; Imai, J.H.; Colavita, A. 2011: VANG-1 and PRKL-1 cooperate to negatively regulate neurite formation in Caenorhabditis elegans. Plos Genetics 7(9): E1002257

Reynolds, A.; McDearmid, J.R.; Lachance, S.; De Marco, P.; Merello, E.; Capra, V.; Gros, P.; Drapeau, P.; Kibar, Z. 2010: VANGL1 rare variants associated with neural tube defects affect convergent extension in zebrafish. Mechanisms of Development 127(7-8): 385-392

Lei, Y-Ping.; Zhang, T.; Li, H.; Wu, B-Lin.; Jin, L.; Wang, H-Yan. 2010: VANGL2 mutations in human cranial neural-tube defects. New England Journal of Medicine 362(23): 2232-2235

Williams, B.B.; Cantrell, V.A.; Mundell, N.A.; Bennett, A.C.; Quick, R.E.; Jessen, J.R. 2012: VANGL2 regulates membrane trafficking of MMP14 to control cell polarity and migration. Journal of Cell Science 125(Part 9): 2141-2147

Wilburne, M.; Schlichter, J.G.; Simon, A.J. 1947: The effect of acetylcholine on the heart; an electrocardiographic study in the dog. Archives Internationales de Pharmacodynamie et de Therapie 76(1): 63-71

Brasch, S.; Linsen, L.; Fuellen, G. 2009: VANLO--interactive visual exploration of aligned biological networks. Bmc Bioinformatics 10: 327

Rohn, H.; Junker, A.; Hartmann, A.; Grafahrend-Belau, E.; Treutler, H.; Klapperstück, M.; Czauderna, T.; Klukas, C.; Schreiber, F. 2012: VANTED v2: a framework for systems biology applications. Bmc Systems Biology 6: 139

Farnier, M.; Perevozskaya, I.; Taggart, W.V.; Kush, D.; Mitchel, Y.B. 2008: VAP Ii analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate. Journal of Lipid Research 49(12): 2641-2647

Benson, S.; Johnson, A.; Petera, C. 2013: VAP free for 1000 days, it can be done. Critical Care Nursing Quarterly 36(4): 421-424

Scamperle, A.; Verginella, F.; Zuliani, M.; Berlot, G. 2014: VAP incidence in cardiac arrest survivors treated with TH and SDD: our experience. Resuscitation 85(4): E51

Polverino, E.; Ferrer, M. 2010: VAP surveillance: role of non-quantitative culture of endotracheal aspirates (NQC-ETA). Minerva Anestesiologica 76(8): 572-574

Koc-Zorawska, E.; Malyszko, J.; Zbroch, E.; Malyszko, J.; Mysliwiec, M. 2013: VAP-1 in peritoneally dialyzed patients. Postepy Higieny i Medycyny Doswiadczalnej 67: 1340-1344

Koc-Zorawska, E.; Malyszko, J.; Malyszko, J.S.; Mysliwiec, M. 2012: VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney allograft recipients. Kidney and Blood Pressure Research 36(1): 242-247

Nakao, S.; Noda, K.; Zandi, S.; Sun, D.; Taher, M.; Schering, A.; Xie, F.; Mashima, Y.; Hafezi-Moghadam, A. 2011: VAP-1-mediated M2 macrophage infiltration underlies IL-1β- but not VEGF-A-induced lymph- and angiogenesis. American Journal of Pathology 178(4): 1913-1921

Hernandez-Guillamon, M.; Solé, M.; Delgado, P.; García-Bonilla, L.; Giralt, D.; Boada, C.; Penalba, A.; García, S.; Flores, A.; Ribó, M.; Alvarez-Sabin, J.é; Ortega-Aznar, A.; Unzeta, M.; Montaner, J. 2012: VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke. Cerebrovascular Diseases 33(1): 55-63

Coulombe, C.; Poitras, C.; Nordell-Markovits, A.; Brunelle, Mène.; Lavoie, M-André.; Robert, Fçois.; Jacques, P-Étienne. 2014: VAP: a versatile aggregate profiler for efficient genome-wide data representation and discovery. Nucleic Acids Research 42(Web Server Issue): W485-W493

Michael, K. 2008: VAP: just how good a benchmark is it really?. Healthcare Benchmarks and Quality Improvement 15(3): 32-33

Martinière, A.; Macia, J.-L.; Bagnolini, G.; Jridi, C.; Bak, A.él.; Blanc, S.ép.; Drucker, M. 2011: VAPA, an innovative "virus-acquisition phenotyping assay" opens new horizons in research into the vector-transmission of plant viruses. Plos one 6(8): E23241

Han, S.M.; El Oussini, H.; Scekic-Zahirovic, J.; Vibbert, J.; Cottee, P.; Prasain, J.K.; Bellen, H.J.; Dupuis, L.; Miller, M.A. 2013: VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism critical for adult survival in caenorhabditis elegans. Plos Genetics 9(9): E1003738

Baron, Y.; Pedrioli, P.G.; Tyagi, K.; Johnson, C.; Wood, N.T.; Fountaine, D.; Wightman, M.; Alexandru, G. 2014: VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase. Bmc Biology 12: 39

Hirano, M. 2008: VAPB: new genetic clues to the pathogenesis of ALS. Neurology 70(14): 1161-1162

Goyal, S.; Gupta, G.; Qin, H.; Upadya, M.H.; Tan, Y.J.; Chow, V.T.K.; Song, J. 2012: VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B. Plos one 7(7): E40341

Liang, Y.; Rowland, E.B.; Rowland, G.B.; Perman, J.A.; Antilla, J.C. 2007: VAPOL phosphoric acid catalysis: the highly enantioselective addition of imides to imines. Chemical Communications 43: 4477-4479

Rovira-Vallbona, E.; Monteiro, I.; Bardají, A.; Serra-Casas, E.; Neafsey, D.E.; Quelhas, D.; Valim, C.; Alonso, P.; Dobaño, C.; Ordi, J.; Menéndez, C.; Mayor, A. 2013: VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta. Plos one 8(7): E69753

Emmons, S.F. 1904: VARAeLE AUCTORITATIS. Science 20(512): 537

Hillebrenner, M.G.; Swain, J.A.; Zuckerman, B. 2011: VARC consensus report: the FDA perspective. European Heart Journal 32(2): 138-139

Kurian, A.; Anitha, C.A.; Nybe, E.V. 2001: Variability and Character Association in Rose Coloured Leadwort (Plumbago Rosea Linn.). Ancient Science of Life 21(2): 92-95

Medina, I.; De Maria, A.; Bleda, M.; Salavert, F.; Alonso, R.; Gonzalez, C.Y.; Dopazo, J. 2012: VARIANT: Command Line, Web service and Web interface for fast and accurate functional characterization of variants found by Next-Generation Sequencing. Nucleic Acids Research 40(Web Server Issue): W54-W58

Cockerell, T.D. 1915: VARIATION IN OEligNOTHERA HEWETTi. Science 42(1095): 908-909

Haynes, H.W. 1904: VARIAe AUCTORITATIS. Science 20(516): 683

Rapallo, A. 2009: VARICELLA: a variable-cell direct space method for structure determination from powder diffraction data. Journal of Chemical Physics 131(4): 044113

Eastman, C.R. 1904: VARLAe AUCTORITATIS. Science 20(502): 215-217

Darty, K.év.; Denise, A.; Ponty, Y. 2009: VARNA: Interactive drawing and editing of the RNA secondary structure. Bioinformatics 25(15): 1974-1975

Hesketh, G.G.; Pérez-Dorado, I.; Jackson, L.P.; Wartosch, L.; Schäfer, I.B.; Gray, S.R.; McCoy, A.J.; Zeldin, O.B.; Garman, E.F.; Harbour, M.E.; Evans, P.R.; Seaman, M.N.J.; Luzio, J.P.; Owen, D.J. 2014: VARP is recruited on to endosomes by direct interaction with retromer, where together they function in export to the cell surface. Developmental Cell 29(5): 591-606

Chae, Y.S.; Lee, S.J.; Moon, J.H.; Kang, B.W.; Kim, J.G.; Sohn, S.K.; Jung, J.H.; Park, H.Y.; Park, J.Y.; Kim, H.J.; Lee, S.-W. 2011: VARS2 V552V variant as prognostic marker in patients with early breast cancer. Medical Oncology 28(4): 1273-1280

Diodato, D.; Melchionda, L.; Haack, T.B.; Dallabona, C.; Baruffini, E.; Donnini, C.; Granata, T.; Ragona, F.; Balestri, P.; Margollicci, M.; Lamantea, E.; Nasca, A.; Powell, C.A.; Minczuk, M.; Strom, T.M.; Meitinger, T.; Prokisch, H.; Lamperti, C.; Zeviani, M.; Ghezzi, D. 2014: VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies. Human Mutation 35(8): 983-989

Apostolico, A.; Comin, M.; Parida, L. 2010: VARUN: discovering extensible motifs under saturation constraints. Ieee/Acm Transactions on Computational Biology and Bioinformatics 7(4): 752

Dalca, A.V.; Rumble, S.M.; Levy, S.; Brudno, M. 2010: VARiD: a variation detection framework for color-space and letter-space platforms. Bioinformatics 26(12): I343-I349

Faiz, K.W. 2014: VAS--visual analog scale. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(3): 323

Wingler, K.; Altenhoefer, S.A.; Kleikers, P.W.M.; Radermacher, K.A.; Kleinschnitz, C.; Schmidt, H.H.H.W. 2012: VAS2870 is a pan-NADPH oxidase inhibitor. Cellular and Molecular Life Sciences: Cmls 69(18): 3159-3160

Ho, E.D.; Cao, Q.; Lee, S.D.; Yip, K.Y. 2014: VAS: a convenient web portal for efficient integration of genomic features with millions of genetic variants. Bmc Genomics 15: 886

Yasui, Y.; Kohchi, T. 2014: Vascular Plant One-Zinc Finger1 and Voz2 Repress the Flowering Locus C Clade Members to Control Flowering time in Arabidopsis. Bioscience Biotechnology and Biochemistry 78(11): 1850-1855

Yamaguchi, M.; Goué, N.; Igarashi, H.; Ohtani, M.; Nakano, Y.; Mortimer, J.C.; Nishikubo, N.; Kubo, M.; Katayama, Y.; Kakegawa, K.; Dupree, P.; Demura, T. 2010: VASCULAR-RELATED NAC-DOMAIN6 and VASCULAR-RELATED NAC-DOMAIN7 effectively induce transdifferentiation into xylem vessel elements under control of an induction system. Plant Physiology 153(3): 906-914

Yamaguchi, M.; Mitsuda, N.; Ohtani, M.; Ohme-Takagi, M.; Kato, K.; Demura, T. 2011: VASCULAR-RELATED NAC-DOMAIN7 directly regulates the expression of a broad range of genes for xylem vessel formation. Plant Journal: for Cell and Molecular Biology 66(4): 579-590

Steinkellner, G.; Rader, R.; Thallinger, G.G.; Kratky, C.; Gruber, K. 2009: VASCo: computation and visualization of annotated protein surface contacts. Bmc Bioinformatics 10: 32

Hoyos, A.E.; Millard, J.A. 2007: VASER-assisted high-definition liposculpture. Aesthetic Surgery Journal 27(6): 594-604

Zhang, Y.-T.; Xu, L.-H.; Lu, Q.; Liu, K.-P.; Liu, P.-Y.; Ji, F.; Liu, X.-M.; Ouyang, D.-Y.; He, X.-H. 2014: VASP activation via the Gα13/RhoA/PKA pathway mediates cucurbitacin-B-induced actin aggregation and cofilin-actin rod formation. Plos one 9(4): E93547

Kris, A.S.; Kamm, R.D.; Sieminski, A.L. 2008: VASP involvement in force-mediated adherens junction strengthening. Biochemical and Biophysical Research Communications 375(1): 134-138

Neel, N.F.; Barzik, M.; Raman, D.; Sobolik-Delmaire, T.; Sai, J.; Ham, A.J.; Mernaugh, R.L.; Gertler, F.B.; Richmond, A. 2009: VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis. Journal of Cell Science 122(Part 11): 1882-1894

Hansen, S.D.; Mullins, R.Dyche. 2010: VASP is a processive actin polymerase that requires monomeric actin for barbed end association. Journal of Cell Biology 191(3): 571-584

Defawe, O.D.; Kim, S.; Chen, L.; Huang, D.; Kenagy, R.D.; Renné, T.; Walter, U.; Daum, G.ün.; Clowes, A.W. 2010: VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagen. Journal of Cellular Physiology 222(1): 230-237

Chen, B.Y. 2014: VASP-E: specificity annotation with a volumetric analysis of electrostatic isopotentials. Plos Computational Biology 10(8): E1003792

Chen, B.Y.; Honig, B. 2010: VASP: a volumetric analysis of surface properties yields insights into protein-ligand binding specificity. Plos Computational Biology 6(8)

Compter, A.; van der Worp, H.B.; Schonewille, W.J.; Vos, J.A.; Algra, A.; Lo, T.H.; Mali, W.P.T.M.; Moll, F.L.; Kappelle, L.J. 2008: VAST: Vertebral Artery Stenting Trial. Protocol for a randomised safety and feasibility trial. Trials 9: 65

Fan, J.-G.; Farrell, G.C. 2008: VAT fat is bad for the liver, SAT fat is not!. Journal of Gastroenterology and Hepatology 23(6): 829-832

Dallas, J.; Kollef, M. 2009: VAT vs VAP: are we heading toward clarity or confusion?. Chest 135(2): 252-255

Mori, F.; Tanigawa, K.; Endo, K.; Minamiguchi, K.; Abe, M.; Yamada, S.; Miyoshi, K. 2011: VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia. Prostate 71(14): 1579-1586

Samouda, H.; Dutour, A.; Chaumoitre, K.; Panuel, M.; Dutour, O.; Dadoun, F.éd.ér. 2013: VAT=TAAT-SAAT: innovative anthropometric model to predict visceral adipose tissue without resort to CT-Scan or DXA. Obesity 21(1): E41-E50

Cocchini, G.; Gregg, N.; Beschin, N.; Dean, M.; Della Sala, S. 2010: VATA-L: visual-analogue test assessing anosognosia for language impairment. Clinical Neuropsychologist 24(8): 1379-1399

Della Sala, S.; Cocchini, G.; Beschin, N.; Cameron, A. 2009: VATA-m: Visual-Analogue Test assessing Anosognosia for motor impairment. Clinical Neuropsychologist 23(3): 406-427

Jain, M.K.; Mahant, S.; Mahant, P.D.; Dhanotiy, A. 2009: VATER association with multiple ribs anomalies. Journal of the Association of Physicians of India 57: 332-333

Reutter, H.; Ludwig, M. 2013: VATER/VACTERL Association: Evidence for the Role of Genetic Factors. Molecular Syndromology 4(1-2): 16-19

Bartels, E.; Schulz, A.C.; Mora, N.W.; Pineda-Alvarez, D.E.; Wijers, C.H.W.; Marcelis, C.M.; Stressig, Rüdiger.; Ritgen, J.; Schmiedeke, E.; Mattheisen, M.; Draaken, M.; Hoffmann, P.; Hilger, A.C.; Dworschak, G.C.; Baudisch, F.; Ludwig, M.; Bagci, S.; Müller, A.; Gembruch, U.; Geipel, A.; Berg, C.; Bartmann, P.; Nöthen, M.M.; van Rooij, I.A.L.M.; Solomon, B.D.; Reutter, H.M. 2012: VATER/VACTERL association: identification of seven new twin pairs, a systematic review of the literature, and a classical twin analysis. Clinical Dysmorphology 21(4): 191-195

Nunes, N.; Karandikar, S.; Cooper, S.; Jaganathan, R.; Irani, S. 2009: VATER/VACTERL syndrome (vertebra/anus/cardiac/trachea/esophogus/radius/renal/limb anomalies) with a noncommunicating functioning uterine horn and a unicornuate uterus: a case report. Fertility and Sterility 91(5): 1957.E11-2

Begum, S.; Hansen, H.Jessen.; Papagiannopoulos, K. 2014: VATS anatomic lung resections-the European experience. Journal of Thoracic Disease 6 Suppl. 2: S203-S210

Rocco, G. 2013: VATS and Uniportal VATS: a glimpse into the future. Journal of Thoracic Disease 5 Suppl. 3: S174

Ambrogi, V.; Mineo, T.Claudio. 2014: VATS biopsy for undetermined interstitial lung disease under non-general anesthesia: comparison between uniportal approach under intercostal block vs. three-ports in epidural anesthesia. Journal of thoracic disease 6(7): 888-895

Panagopoulos, N.; Papavasileiou, G.; Koletsis, E.; Kastanaki, M.; Anastasiou, N. 2014: VATS bullectomy and apical pleurectomy for spontaneous pneumothorax in a young patient with Swyer-James-Mc Leod syndrome: case report presentation and literature review focusing on surgically treated cases. Journal of cardiothoracic surgery 9: 13

Granato, F.; Voltolini, L.; Spina, D.; Paladini, P.; Gallazzi, M.; Gotti, G. 2009: VATS for congenital lobar emphysema: a case report. Minerva Chirurgica 64(1): 111-115

Prisadov, G.; Uchikov, A.; Atliev, K.; Paskalev, G.; Dimitrov, I.; Bonev, P.; Batashki, A. 2010: VATS in patients with solitary periferal pulmonary tumors. Khirurgiia 2010(4-5): 5-9

Willekes, L.; Boutros, C.; Goldfarb, M.A. 2008: VATS intraoperative tattooing to facilitate solitary pulmonary nodule resection. Journal of cardiothoracic surgery 3: 13

Xu, M.; Liu, C.; Luo, J.; Guo, M. 2013: VATS left upper lobe posterior segmentectomy. Journal of Thoracic Disease 5 Suppl. 3: S317-S318

Zhao, X.; Qian, L.; Wang, J. 2013: VATS left upper lobectomy. Journal of Thoracic Disease 5 Suppl. 3: S296-S297

Krueger, T.; Perentes, J.Y.; Peters, S.; Ris, H-B.; Gonzalez, M. 2012: VATS lobectomy for early-stage primary lung cancer. Revue Medicale Suisse 8(346): 1337-1341

Grogan, E.L.; Jones, D.R. 2008: VATS lobectomy is better than open thoracotomy: what is the evidence for short-term outcomes?. Thoracic surgery clinics 18(3): 249-258

Wright, G.M. 2012: VATS lobectomy lymph node management. Annals of cardiothoracic surgery 1(1): 51-55

McNiel, A.; Blackmon, S. 2008: VATS lobectomy to treat early-stage non-small cell lung cancer. JAAPA: official journal of the American Academy of Physician Assistants 21(9): 31

Rocco, G. 2005: VATS lung biopsy: the uniportal technique. Multimedia manual of cardiothoracic surgery: MMCTS 2005(121): mmcts.2004.000356

Wright, G.M. 2012: VATS lymph node dissection. Annals of cardiothoracic surgery 1(1): 102-103

Tschopp, J-M.; Schnyder, J-M.; Froudarakis, M.; Astoul, P. 2009: VATS or simple talc poudrage under medical thoracoscopy for recurrent spontaneous pneumothorax. European Respiratory Journal 33(2): 442-443

Neragi-Miandoab, S.; Linden, P.A.; Ducko, C.T.; Bueno, R.; Richards, W.G.; Sugarbaker, D.J.; Jaklitsch, M.T. 2008: VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study. International Journal of Surgery 6(2): 110-114

Ke, L.; Tian, J.; Sun, X. 2013: VATS right middle lobectomy. Journal of Thoracic Disease 5 Suppl. 3: S319-S320

Phan, K.; Yan, T.D. 2014: VATS segmentectomy for pulmonary metastasis. Annals of cardiothoracic surgery 3(2): 192-193

Petersen, Ré.Horsleben.; Hansen, H.Jessen. 2014: VATS segmentectomy utilizing the Copenhagen approach. Annals of cardiothoracic surgery 3(2): 211-212

Csiszkó, A.; Herr, Görgy.; Sz Kiss, Sándor.; Hallay, J.; Gyöngyösi, Zán.; Szentkereszty, Z. 2013: VATS therapy of chylothorax caused by leiomyomatosis complicated with tuberous sclerosis complex. Journal of minimal access surgery 9(2): 84-86

Keating, C.P.; Kong, Y.X.; Tay, V.; Knight, S.R.; Clarke, C.Peter.; Wright, G.M. 2011: VATS thymectomy for nonthymomatous myasthenia gravis: standardized outcome assessment using the myasthenia gravis foundation of America clinical classification. Innovations 6(2): 104-109

Melfi, F.M.A.; Fanucchi, O.; Davini, F.; Mussi, A. 2014: VATS-based approach for robotic lobectomy. Thoracic Surgery Clinics 24(2): 143-9 V

Di Napoli, G.; Ronzini, M.; Paradies, G. 2014: VATS: first step in the parapneumonic empyema*. Il Giornale di chirurgia 35(5-6): 146-148

Avidan, N.; Le Panse, R.; Harbo, H.F.; Bernasconi, P.; Poulas, K.; Ginzburg, E.; Cavalcante, P.; Colleoni, L.; Baggi, F.; Antozzi, C.; Truffault, F.éd.ér.; Horn-Saban, S.; Pöschel, S.; Zagoriti, Z.; Maniaol, A.; Lie, B.A.; Bernard, I.; Saoudi, A.; Illes, Z.; Casasnovas Pons, C.; Melms, A.; Tzartos, S.; Willcox, N.; Kostera-Pruszczyk, A.; Tallaksen, C.; Mantegazza, R.; Berrih-Aknin, S.; Miller, A. 2014: VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis. Annals of Clinical and Translational Neurology 1(5): 329-339

Wakahashi, S.; Sudo, T.; Oka, N.; Ueno, S.; Yamaguchi, S.; Fujiwara, K.; Ohbayashi, C.; Nishimura, R. 2013: VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer. Translational Research: the Journal of Laboratory and Clinical Medicine 162(3): 181-190

Fujikawa, K.; Iwata, T.; Inoue, K.; Akahori, M.; Kadotani, H.; Fukaya, M.; Watanabe, M.; Chang, Q.; Barnett, E.M.; Swat, W. 2010: VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. Plos one 5(2): E9050

Aguilar, H.; Urruticoechea, A.; Halonen, P.; Kiyotani, K.; Mushiroda, T.; Barril, X.; Serra-Musach, J.; Islam, A.; Caizzi, L.; Di Croce, L.; Nevedomskaya, E.; Zwart, W.; Bostner, J.; Karlsson, E.; Pérez Tenorio, G.; Fornander, T.; Sgroi, D.C.; Garcia-Mata, R.; Jansen, M.P.H.M.; García, N.; Bonifaci, N.úr.; Climent, F.; Soler, M.ía.T.; Rodríguez-Vida, A.; Gil, M.; Brunet, J.; Martrat, G.; Gómez-Baldó, L.; Extremera, A.I.; Figueras, A.; Balart, J.; Clarke, R.; Burnstein, K.L.; Carlson, K.E.; Katzenellenbogen, J.A.; Vizoso, M.; Esteller, M.; Villanueva, A.; Rodríguez-Peña, A.B.; Bustelo, X.é R.; Nakamura, Y.; Zembutsu, H.; Stål, O.; Beijersbergen, R.L.; Pujana, M.A. 2014: VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Research: Bcr 16(3): R53

Slavotinek, A.M.; Chao, R.; Vacik, T.; Yahyavi, M.; Abouzeid, H.; Bardakjian, T.; Schneider, A.; Shaw, G.; Sherr, E.H.; Lemke, G.; Youssef, M.; Schorderet, D.F. 2012: VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans. Human Mutation 33(2): 364-368

Triozzi, P.L.; Borden, E.C. 2011: VB-111 for cancer. Expert Opinion on Biological Therapy 11(12): 1669-1676

Mendel, I.; Feige, E.; Yacov, N.; Salem, Y.; Levi, I.; Propheta-Meiran, O.; Shoham, A.; Ishai, E.; George, J.; Harats, D.; Breitbart, E. 2014: VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis. Clinical and Experimental Immunology 175(1): 126-137

Sharir-Ivry, A.; Shnerb, T.; Strajbl, M.; Shurki, A. 2010: VB/MM protein landscapes: a study of the S(N)2 reaction in haloalkane dehalogenase. Journal of Physical Chemistry. B 114(6): 2212-2218

Sharir-Ivry, A.; Shurki, A. 2008: VB/MM--the validity of the underlying approximations. Journal of Physical Chemistry. B 112(39): 12491-12497

Biggers, K.; Scheinfeld, N. 2008: VB4-845, a conjugated recombinant antibody and immunotoxin for head and neck cancer and bladder cancer. Current Opinion in Molecular Therapeutics 10(2): 176-186

Daunizeau, J.; Adam, V.; Rigoux, L. 2014: VBA: a probabilistic treatment of nonlinear models for neurobiological and behavioural data. Plos Computational Biology 10(1): E1003441

Wainer, N. 2008: VBAC & choice: many questions and a few answers. Midwifery Today with International Midwife 2008(86): 9

Silla, J.é M.; Freitas, M.P.; Cormanich, R.A.; Rittner, R. 2014: The reverse fluorine Perlin-like effect and related stereoelectronic interactions. Journal of Organic Chemistry 79(13): 6385-6388

Rennick, B. 2013: VBAC breech hospital birth: the story of Ezra. Midwifery Today with International Midwife 106: 34

Fineberg, A.E.; Tilton, Z.A. 2012: VBAC in the trenches: a community perspective. Clinical Obstetrics and Gynecology 55(4): 997-1004

Cohain, J.S. 2007: VBAC rupture and birth weight. Midwifery Today with International Midwife 83: 50

Raja, J.Farzand.; Bangash, K.Tasneem.; Mahmud, G. 2013: VBAC scoring: successful vaginal delivery in previous one caesarean section in induced labour. Jpma. Journal of the Pakistan Medical Association 63(9): 1147-1151

Bridle, L. 2010: VBAC to the future. Practising Midwife 13(9): 29-30

Reid, A.J. 1986: VBAC: Is it Safe for your Patients?. Canadian Family Physician Medecin de Famille Canadien 32: 2123-2127

Rosine, N. 2007: VBAC: a mother's story. Practising Midwife 10(5): 28 30

Signore, C. 2012: VBAC: what does the evidence show?. Clinical Obstetrics and Gynecology 55(4): 961-968

Ying, F.; Chang, X.; Su, P.; Wu, W. 2012: VBEFP: a valence bond approach that incorporates effective fragment potential method. Journal of Physical Chemistry. a 116(7): 1846-1853

Rutter, J.M. 2012: VBF bungalows. Veterinary Record 171(16): 408

Anonymous 2012: VBF fellowships for 'extraordinary' care. Veterinary Record 171(5): 111

Tang, T.; Walsh, S.R.; Prytherch, D.R.; Lees, T.; Varty, K.; Boyle, J.R. 2007: VBHOM, a data economic model for predicting the outcome after open abdominal aortic aneurysm surgery. British Journal of Surgery 94(6): 717-721

Hadjianastassiou, V. 2007: VBHOM, a data economic model for predicting the outcome after open abdominal aortic aneurysm surgery (Br J Surg 2007; 94: 717-721). British Journal of Surgery 94(10): 1308; Author Reply 1308-9

Fairman, K.A.; Curtiss, F.R. 2012: VBID, the PPACA, and FREEE medications: Did politics trump the evidence about cost sharing?. Journal of managed care pharmacy: JMCP 18(2): 146-155

Lin, C.-H.; Chen, C.-M.; Lu, M.-K.; Tsai, C.-H.; Chiou, J.-C.; Liao, J.-R.; Duann, J.-R. 2013: VBM Reveals Brain Volume Differences between Parkinson's Disease and Essential Tremor Patients. Frontiers in Human Neuroscience 7: 247

Shen, S.; Szameitat, A.J.; Sterr, A. 2007: VBM lesion detection depends on the normalization template: a study using simulated atrophy. Magnetic Resonance Imaging 25(10): 1385-1396

Pereira, J.M.S.; Acosta-Cabronero, J.; Pengas, G.; Xiong, L.; Nestor, P.J.; Williams, G.B. 2013: VBM with viscous fluid registration of gray matter segments in SPM. Frontiers in Aging Neuroscience 5: 30

Konrad, A.; Vucurevic, G.; Musso, F.; Winterer, G. 2012: VBM-DTi correlates of verbal intelligence: a potential link to Broca's area. Journal of Cognitive Neuroscience 24(4): 888-895

Alleron, L.ët.; Khemiri, A.; Koubar, M.; Lacombe, C.; Coquet, L.; Cosette, P.; Jouenne, T.; Frere, J. 2013: VBNC Legionella pneumophila cells are still able to produce virulence proteins. Water Research 47(17): 6606-6617

Mulvany, C. 2011: VBP in the works: perspectives on CMS's proposed rule. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 65(4): 36; 38

Warye, K. 2011: VBP will reward HAi reduction. Mlo: Medical Laboratory Observer 43(4): 58

Xu, Y.; Her, C. 2013: VBP1 facilitates proteasome and autophagy-mediated degradation of MutS homologue hMSH4. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(12): 4799-4810

Damsker, J.M.; Dillingham, B.C.; Rose, M.C.; Balsley, M.A.; Heier, C.R.; Watson, A.M.; Stemmy, E.J.; Jurjus, R.A.; Huynh, T.; Tatem, K.; Uaesoontrachoon, K.; Berry, D.M.; Benton, A.S.; Freishtat, R.J.; Hoffman, E.P.; McCall, J.M.; Gordish-Dressman, H.; Constant, S.L.; Reeves, E.K.M.; Nagaraju, K. 2013: VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice. Plos one 8(5): E63871

Heier, C.R.; Damsker, J.M.; Yu, Q.; Dillingham, B.C.; Huynh, T.; Van der Meulen, J.H.; Sali, A.; Miller, B.K.; Phadke, A.; Scheffer, L.; Quinn, J.; Tatem, K.; Jordan, S.; Dadgar, S.; Rodriguez, O.C.; Albanese, C.; Calhoun, M.; Gordish-Dressman, H.; Jaiswal, J.K.; Connor, E.M.; McCall, J.M.; Hoffman, E.P.; Reeves, E.K.M.; Nagaraju, K. 2013: VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. Embo Molecular Medicine 5(10): 1569-1585

Dillingham, B.C.; Knoblach, S.M.; Many, G.M.; Harmon, B.T.; Mullen, A.M.; Heier, C.R.; Bello, L.; McCall, J.M.; Hoffman, E.P.; Connor, E.M.; Nagaraju, K.; Reeves, E.K.M.; Damsker, J.M. 2015: VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. Cellular and Molecular Neurobiology 35(3): 377-387

Alexander, J. 2008: VBP: considering the worst case scenario. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 62(1): 32-33

Wu, W.; Shaik, S.; Saunders, W.H. 2010: VBSCF calculations on the bimolecular (E2) elimination reaction. the nature of the transition state. Journal of Organic Chemistry 75(11): 3722-3728

Su, P.; Wu, W.; Kelly, C.P.; Cramer, C.J.; Truhlar, D.G. 2008: VBSM: a solvation model based on valence bond theory. Journal of Physical Chemistry. a 112(50): 12761-12768

Stanley, A.C.; Dalton, J.E.; Rossotti, S.H.; MacDonald, K.P.; Zhou, Y.; Rivera, F.; Schroder, W.A.; Maroof, A.; Hill, G.R.; Kaye, P.M.; Engwerda, C.R. 2008: VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. Plos Pathogens 4(9): E1000158

Eweiss, A.; Dogheim, Y.; Hassab, M.; Tayel, H.; Hammad, Z. 2009: VCAM-1 and eosinophilia in diffuse sino-nasal polyps. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 266(3): 377-383

Lu, X.; Mu, E.; Wei, Y.; Riethdorf, S.; Yang, Q.; Yuan, M.; Yan, J.; Hua, Y.; Tiede, B.J.; Lu, X.; Haffty, B.G.; Pantel, K.; Massagué, J.; Kang, Y. 2011: VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell 20(6): 701-714

Nell-Duxneuner, V.; Axmann, R.; Husar-Memmer, E.; Dallos, T.ás.; Datz, C.; Stadlmayr, A.; Aigner, E.; Englbrecht, M.; Schett, G.; Zwerina, J. 2013: VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis. Annals of the Rheumatic Diseases 72(12): 2006-2010

Qu, Y.; Shi, X.; Zhang, H.; Sun, W.; Han, S.; Yu, C.; Li, J. 2009: VCAM-1 siRNA reduces neointimal formation after surgical mechanical injury of the rat carotid artery. Journal of Vascular Surgery 50(6): 1452-1458

Leus, N.G.J.; Morselt, H.ët.W.M.; Zwiers, P.J.; Kowalski, P.S.; Ruiters, M.H.J.; Molema, G.; Kamps, J.A.A.M. 2014: VCAM-1 specific PEGylated SAINT-based lipoplexes deliver siRNA to activated endothelium in vivo but do not attenuate target gene expression. International Journal of Pharmaceutics 469(1): 121-131

Yang, H.; Zhao, F.; Li, Y.; Xu, M.; Li, L.; Wu, C.; Miyoshi, H.; Liu, Y. 2013: VCAM-1-targeted core/shell nanoparticles for selective adhesion and delivery to endothelial cells with lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance imaging in vitro. International Journal of Nanomedicine 8: 1897-1906

Serres, Sébastien.; Mardiguian, S.; Campbell, S.J.; McAteer, M.A.; Akhtar, A.; Krapitchev, A.; Choudhury, R.P.; Anthony, D.C.; Sibson, N.R. 2011: VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 25(12): 4415-4422

Rouleau, L.; Berti, R.; Ng, V.W.K.; Matteau-Pelletier, C.; Lam, T.; Saboural, P.; Kakkar, A.K.; Lesage, F.éd.ér.; Rhéaume, E.; Tardif, J.-C. 2013: VCAM-1-targeting gold nanoshell probe for photoacoustic imaging of atherosclerotic plaque in mice. Contrast Media and Molecular Imaging 8(1): 27-39

Sa, Q.; Ochiai, E.; Sengoku, T.; Wilson, M.E.; Brogli, M.; Crutcher, S.; Michie, S.A.; Xu, B.; Payne, L.; Wang, X.; Suzuki, Y. 2014: VCAM-1/α4β1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis. Infection and Immunity 82(7): 2826-2839

Seyedmajidi, M.; Shafaee, S.; Bijani, A.; Bagheri, S. 2013: VCAM1 and ICAM1 expression in oral lichen planus. International Journal of Molecular and Cellular Medicine 2(1): 34-40

Huang, J.; Zhang, J.; Li, H.; Lu, Z.; Shan, W.; Mercado-Uribe, I.; Liu, J. 2013: VCAM1 expression correlated with tumorigenesis and poor prognosis in high grade serous ovarian cancer. American Journal of Translational Research 5(3): 336-346

Kokovay, E.; Wang, Y.; Kusek, G.; Wurster, R.; Lederman, P.; Lowry, N.; Shen, Q.; Temple, S. 2012: VCAM1 is essential to maintain the structure of the SVZ niche and acts as an environmental sensor to regulate SVZ lineage progression. Cell Stem Cell 11(2): 220-230

Tsukasaki, K.; Utsunomiya, A.; Fukuda, H.; Shibata, T.; Fukushima, T.; Takatsuka, Y.; Ikeda, S.; Masuda, M.; Nagoshi, H.; Ueda, R.; Tamura, K.; Sano, M.; Momita, S.; Yamaguchi, K.; Kawano, F.; Hanada, S.; Tobinai, K.; Shimoyama, M.; Hotta, T.; Tomonaga, M. 2007: VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(34): 5458-5464

Muñoz, M.A.; Areche, C.; San-Martín, A.; Rovirosa, J.; Joseph-Nathan, P. 2009: VCD determination of the absolute configuration of stypotriol. Natural Product Communications 4(8): 1037-1040

Hatfield, M.P.D.; Murphy, R.F.; Lovas, S.án. 2010: VCD spectroscopic properties of the beta-hairpin forming miniprotein CLN025 in various solvents. Biopolymers 93(5): 442-450

Sadlej, J.; Dobrowolski, J.C.; Rode, J.E. 2010: VCD spectroscopy as a novel probe for chirality transfer in molecular interactions. Chemical Society Reviews 39(5): 1478-1488

Sato, H.; Yamagishi, A. 2013: VCD studies on chiral characters of metal complex oligomers. International Journal of Molecular Sciences 14(1): 964-978

Vass, E.; Strijowski, U.; Wollschläger, K.; Mándity, I.M.; Szilvágyi, G.; Jewgiński, M.; Gaus, K.; Royo, S.; Majer, Z.; Sewald, N.; Hollósi, M. 2010: VCD studies on cyclic peptides assembled from L-α-amino acids and a trans-2-aminocyclopentane- or trans-2-aminocyclohexane carboxylic acid. Journal of Peptide Science: An Official Publication of the European Peptide Society 16(11): 613-620

Merten, C.; Amkreutz, M.; Hartwig, A. 2010: VCD study of alpha-methylbenzyl amine derivatives: detection of the unchanged chiral motif. Chirality 22(8): 754-761

Felippe, L.G.; Batista, J.ão.M.; Baldoqui, D.C.; Nascimento, I.R.; Kato, M.J.; He, Y.; Nafie, L.A.; Furlan, M. 2012: VCD to determine absolute configuration of natural product molecules: secolignans from Peperomia blanda. Organic and Biomolecular Chemistry 10(21): 4208-4214

Dall'Olio, G.M.; Vahdati, A.R.; Bertranpetit, J.; Wagner, A.; Laayouni, H. 2015: VCF2Networks: applying genotype networks to single-nucleotide variants data. Bioinformatics 31(3): 438-439

Ling, Y.; Jin, Z.; Su, M.; Zhong, J.; Zhao, Y.; Yu, J.; Wu, J.; Xiao, J. 2014: VCGDB: a dynamic genome database of the Chinese population. Bmc Genomics 15: 265

Smith, N.E.; Deyrup, A.T.; Mariño-Enriquez, A.; Fletcher, J.A.; Bridge, J.A.; Illei, P.B.; Netto, G.J.; Argani, P. 2014: VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?. American Journal of Surgical Pathology 38(6): 858-863

Schleiss, M.R. 2009: VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection. Current Opinion in Molecular Therapeutics 11(5): 572-578

Bai, S.; Lu, B. 2014: VCMM: a visual tool for continuum molecular modeling. Journal of Molecular Graphics and Modelling 50: 44-49

Murakami, K.; Ichinohe, Y.; Koike, M.; Sasaoka, N.; Iemura, S-ichiro.; Natsume, T.; Kakizuka, A. 2013: VCP Is an integral component of a novel feedback mechanism that controls intracellular localization of catalase and H2O2 Levels. Plos one 8(2): E56012

Badadani, M.; Nalbandian, A.èl.; Watts, G.D.; Vesa, J.; Kitazawa, M.; Su, H.; Tanaja, J.; Dec, E.; Wallace, D.C.; Mukherjee, J.; Caiozzo, V.; Warman, M.; Kimonis, V.E. 2010: VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. Plos one 5(10)

Wilbrey, A.L.; Haley, J.E.; Wishart, T.M.; Conforti, L.; Morreale, G.; Beirowski, B.; Babetto, E.; Adalbert, R.; Gillingwater, T.H.; Smith, T.; Wyllie, D.J.A.; Ribchester, R.R.; Coleman, M.P. 2008: VCP binding influences intracellular distribution of the slow Wallerian degeneration protein, Wld(S). Molecular and Cellular Neurosciences 38(3): 325-340

Gitcho, M.A.; Strider, J.; Carter, D.; Taylor-Reinwald, L.; Forman, M.S.; Goate, A.M.; Cairns, N.J. 2009: VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. Journal of Biological Chemistry 284(18): 12384-12398

Yu, C-Chou.; Yang, J-Chin.; Chang, Y-Ching.; Chuang, J-Guang.; Lin, C-Wu.; Wu, M-Shiang.; Chow, L-Ping. 2013: VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells. Plos one 8(1): E55724

Tresse, E.; Salomons, F.A.; Vesa, J.; Bott, L.C.; Kimonis, V.; Yao, T.-P.; Dantuma, N.P.; Taylor, J.P. 2010: VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6(2): 217-227

Liu, Y.; Hei, Y.; Shu, Q.; Dong, J.; Gao, Y.; Fu, H.; Zheng, X.; Yang, G. 2012: VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma. Plos one 7(4): E35800

Albee, G.W. 1985: VCPPP update VCPPP award to be given to an article published in JPPR. Journal of Primary Prevention 6(2): 71-72

Cima, G. 2012: VCPR definition could change. Journal of the American Veterinary Medical Association 241(2): 164

He, Y-jin.; Lin, T-ting.; Zhu, L-min.; Luo, H.; Chang, J.; Zhang, H.; Zhang, H-mei. 2010: VCR-loaded nanoparticles as targeted delivery system for the treatment of orbital adenoid cystic carcinoma. Chinese Journal of Ophthalmology 46(9): 795-801

Imashuku, S.; Shioda, Y.; Tsunematsu, Y.; Imamura, T.; Morimoto, A. 2010: VCR/AraC chemotherapy and ND-CNS-LCH. Pediatric Blood and Cancer 55(1): 215-216

Hallmann, A. 2008: VCRPs, small cysteine-rich proteins, might be involved in extracellular signaling in the green alga Volvox. Plant Signaling and Behavior 3(2): 124-127

Kim, H.; Sung, S.; Cho, S.; Kim, T.-H.; Seo, K.; Kim, H. 2014: VCS: Tool for Visualizing Copy Number Variation and Single Nucleotide Polymorphism. Asian-Australasian Journal of Animal Sciences 27(12): 1691-1694

Kollmann, D.; Hogan, W.K.; Steidl, C.; Hibbs-Brenner, M.K.; Hedin, D.S.; Lichter, P.A. 2013: VCSEL based, wearable, continuously monitoring pulse oximeter. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2013: 4156-4159

Goldberg, L.; McIntosh, C.; Cole, B. 2011: VCSEL end-pumped passively Q-switched Nd:YAG laser with adjustable pulse energy. Optics Express 19(5): 4261-4267

Li, Y.; Wang, T.; Linke, R.A. 1996: VCSEL-array-based angle-multiplexed optoelectronic crossbar interconnects. Applied Optics 35(8): 1282-1295

Witzel, O.; Klein, A.; Meffert, C.; Wagner, S.; Kaiser, S.; Schulz, C.; Ebert, V. 2013: VCSEL-based, high-speed, in situ TDLAS for in-cylinder water vapor measurements in IC engines. Optics Express 21(17): 19951-19965

Guo, T.; Liu, F.; Du, F.; Zhang, Z.; Li, C.; Guan, B.-O.; Albert, J. 2013: VCSEL-powered and polarization-maintaining fiber-optic grating vector rotation sensor. Optics Express 21(16): 19097-19102

Alemie, G.Asres.; Balcha, S.Alemu. 2012: VCT clinic HIV burden and its link with HIV care clinic at the University of Gondar hospital. BMC public health 12: 1010

Coley, B.D. 2012: VCUG and the question of sedation. Pediatric Radiology 42(3): 284

Bates, D.Gregory. 2012: VCUG and the recurring question of sedation: preparation and catheterization technique are the key. Pediatric Radiology 42(3): 285-289

Cenydd, L.A.; John, N.W.; Phillips, N.I.; Gray, W.P. 2013: VCath: a tablet-based neurosurgery training tool. Studies in Health Technology and Informatics 184: 20-23

Wang, J.; Wang, X. 2012: VCells: simple and efficient superpixels using Edge-Weighted Centroidal Voronoi Tessellations. IEEE Transactions on Pattern Analysis and Machine Intelligence 34(6): 1241-1247

Pal, S.; Choudhury, L.H.; Parvin, T. 2012: VCl3 catalyzed imine-based multicomponent reactions for the facile access of functionalized tetrahydropyridines and β-amino carbonyls. Molecular Diversity 16(1): 129-143

Harris, J.F. 1948: VD control school. Surgeon's Circular Letter. United States. Far East Command. Medical Section 3(2): 9-12

Stewart, F.E. 1949: VD control; the problem and some answers. Hospital Corps Quarterly 22(3): 27-43

Bader, M. 1979: VD in China. Western Journal of Medicine 131(1): 65-66

Strino, F.; Parisi, F.; Kluger, Y. 2011: VDA, a method of choosing a better algorithm with fewer validations. Plos one 6(10): E26074

Veenman, L.; Shandalov, Y.; Gavish, M. 2008: VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. Journal of Bioenergetics and Biomembranes 40(3): 199-205

Ramírez, C.M.; González, M.; Díaz, M.; Alonso, R.; Ferrer, I.; Santpere, G.; Puig, B.; Meyer, G.; Marin, R. 2009: VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease. Molecular and Cellular Neurosciences 42(3): 172-183

Gałgańska, H.; Antoniewicz, M.; Budzińska, Młgorzata.; Gałgański, L.; Kmita, H. 2010: VDAC contributes to mRNA levels in Saccharomyces cerevisiae cells by the intracellular reduction/oxidation state dependent and independent mechanisms. Journal of Bioenergetics and Biomembranes 42(6): 483-489

Lemeshko, V.V. 2014: VDAC electronics: 1. VDAC-hexo(gluco)kinase generator of the mitochondrial outer membrane potential. Biochimica et Biophysica Acta 1838(5): 1362-1371

Lemeshko, V.V. 2014: VDAC electronics: 2. a new, anaerobic mechanism of generation of the membrane potentials in mitochondria. Biochimica et Biophysica Acta 1838(7): 1801-1808

Martel, C.éc.; Wang, Z.; Brenner, C. 2014: VDAC phosphorylation, a lipid sensor influencing the cell fate. Mitochondrion 19 Pt A: 69-77

Rostovtseva, T.K.; Bezrukov, S.M. 2008: VDAC regulation: role of cytosolic proteins and mitochondrial lipids. Journal of Bioenergetics and Biomembranes 40(3): 163-170

Rostovtseva, T.K. 2012: VDAC structure, function, and regulation of mitochondrial and cellular metabolism. Biochimica et Biophysica Acta 1818(6): 1437

Shoshan-Barmatz, V.; De Pinto, V.; Zweckstetter, M.; Raviv, Z.; Keinan, N.; Arbel, N. 2010: VDAC, a multi-functional mitochondrial protein regulating cell life and death. Molecular Aspects of Medicine 31(3): 227-285

Thinnes, F.P. 2009: VDAC-cored CaCC, CF patients best friend - finding novel therapeutics for CF. Molecular Genetics and Metabolism 97(1): 92-93

Aram, L.; Geula, S.; Arbel, N.; Shoshan-Barmatz, V. 2010: VDAC1 cysteine residues: topology and function in channel activity and apoptosis. Biochemical Journal 427(3): 445-454

Shoshan-Barmatz, V.; Mizrachi, D. 2012: VDAC1: from structure to cancer therapy. Frontiers in Oncology 2: 164

Majumder, S.; Fisk, H.A. 2013: VDAC3 and Mps1 negatively regulate ciliogenesis. Cell Cycle 12(5): 849-858

Anflous-Pharayra, K.; Lee, N.; Armstrong, D.L.; Craigen, W.J. 2011: VDAC3 has differing mitochondrial functions in two types of striated muscles. Biochimica et Biophysica Acta 1807(1): 150-156

Majumder, S.; Slabodnick, M.; Pike, A.; Marquardt, J.; Fisk, H.A. 2012: VDAC3 regulates centriole assembly by targeting Mps1 to centrosomes. Cell Cycle 11(19): 3666-3678

Sasaki, K.; Donthamsetty, R.; Heldak, M.; Cho, Y.-E.; Scott, B.T.; Makino, A. 2012: VDAC: old protein with new roles in diabetes. American Journal of Physiology. Cell Physiology 303(10): C1055-C1060

Spada, M.M.; Caselli, G.; Wells, A. 2012: A triphasic metacognitive formulation of problem drinking. Clinical Psychology and PsychoTherapy 20(6): 494-500

Shurrab, M.; Elitzur, Y.; Healey, J.S.; Gula, L.; Kaoutskaia, A.; Israel, C.; Lau, C.; Crystal, E. 2014: VDD vs DDD pacemakers: a meta-analysis. Canadian Journal of Cardiology 30(11): 1385-1391

Lygidakis, C.; Freund, T. 2013: VDGM:Vasco Da Gama Movement Awards, fund and web site. European journal of general practice 19(3): 203-204

Murray, J.M.; Messier, T.; Rivers, J.; O'Neill, J.P.; Walker, V.E.; Vacek, P.M.; Finette, B.A. 2012: VDJ recombinase-mediated TCR β locus gene usage and coding joint processing in peripheral T cells during perinatal and pediatric development. Journal of Immunology 189(5): 2356-2364

Bishop, T.C. 2009: VDNA: the virtual DNA plug-in for VMD. Bioinformatics 25(23): 3187-3188

Aslani, S.; Hossein-Nezhad, A.; Mirzaei, K.; Maghbooli, Z.; Afshar, A.N.; Karimi, F. 2011: VDR Foki polymorphism and its potential role in the pathogenesis of gestational diabetes mellitus and its complications. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(12): 1055-1060

Vasilopoulos, Y.; Sarafidou, T.; Kotsa, K.; Papadimitriou, M.; Goutzelas, Y.; Stamatis, C.; Bagiatis, V.; Tsekmekidou, X.; Yovos, J.G.; Mamuris, Z. 2013: VDR Taqi is associated with obesity in the Greek population. Gene 512(2): 237-239

Solomon, J.D.; Heitzer, M.D.; Liu, T.T.; Beumer, J.H.; Parise, R.A.; Normolle, D.P.; Leach, D.A.; Buchanan, G.; DeFranco, D.B. 2014: VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells. Molecular Cancer Research: Mcr 12(8): 1166-1180

Cozzolino, M. 2010: VDR and CaSR: from parathyroids to arteries. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 27(4): 334

Peric, M.; Koglin, S.; Dombrowski, Y.; Gross, K.; Bradac, E.; Ruzicka, T.; Schauber, J.ür. 2009: VDR and MEK-ERK dependent induction of the antimicrobial peptide cathelicidin in keratinocytes by lithocholic acid. Molecular Immunology 46(16): 3183-3187

Torkko, K.C.; van Bokhoven, A.; Mai, P.; Beuten, J.; Balic, I.; Byers, T.E.; Hokanson, J.E.; Norris, J.M.; Barón, A.E.; Lucia, M.S.; Thompson, I.M.; Leach, R.J. 2008: VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(10): 3223-3229

Kong, J.; Zhu, X.; Shi, Y.; Liu, T.; Chen, Y.; Bhan, I.; Zhao, Q.; Thadhani, R.; Li, Y.C. 2013: VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system. Molecular Endocrinology 27(12): 2116-2125

Zhang, X.; Rahemtulla, F.; Zhang, P.; Thomas, H.F. 2011: VDR deficiency affects alveolar bone and cementum apposition in mice. Archives of Oral Biology 56(7): 672-677

Willems, H.M.E.; van den Heuvel, E.G.H.M.; Carmeliet, G.; Schaafsma, A.; Klein-Nulend, J.; Bakker, A.D. 2012: VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts. Steroids 77(1-2): 126-131

Cianciolo, G.; La Manna, G.; Cappuccilli, M.L.; Lanci, N.; Della Bella, E.; Cuna, V.; Dormi, A.; Todeschini, P.; Donati, G.; Alviano, F.; Costa, R.; Bagnara, G.P.; Stefoni, S. 2011: VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy. Blood Purification 32(3): 161-173

Małodobra-Mazur, Młgorzata.; Paduch, A.; Lebioda, A.; Konopacka, M.; Rogoliński, J.; Szymczyk, C.; Wierzgoń, J.; Maciejewski, A.; Chmielik, E.; Jonkisz, A.; Półtorak, Sław.; Dobosz, T. 2012: VDR gene single nucleotide polymorphisms and their association with risk of oral cavity carcinoma. Acta Biochimica Polonica 59(4): 627-630

Kuningas, M.; Mooijaart, S.P.; Jolles, J.; Slagboom, P.E.; Westendorp, R.G.J.; van Heemst, D. 2009: VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiology of Aging 30(3): 466-473

Chandel, N.; Husain, M.; Goel, H.; Salhan, D.; Lan, X.; Malhotra, A.; McGowan, J.; Singhal, P.C. 2013: VDR hypermethylation and HIV-induced T cell loss. Journal of Leukocyte Biology 93(4): 623-631

Essa, S.; Denzer, N.; Mahlknecht, U.; Klein, R.; Collnot, E.M.; Tilgen, W.; Reichrath, J. 2010: VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells. Journal of Steroid Biochemistry and Molecular Biology 121(1-2): 110-113

Canto-Cetina, T.; Cetina Manzanilla, Jé.Antonio.; González Herrera, L.; Rojano-Mejía, D.; Coral-Vázquez, Rón.Mauricio.; Coronel, Aín.; Canto, P. 2015: VDR polymorphisms are associated with bone mineral density in post-menopausal Mayan-Mestizo women. Annals of Human Biology 42(5): 470-475

Goeman, F.; De Nicola, F.; D'Onorio De Meo, P.; Pallocca, M.; Elmi, B.; Castrignanò, T.; Pesole, G.; Strano, S.; Blandino, G.; Fanciulli, M.; Muti, P. 2014: VDR primary targets by genome-wide transcriptional profiling. Journal of Steroid Biochemistry and Molecular Biology 143: 348-356

Zhang, Y.; Guo, Q.; Zhang, Z.; Bai, N.; Liu, Z.; Xiong, M.; Wei, Y.; Xiang, R.; Tan, X. 2014: VDR status arbitrates the prometastatic effects of tumor-associated macrophages. Molecular Cancer Research: Mcr 12(8): 1181-1191

Meyer, M.B.; Goetsch, P.D.; Pike, J.W. 2012: VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Molecular Endocrinology 26(1): 37-51

Cozzolino, M.; Brancaccio, D.; Cannella, G.; Messa, P.; Gesualdo, L.; Marangella, M.; LoDeserto, C.; Pozzato, M.; Rombolà, G.; Costanzo, A.M.; di Luzio Paparatti, U.; Mazzaferro, S.; Andreucci, V.E.; Bellinghieri, G.; Bigazzi, R.; Bolasco, P.; Bonomini, M.; Cancarini, G.; Caruso, M.R.; Cascone, C.; Di Luca, M.; Emiliani, G.; Lombardi, L.; Malberti, F.; Morosetti, M.; Panzetta, G.; Procaccini, D.A.; Procida, M.; Quarello, F.; Salvadori, M.; Schena, F.P.; Stefoni, S. 2012: VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 27(9): 3588-3594

Nayak, S.; Acharjya, B. 2012: VDRL test and its interpretation. Indian Journal of Dermatology 57(1): 3-8

Drake, M.R.; Ferraro, M.C. 1997: VDT ergonomics: upper extremity assessment requires a holistic approach. Work 8(1): 15-28

Wu, S.-P.; Yang, C.-H.; Ho, C.-P.; Jane, D.-H. 2009: VDT screen height and inclination effects on visual and musculoskeletal discomfort for Chinese wheelchair users with spinal cord injuries. Industrial Health 47(1): 89-93

Holden, C. 1983: VDT's No Threat to Vision. Science 221(4608): 344

Tebboune, C.El-Bachir.; Mebarki, B. 2012: VDU workstations and vision in post office and bank operators. Work 41 Suppl. 1: 3563-3567

Shin, D.; Jeon, J.-H.; Jeong, M.; Suh, H.-W.; Kim, S.; Kim, H.-C.; Moon, O.-S.; Kim, Y.-S.; Chung, J.W.; Yoon, S.R.; Kim, W.-H.; Choi, I. 2008: VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway. Biochimica et Biophysica Acta 1783(5): 838-848

Zheng, Z.; Xu, W.; Mueller, K. 2010: VDVR: verifiable visualization of projection-based data. IEEE Transactions on Visualization and Computer Graphics 16(6): 1515-1524

Mazzei, E.M. 2013: VE debate. Australian Nursing Journal 21(1): 3

Wang, C.-H.; Hsieh, I.-C.; Chen, S.-J.; Wang, J.-S.; Cherng, W.-J.; Chen, C.-C.; Lam, I.-J.; Lin, S.-J. 2012: VE-Cadherin(low)α-smooth muscle actin+ component of vascular progenitor cells correlates with the coronary artery Gensini score. Circulation Journal: Official Journal of the Japanese Circulation Society 76(2): 477-484

Abraham, S.; Yeo, M.; Montero-Balaguer, M.; Paterson, H.; Dejana, E.; Marshall, C.J.; Mavria, G. 2009: VE-Cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation. Current Biology: Cb 19(8): 668-674

Yuan, Y.; Luo, Y.; Chung, A.C.S. 2011: VE-LLI-VO: vessel enhancement using local line integrals and variational optimization. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 20(7): 1912-1924

Winderlich, M.; Keller, L.; Cagna, G.; Broermann, A.; Kamenyeva, O.; Kiefer, F.; Deutsch, U.; Nottebaum, A.F.; Vestweber, D. 2009: VE-PTP controls blood vessel development by balancing Tie-2 activity. Journal of Cell Biology 185(4): 657-671

Nottebaum, A.F.; Cagna, G.; Winderlich, M.; Gamp, A.C.; Linnepe, R.; Polaschegg, C.; Filippova, K.; Lyck, R.; Engelhardt, B.; Kamenyeva, O.; Bixel, M.G.; Butz, S.; Vestweber, D. 2008: VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. Journal of Experimental Medicine 205(12): 2929-2945

O'Leary, H.; Akers, S.M.; Piktel, D.; Walton, C.; Fortney, J.E.; Martin, K.H.; Craig, M.; Coad, J.; Gibson, L.F. 2010: VE-cadherin Regulates Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Sensitivity to Apoptosis. Cancer Microenvironment: Official Journal of the International Cancer Microenvironment Society 3(1): 67-81

Sidibé, A.; Polena, H.; Pernet-Gallay, K.; Razanajatovo, J.; Mannic, T.; Chaumontel, N.; Bama, S.; Maréchal, I.èn.; Huber, P.; Gulino-Debrac, D.; Bouillet, L.; Vilgrain, I. 2014: VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs. American Journal of Physiology. Heart and Circulatory Physiology 307(3): H455-H463

Akers, S.M.; O'Leary, H.A.; Minnear, F.L.; Craig, M.D.; Vos, J.A.; Coad, J.E.; Gibson, L.F. 2010: VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers. Experimental Hematology 38(9): 733-743

Giannotta, M.; Trani, M.; Dejana, E. 2013: VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Developmental Cell 26(5): 441-454

Bravi, L.; Dejana, E.; Lampugnani, M.G. 2014: VE-cadherin at a glance. Cell and Tissue Research 355(3): 515-522

Golovkine, G.; Faudry, E.; Bouillot, S.ép.; Voulhoux, R.é; Attrée, I.; Huber, P. 2014: VE-cadherin cleavage by LasB protease from Pseudomonas aeruginosa facilitates type IIi secretion system toxicity in endothelial cells. Plos Pathogens 10(3): E1003939

Oberlin, E.; Fleury, M.; Clay, D.; Petit-Cocault, L.; Candelier, J.-J.; Mennesson, B.ît.; Jaffredo, T.; Souyri, M.èl. 2010: VE-cadherin expression allows identification of a new class of hematopoietic stem cells within human embryonic liver. Blood 116(22): 4444-4455

Komarova, Y.A.; Huang, F.; Geyer, M.; Daneshjou, N.; Garcia, A.; Idalino, L.; Kreutz, B.; Mehta, D.; Malik, A.B. 2012: VE-cadherin signaling induces EB3 phosphorylation to suppress microtubule growth and assemble adherens junctions. Molecular Cell 48(6): 914-925

Monaghan-Benson, E.; Burridge, K. 2013: VE-cadherin status as an indicator of microvascular permeability. Methods in Molecular Biology 1046: 335-342

Bouillet, L.; Vilgrain, I. 2014: VE-cadherin, a potential marker for endothelial cell activation during hereditary angioedema attacks. Journal of Allergy and Clinical Immunology 134(1): 241

Hamilla, S.M.; Stroka, K.M.; Aranda-Espinoza, H. 2014: VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration. Plos one 9(10): E109748

Harris, E.S.; Nelson, W.J. 2010: VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Current Opinion in Cell Biology 22(5): 651-658

Huang, C.; Yuan, X.; Wan, Y.; Liu, F.; Chen, X.; Zhan, X.; Li, X. 2014: VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network. International Journal of Clinical and Experimental Pathology 7(3): 1022-1031

Huang, C.; Yuan, X.; Li, Z.; Tian, Z.; Zhan, X.; Zhang, J.; Li, X. 2014: VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro. International Journal of Clinical and Experimental Pathology 7(3): 1077-1084

Le Bras, A.; Samson, C.; Trentini, M.; Caetano, B.; Lelievre, E.; Mattot, V.; Beermann, F.; Soncin, F. 2010: VE-statin/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2. Plos one 5(8): E12156

Moore, B.; Brubaker, P.H.; Stewart, K.P.; Kitzman, D.W. 2007: VE/VCO2 slope in older heart failure patients with normal versus reduced ejection fraction compared with age-matched healthy controls. Journal of Cardiac Failure 13(4): 259-262

Mordes, D.A.; Lynch, K.; Campbell, S.; Dias-Santagata, D.; Nose, V.; Louis, D.N.; Hoang, M.P. 2014: VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations. American Journal of Clinical Pathology 141(6): 811-815

Sajanti, S.; Sirniö, Päivi.; Väyrynen, J.P.; Tuomisto, A.; Klintrup, K.; Mäkelä, J.; Ristimäki, A.; Mäkinen, M.J. 2014: VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma. Virchows Archiv: An International Journal of Pathology 464(6): 637-643

Sperveslage, J.; Gierke, M.; Capper, D.; Honegger, J.ür.; Sipos, B.; Beschorner, R.; Schittenhelm, J. 2013: VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation. Acta Neuropathologica 125(6): 911-912

Laskowski-Peak, M.C.; Calvo, A.M.; Rohrssen, J.; Smulian, A.G. 2012: VEA1 is required for cleistothecial formation and virulence in Histoplasma capsulatum. Fungal Genetics and Biology: Fg and B 49(10): 838-846

Potron, A.ïs.; Poirel, L.; Elhag, K.; Al Yaqoubi, F.; Nordmann, P. 2009: VEB-6 extended-spectrum beta-lactamase-producing Proteus mirabilis from Sultanate of Oman. International Journal of Antimicrobial Agents 34(5): 493-494

Archambault, D. 2008: VEBA is shifting Michigan's health care gears. Michigan Medicine 107(2): 10-12

Atkinson, W. 2008: VEBAs employers to unions: see if you can do better. Biotechnology Healthcare 5(4): 16-26

Mangold, M.; Wittwer, V.J.; Sieber, O.D.; Hoffmann, M.; Krestnikov, I.L.; Livshits, D.A.; Golling, M.; Südmeyer, T.; Keller, U. 2012: VECSEL gain characterization. Optics Express 20(4): 4136-4148

Anonymous 1948: VECTOR of scrub typhus in Bengal. Nature 162(4133): 107

Melcher, J.; Hu, S.; Raman, A. 2008: VEDA: a web-based virtual environment for dynamic atomic force microscopy. Review of Scientific Instruments 79(6): 061301

Linkin, V.M.; Kerzhanovich, V.V.; Lipatov, A.N.; Pichkadze, K.M.; Shurupov, A.A.; Terterashvili, A.V.; Ingersoli, A.P.; Crisp, D.; Grossman, A.W.; Young, R.E.; Seiff, A.; Ragent, B.; Blamont, J.E.; Elson, L.S.; Preston, R.A. 1986: VEGA Balloon Dynamics and Vertical Winds in the Venus Middle Cloud Region. Science 231(4744): 1417-1419

Kremnev, R.S.; Linkin, V.M.; Lipatov, A.N.; Pichkadze, K.M.; Shurupov, A.A.; Terterashvili, A.V.; Bakitko, R.V.; Blamont, J.E.; Malique, C.; Ragent, B.; Preston, R.A.; Elson, L.S.; Crisp, D. 1986: VEGA Balloon System and Instrumentation. Science 231(4744): 1408-1411

Kerr, R.A. 1986: VEGA's 1 and 2 Visit Halley: Soviet spacecraft obtain photos showing Halley is king of the comets. Science 231(4744): 1366

Morganella, S.; Cerulo, L.; Viglietto, G.; Ceccarelli, M. 2010: VEGA: variational segmentation for copy number detection. Bioinformatics 26(24): 3020-3027

McBride, T.H. 1885: VEGETABLE MORPHOLOGY a CENTURY AGO. -- Goethe. Science 6(132): 130-131

McBride, T.H. 1885: VEGETABLE MORPHOLOGY a CENTURY AGO.--Linne and Wolff. Science 5(123): 477-478

Reith, J.F.; Indemans, A.W.M.; Becker, W.R. 1948: The content of morphine and alkaloids in the puff of blue poppy seed varieties, cultivated in Dutch experimental fields in 1947. Pharmaceutisch Weekblad 83(29-30): 449-459

Anonymous 1946: VEGETABLE ghee. Current Science 15: 94

Guo, Q.; Dai, S.-B.; Shen, F.; Yu, D.; Shen, S.-T.; Zhang, Q.; Huang, J.-X.; Wu, Z.-D. 2014: VEGF +405G/C (rs2010963) polymorphisms and digestive system cancer risk: a meta-analysis. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(5): 4977-4982

Zhao, S.-F.; Zhan, P.; Yang, X.-D.; Lu, M.-X.; Sun, G.-W.; Wang, Y.-X.; Zhang, Y.-K.; Pu, Y.-M.; Tang, E.-Y. 2013: VEGF +936C/T and +460C/T gene polymorphisms and oral cancer risk: a meta-analysis. Molecular Biology Reports 40(12): 6637-6643

Xu, B.; Feng, N.-H.; Tong, N.; Wang, Z.-D.; Zhang, W.; Wu, H.-F.; Hua, L.-X. 2010: VEGF -460C>T polymorphism and cancer risk: a meta-analysis. Medical Oncology 27(4): 1031-1036

Tamura, T.; Kuwahara, A.; Yamamori, M.; Nishiguchi, K.; Nakamura, T.; Okuno, T.; Miki, I.; Manabe, Y.; Sakaeda, T. 2012: VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. International Journal of Medical Sciences 9(10): 833-837

Qiu, M.; Xiong, W.; Liao, H.; Li, F. 2013: VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis. Gene 518(2): 310-315

Rodrigues, C.G.; Plentz, R.D.M.; Dipp, T.; Salles, F.B.; Giusti, I.I.; Sant'Anna, R.T.; Eibel, B.; Nesralla, I.A.; Markoski, M.; Beyer, N.N.; Kalil, R.A.K. 2013: VEGF 165 gene therapy for patients with refractory angina: mobilization of endothelial progenitor cells. Arquivos Brasileiros de Cardiologia 101(2): 149-153

Wehrschuetz, M.; Schöllnast, H.; Wehrschuetz, E.; Renner, W.; Luschin, G. 2009: VEGF 936C > T Polymorphism and Association of BI-RADS Score in Women with Suspected Breast Cancer. Breast cancer: basic and clinical research 3: 77-81

Gu, D.; Wang, M. 2011: VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls. Breast Cancer Research and Treatment 125(2): 489-493

Liu, L.; Hua, F-Zhou.; Cao, J-Qing.; Zhu, P-Qian. 2011: VEGF 936C>T polymorphism and breast cancer risk: evidence needed further clarification. Breast Cancer Research and Treatment 127(2): 569-571

Cruz-González, F.; Cieza-Borrella, C.; Cabrillo-Estévez, L.; Cañete-Campos, C.; Escudero-Domínguez, F.; González-Sarmiento, R. 2013: VEGF a (rs699947 and rs833061) and VEGFR2 (rs2071559) gene polymorphisms are not associated with AMD susceptibility in a Spanish population. Current Eye Research 38(12): 1274-1277

Sakaeda, T.; Yamamori, M.; Kuwahara, A.; Hiroe, S.; Nakamura, T.; Okumura, K.; Okuno, T.; Miki, I.; Chayahara, N.; Okamura, N.; Tamura, T. 2008: VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients. Therapeutic Drug Monitoring 30(4): 497-503

Hao, Q.; Zhu, Y.; Su, H.; Shen, F.; Yang, G.-Y.; Kim, H.; Young, W.L. 2010: VEGF Induces more Severe Cerebrovascular Dysplasia in Endoglin than in Alk1 Mice. Translational Stroke Research 1(3): 197-201

De Castro, L.F.; Maycas, M.; Bravo, B.; Esbrit, P.; Gortazar, A. 2015: VEGF Receptor 2 (VEGFR2) Activation Is Essential for Osteocyte Survival Induced by Mechanotransduction. Journal of Cellular Physiology 230(2): 278-285

Karali, E.; Bellou, S.; Stellas, D.; Klinakis, A.; Murphy, C.; Fotsis, T. 2014: VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress. Molecular Cell 54(4): 559-572

Narasimhan, P.; Liu, J.; Song, Y.S.; Massengale, J.L.; Chan, P.H. 2009: VEGF Stimulates the ERK 1/2 signaling pathway and apoptosis in cerebral endothelial cells after ischemic conditions. Stroke 40(4): 1467-1473

Yamamori, M.; Taniguchi, M.; Maeda, S.; Nakamura, T.; Okamura, N.; Kuwahara, A.; Iwaki, K.; Tamura, T.; Aoyama, N.; Markova, S.; Kasuga, M.; Okumura, K.; Sakaeda, T. 2008: VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese. International Journal of Medical Sciences 5(2): 80-86

Becker, G.; Blum, H.E. 2012: VEGF Trap for the treatment of malignant ascites. LANCET. Oncology 13(2): 115-116

Gomez-Manzano, C.; Holash, J.; Fueyo, J.; Xu, J.; Conrad, C.A.; Aldape, K.D.; de Groot, J.F.; Bekele, B.N.; Yung, W.K.A. 2008: VEGF Trap induces antiglioma effect at different stages of disease. Neuro-Oncology 10(6): 940-945

Oliveira, H.B.; Sakimoto, T.; Javier, J.A.D.; Azar, D.T.; Wiegand, S.J.; Jain, S.; Chang, J.-H. 2010: VEGF Trap(R1R2) suppresses experimental corneal angiogenesis. European Journal of Ophthalmology 20(1): 48-54

Dixon, J.A.; Oliver, S.C.N.; Olson, J.L.; Mandava, N. 2009: VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration. Expert Opinion on Investigational Drugs 18(10): 1573-1580

Howell, K.R.; Hoda, M.N.; Pillai, A. 2013: VEGF activates NR2B phosphorylation through Dab1 pathway. Neuroscience Letters 552: 30-34

Yang, J.; Yao, Y.; Chen, T.; Zhang, T. 2014: VEGF ameliorates cognitive impairment in in vivo and in vitro ischemia via improving neuronal viability and function. Neuromolecular Medicine 16(2): 376-388

Farkas, L.; Farkas, D.; Ask, K.; Möller, A.; Gauldie, J.; Margetts, P.; Inman, M.; Kolb, M. 2009: VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. Journal of Clinical Investigation 119(5): 1298-1311

Sobczyńska-Rak, A.; Brodzki, A. 2014: VEGF and 17-β-estradiol levels after tamoxifen administration in canine hepatoid gland adenomas and hepatoid gland epitheliomas. In Vivo 28(5): 871-877

Wang, L.; Gao, W.; Xiong, K.; Hu, K.; Liu, X.; He, H. 2014: VEGF and BFGF Expression and Histological Characteristics of the Bone-Tendon Junction during Acute Injury Healing. Journal of Sports Science and Medicine 13(1): 15-21

Zhang, W.; Zhu, C.; Wu, Y.; Ye, D.; Wang, S.; Zou, D.; Zhang, X.; Kaplan, D.L.; Jiang, X. 2014: VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. European Cells and Materials 27: 1-11; Discussion: 11-12

Cui, F.; Wang, X.; Liu, X.; Dighe, A.S.; Balian, G.; Cui, Q. 2010: VEGF and BMP-6 enhance bone formation mediated by cloned mouse osteoprogenitor cells. Growth Factors 28(5): 306-317

Wang, D.; Weng, Q.; Zhang, L.; He, Q.; Yang, B. 2009: VEGF and Bcl-2 interact via MAPKs signaling pathway in the response to hypoxia in neuroblastoma. Cellular and Molecular Neurobiology 29(3): 391-401

Kukreja, I.; Kapoor, P.; Deshmukh, R.; Kulkarni, V. 2013: VEGF and CD 34: a correlation between tumor angiogenesis and microvessel density-an immunohistochemical study. Journal of Oral and Maxillofacial Pathology: Jomfp 17(3): 367-373

Stepan, D.; Simionescu, C.; Stepan, A.; Muntean, M.; Voinea, B. 2012: VEGF and CD105 immunoexpression in squamous cervical carcinomas and associated precancerous lesions. Romanian Journal of Morphology and Embryology 53(3): 585-589

Cristina, C.; Perez-Millan, Mía.Inés.; Luque, G.; Dulce, Rúl.Ariel.; Sevlever, G.; Berner, S.Inés.; Becu-Villalobos, D. 2010: VEGF and CD31 association in pituitary adenomas. Endocrine Pathology 21(3): 154-160

Melinte, R.; Jung, I.; Georgescu, L.; Gurzu, S. 2012: VEGF and CD31 expression in arthritic synovium and cartilage of human knee joints. Romanian Journal of Morphology and Embryology 53(4): 911-915

Zhou, Q.; Zhu, Y.; Deng, Z.; Long, H.; Zhang, S.; Chen, X. 2011: VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma. Surgical Oncology 20(1): 13-19

Stratman, A.N.; Davis, M.J.; Davis, G.E. 2011: VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood 117(14): 3709-3719

Bilgici, B.; Ecemis, G.C.; Tuncel, O.K.; Bayrak, I.K.; Kan, E.K.; Atmaca, A. 2014: VEGF and GM-CSF levels in nodular thyroid diseases. Endocrine 45(1): 61-66

Pierre, M.; Yoshimoto, M.; Huang, L.; Richardson, M.; Yoder, M.C. 2009: VEGF and IHH rescue definitive hematopoiesis in Gata-4 and Gata-6-deficient murine embryoid bodies. Experimental Hematology 37(9): 1038-1053

Rovina, N.; Hillas, G.; Dima, E.; Vlastos, F.; Loukides, S.; Veldekis, D.; Roussos, C.; Alhanatis, M.; Bakakos, P. 2011: VEGF and IL-18 in induced sputum of lung cancer patients. Cytokine 54(3): 277-281

Sobti, R.C.; Maithil, N.; Thakur, H.; Sharma, Y.; Talwar, K.K. 2010: VEGF and IL-4 gene variability and its association with the risk of coronary heart disease in north Indian population. Molecular and Cellular Biochemistry 341(1-2): 139-148

Georgiadou, D.; Sergentanis, T.N.; Sakellariou, S.; Filippakis, G.M.; Zagouri, F.; Vlachodimitropoulos, D.; Psaltopoulou, T.; Lazaris, A.C.; Patsouris, E.; Zografos, G.C. 2014: VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 40(10): 1331-1337

Kaku, M.; Motokawa, M.; Tohma, Y.; Tsuka, N.; Koseki, H.; Sunagawa, H.; Arturo Marquez Hernandes, R.; Ohtani, J.; Fujita, T.; Kawata, T.; Tanne, K. 2008: VEGF and M-CSF levels in periodontal tissue during tooth movement. Biomedical Research 29(4): 181-187

Boëck-Neto, R.J.; Artese, L.; Piattelli, A.; Shibli, J.A.; Perrotti, V.; Piccirilli, M.; Marcantonio, E. 2009: VEGF and MVD expression in sinus augmentation with autologous bone and several graft materials. Oral Diseases 15(2): 148-154

Hellström, M.; Phng, L.-K.; Gerhardt, H. 2007: VEGF and Notch signaling: the yin and yang of angiogenic sprouting. Cell Adhesion and Migration 1(3): 133-136

Kannan, R.; Sreekumar, P.G.; Hinton, D.R. 2011: VEGF and PEDF secretion in ARPE-19 and fhRPE cells. Investigative Ophthalmology and Visual Science 52(12): 9047

Combs, M.D.; Yutzey, K.E. 2009: VEGF and RANKL regulation of NFATc1 in heart valve development. Circulation Research 105(6): 565-574

Scartozzi, M.; Faloppi, L.; Svegliati Baroni, G.; Loretelli, C.; Piscaglia, F.; Iavarone, M.; Toniutto, P.; Fava, G.; De Minicis, S.; Mandolesi, A.; Bianconi, M.; Giampieri, R.; Granito, A.; Facchetti, F.; Bitetto, D.; Marinelli, S.; Venerandi, L.; Vavassori, S.; Gemini, S.; D'Errico, A.; Colombo, M.; Bolondi, L.; Bearzi, I.; Benedetti, A.; Cascinu, S. 2014: VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study. International Journal of Cancer 135(5): 1247-1256

Mărgăritescu, C.; Pirici, D.; Simionescu, C.; Mogoantă, L.; Raica, M.; Stîngă, A.; Ciurea, R.; Stepan, A.; Stîngă, A.; Ribatti, D. 2009: VEGF and VEGFRs expression in oral squamous cell carcinoma. Romanian Journal of Morphology and Embryology 50(4): 527-548

McKay, G.J.; Silvestri, G.; Orr, N.; Chakravarthy, U.; Hughes, A.E. 2009: VEGF and age-related macular degeneration. Ophthalmology 116(6): 1227.E1-3

Roscoe, W.A.; Welsh, M.E.; Carter, D.E.; Karlik, S.J. 2009: VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. Journal of Neuroimmunology 209(1-2): 6-15

Saharinen, P.; Eklund, L.; Pulkki, K.; Bono, P.; Alitalo, K. 2011: VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends in Molecular Medicine 17(7): 347-362

Sinnathamby, T.; Yun, J.; Clavet-Lanthier, M.-Él.; Cheong, C.; Sirois, M.G. 2015: VEGF and angiopoietins promote inflammatory cell recruitment and mature blood vessel formation in murine sponge/Matrigel model. Journal of Cellular Biochemistry 116(1): 45-57

Wróbel, T.; Mazur, G.; Dzietczenia, J.; Gębura, K.; Kuliczkowski, K.; Bogunia-Kubik, K. 2013: VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma. Biomed Research International 2013: 159813

Wang, L.; Ying, Y.-f.; Ouyang, Y.-l.; Wang, J.-f.; Xu, J. 2013: VEGF and bFGF increase survival of xenografted human ovarian tissue in an experimental rabbit model. Journal of Assisted Reproduction and Genetics 30(10): 1301-1311

Zhang, L.-Y.; Fan, Y.-Y.; Liu, Z. 2009: VEGF and central nervous system diseases. Zhejiang da Xue Xue Bao. Yi Xue Ban 38(6): 644-648

Wang, X.; Cao, W.; Mo, M.; Wang, W.; Wu, H.; Wang, J. 2010: VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer. Journal of Surgical Oncology 102(4): 325-330

Bhavina, K.; Radhika, J.; Pandian, S.S. 2014: VEGF and eNOS expression in umbilical cord from pregnancy complicated by hypertensive disorder with different severity. Biomed Research International 2014: 982159

Gerhardt, H. 2008: VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 4(4): 241-246

Ciurea, R.; Mărgăritescu, C.; Simionescu, C.; Stepan, A.; Ciurea, M. 2011: VEGF and his R1 and R2 receptors expression in mast cells of oral squamous cells carcinomas and their involvement in tumoral angiogenesis. Romanian Journal of Morphology and Embryology 52(4): 1227-1232

Liu, Z.; Kobayashi, K.; van Dinther, M.; van Heiningen, S.H.; Valdimarsdottir, G.; van Laar, T.; Scharpfenecker, M.; Löwik, C.W.G.M.; Goumans, M.-J.é; Ten Dijke, P.; Pardali, E. 2009: VEGF and inhibitors of TGFbeta type-i receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression. Journal of Cell Science 122(Part 18): 3294-3302

Lin, J.; Li, G.; Den, X.; Xu, C.; Liu, S.; Gao, Y.; Liu, H.; Zhang, J.; Li, X.; Liang, S. 2010: VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X₂(/)₃ receptor of primary sensory neurons. Brain Research Bulletin 83(5): 284-291

Allerstorfer, D.; Longato, S.; Schwarzer, C.; Fischer-Colbrie, R.; Hayman, A.R.; Blumer, M.J.F. 2010: VEGF and its role in the early development of the long bone epiphysis. Journal of Anatomy 216(5): 611-624

Faratzis, G.; Tsiambas, E.; Rapidis, A.D.; Machaira, A.; Xiromeritis, K.; Patsouris, E. 2009: VEGF and ki 67 expression in squamous cell carcinoma of the tongue: An immunohistochemical and computerized image analysis study. Oral Oncology 45(7): 584-588

Hamzaoui, K.; Ayed, K.; Hamza, M.'H.; Hamzaoui, A.ès. 2009: VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement. Journal of Neuroimmunology 213(1-2): 148-153

Partyka, R.; Gonciarz, M.; Jałowiecki, P.ła.; Kokocińska, D.; Byrczek, T. 2012: VEGF and metalloproteinase 2 (MMP 2) expression in gastric cancer tissue. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 18(4): Br130-Br134

Salvolini, E.; Orciani, M.; Lucarini, G.; Vignini, A.; Tranquilli, A.L.; Di Primio, R. 2011: VEGF and nitric oxide synthase immunoexpression in Down's syndrome amniotic fluid stem cells. European Journal of Clinical Investigation 41(1): 23-29

Scheven, B.A.; Man, J.; Millard, J.L.; Cooper, P.R.; Lea, S.C.; Walmsley, A.D.; Smith, A.J. 2009: VEGF and odontoblast-like cells: stimulation by low frequency ultrasound. Archives of Oral Biology 54(2): 185-191

Mehrazma, M.; Mahjoob, F.; Rafsanjani, K.A.; Jafari, D.; Farahani, S.J.; Lahouti H, A. 2013: VEGF and p53 biomarkers in pediatric patients with Langerhans cell histiocytosis. Journal of Pediatric Hematology/Oncology 35(7): E292-E295

Lynn, K.D.; Roland, C.L.; Brekken, R.A. 2010: VEGF and pleiotrophin modulate the immune profile of breast cancer. Cancers 2(2): 970-988

Botelho, F.; Pina, F.; Lunet, N. 2010: VEGF and prostatic cancer: a systematic review. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 19(5): 385-392

Jonas, J.B.; Tao, Y.; Neumaier, M.; Findeisen, P. 2010: VEGF and refractive error. Ophthalmology 117(11): 2234.E1

Simons, M. 2009: VEGF and restenosis: the rest of the story. Arteriosclerosis Thrombosis and Vascular Biology 29(4): 439-440

Wu, F.T.H.; Stefanini, M.O.; Mac Gabhann, F.; Kontos, C.D.; Annex, B.H.; Popel, A.S. 2010: VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model. American Journal of Physiology. Heart and Circulatory Physiology 298(6): H2174-H2191

Miura, Y.; Klettner, A.; Roider, J. 2010: VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: possible participation of intracellular glutathione. Investigative Ophthalmology and Visual Science 51(9): 4848-4855

Ghosh, S.; Maity, P. 2010: VEGF antibody plus cisplatin reduces angiogenesis and tumor growth in a xenograft model of ovarian cancer. Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 29(1): 17-30

Vourtsis, S.A.; Spyriounis, P.K.; Agrogiannis, G.D.; Ionac, M.; Papalois, A.E. 2012: VEGF application on rat skin flap survival. Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research 25(1): 14-19

Barak, V.; Pe'er, J.; Kalickman, I.; Frenkel, S. 2011: VEGF as a biomarker for metastatic uveal melanoma in humans. Current Eye Research 36(4): 386-390

Burstein, H.J.; Chen, Y.-H.; Parker, L.M.; Savoie, J.; Younger, J.; Kuter, I.; Ryan, P.D.; Garber, J.E.; Chen, H.; Campos, S.M.; Shulman, L.N.; Harris, L.N.; Gelman, R.; Winer, E.P. 2008: VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(23): 7871-7877

Yoon, M.S.; Nam, T.-K.; Lee, J.-S.; Cho, S.-H.; Song, J.-Y.; Ahn, S.-J.; Chung, I.-J.; Jeong, J.-U.; Chung, W.-K.; Nah, B.-S. 2011: VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinoma. Journal of Korean Medical Science 26(4): 513-520

Greenberg, J.I.; Cheresh, D.A. 2009: VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy. Expert Opinion on Biological Therapy 9(11): 1347-1356

Bellou, S.; Hink, M.A.; Bagli, E.; Panopoulou, E.; Bastiaens, P.I.H.; Murphy, C.; Fotsis, T. 2009: VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells. American Journal of Physiology. Cell Physiology 297(6): C1477-C1489

Herzog, B.; Pellet-Many, C.; Britton, G.; Hartzoulakis, B.; Zachary, I.C. 2011: VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Molecular Biology of the Cell 22(15): 2766-2776

Yin, D.; Jia, T.; Gong, W.; Yu, H.; Wooley, P.H.; Mott, M.P.; Yang, S.-Y. 2008: VEGF blockade decelerates the growth of a murine experimental osteosarcoma. International Journal of Oncology 33(2): 253-259

Fan, X.; Krieg, S.; Kuo, C.J.; Wiegand, S.J.; Rabinovitch, M.; Druzin, M.L.; Brenner, R.M.; Giudice, L.C.; Nayak, N.R. 2008: VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 22(10): 3571-3580

Zhang, J.; Silva, T.; Yarovinsky, T.; Manes, T.D.; Tavakoli, S.; Nie, L.; Tellides, G.; Pober, J.S.; Bender, J.R.; Sadeghi, M.M. 2010: VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling. Circulation Research 107(3): 408-417

Ishida, S. 2010: VEGF blockers. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 9): 304-309

Phillips, J.M.; Goodman, J.I. 2009: Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors. Toxicological Sciences: An Official Journal of the Society of Toxicology 108(2): 273-289

Takyar, S.; Vasavada, H.; Zhang, J.-g.; Ahangari, F.; Niu, N.; Liu, Q.; Lee, C.G.; Cohn, L.; Elias, J.A. 2013: VEGF controls lung Th2 inflammation via the miR-1-Mpl (myeloproliferative leukemia virus oncogene)-P-selectin axis. Journal of Experimental Medicine 210(10): 1993-2010

Zhou, Q.; Liu, H.; Qiao, F.; Wu, Y.; Xu, J. 2010: VEGF deficit is involved in endothelium dysfunction in preeclampsia. Journal of Huazhong University of Science and Technology. Medical Sciences 30(3): 370-374

Luo, X.; Feng, M.; Zhu, X.; Li, Y.; Fei, J.; Zhang, Y. 2013: VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia. Hematology 18(6): 334-340

Ziogas, A.C.; Gavalas, N.G.; Tsiatas, M.; Tsitsilonis, O.; Politi, E.; Terpos, E.; Rodolakis, A.; Vlahos, G.; Thomakos, N.; Haidopoulos, D.; Antsaklis, A.; Dimopoulos, M.A.; Bamias, A. 2012: VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2. International Journal of Cancer 130(4): 857-864

Gonzalez-Moreno, O.; Lecanda, J.; Green, J.E.; Segura, V.; Catena, R.; Serrano, D.; Calvo, A. 2010: VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. Experimental Cell Research 316(4): 554-567

Wang, Y.-Q.; Cui, H.-R.; Yang, S.-Z.; Sun, H.-P.; Qiu, M.-H.; Feng, X.-Y.; Sun, F.-Y. 2009: VEGF enhance cortical newborn neurons and their neurite development in adult rat brain after cerebral ischemia. Neurochemistry International 55(7): 629-636

Yang, Q.; McHugh, K.P.; Patntirapong, S.; Gu, X.; Wunderlich, L.; Hauschka, P.V. 2008: VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biology: Journal of the International Society for Matrix Biology 27(7): 589-599

Cao, Y.; E, G.; Wang, E.; Pal, K.; Dutta, S.K.; Bar-Sagi, D.; Mukhopadhyay, D. 2012: VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression. Cancer Research 72(16): 3912-3918

Mărgăritescu, C.; Pirici, D.; Stîngă, A.; Simionescu, C.; Raica, M.; Mogoantă, L.; Stepan, A.; Ribatti, D. 2010: VEGF expression and angiogenesis in oral squamous cell carcinoma: an immunohistochemical and morphometric study. Clinical and Experimental Medicine 10(4): 209-214

Li, C.-R.; Sun, S.-G. 2010: VEGF expression and cell apoptosis in NOD mouse retina. International Journal of Ophthalmology 3(3): 224-227

Ganggaiswari, A.; Kresno, S.B.; Krisnuhoni, E. 2010: VEGF expression and desmoplastic reaction as potential progressive factors in young patients with colorectal cancer. Acta Medica Indonesiana 42(1): 6-11

Minardi, D.; Lucarini, G.; Santoni, M.; Mazzucchelli, R.; Burattini, L.; Pistelli, M.; Bianconi, M.; Di Primio, R.; Scartozzi, M.; Montironi, R.; Cascinu, S.; Muzzonigro, G. 2013: VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma. Anticancer Research 33(11): 5017-5022

Urick, M.E.; Giles, J.R.; Johnson, P.A. 2008: VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecologic Oncology 110(3): 418-424

Bajpai, J.; Sharma, M.; Sreenivas, V.; Kumar, R.; Gamnagatti, S.; Khan, S.A.; Rastogi, S.; Malhotra, A.; Bakhshi, S. 2009: VEGF expression as a prognostic marker in osteosarcoma. Pediatric Blood and Cancer 53(6): 1035-1039

Mederle, O.; Mederle, N.; Bocan, E.V.; Ceauşu, R.; Raica, M. 2010: VEGF expression in dog mastocytoma. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 114(1): 185-188

Andrini, L.; Blanco, A.Fernandez.; Inda, A.; García, M.; Garcia, A.; Errecalde, A. 2011: VEGF expression in hepatectomized tumor-bearing mice. Journal of Immunoassay and Immunochemistry 32(4): 318-325

Mărgăritescu, O.; Pirici, D.; Mărgăritescu, C. 2011: VEGF expression in human brain tissue after acute ischemic stroke. Romanian Journal of Morphology and Embryology 52(4): 1283-1292

Liu, B.; Li, X.; Liang, G.; Liu, X. 2011: VEGF expression in mesenchymal stem cells promotes bone formation of tissue-engineered bones. Molecular Medicine Reports 4(6): 1121-1126

Scott, A.; Lian, Øy.; Bahr, R.; Hart, D.A.; Duronio, V. 2008: VEGF expression in patellar tendinopathy: a preliminary study. Clinical Orthopaedics and Related Research 466(7): 1598-1604

Wang, J.; Ikeda, R.; Che, X.-F.; Ooyama, A.; Yamamoto, M.; Furukawa, T.; Hasui, K.; Zheng, C.-L.; Tajitsu, Y.; Oka, T.; Tabata, S.; Nishizawa, Y.; Eizuru, Y.; Akiyama, S.-I. 2013: VEGF expression is augmented by hypoxia‑induced PGIS in human fibroblasts. International Journal of Oncology 43(3): 746-754

Koh, Y.; Lee, H.E.; Im, S.-A.; Kim, S.-H.; Kim, T.M.; Han, S.-W.; Oh, D.-Y.; Kim, J.H.; Lee, S.-H.; Kim, D.-W.; Kim, T.-Y.; Kim, W.-H.; Heo, D.S.; Bang, Y.-J. 2011: VEGF expression is related to good response and long progression-free survival in gastrointestinal stromal tumor patients treated with Sunitinib. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 20(3): 143-147

Anonymous 1913: Wealth's Opportunity. Hospital 54(1402): 212

Fujii, T.; Yonemitsu, Y.; Onimaru, M.; Inoue, M.; Hasegawa, M.; Kuwano, H.; Sueishi, K. 2008: VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis. Atherosclerosis 200(1): 51-57

Tinahones, F.; Salas, J.; Mayas, M.ía.D.; Ruiz-Villalba, A.; Macias-Gonzalez, M.; Garrido-Sanchez, L.; DeMora, M.; Moreno-Santos, I.; Bernal, R.; Cardona, F.; El Bekay, R. 2009: VEGF gene expression in adult human thymus fat: a correlative study with hypoxic induced factor and cyclooxygenase-2. Plos one 4(12): E8213

Smirnikhina, S.A.; Lavrov, A.V.; Bochkov, N.P. 2011: VEGF gene expression in transfected human multipotent stromal cells. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 9: 54-57

Pabst, S.; Karpushova, A.; Diaz-Lacava, A.; Herms, S.; Walier, M.; Zimmer, S.; Cichon, S.; Nickenig, G.; Nöthen, M.M.; Wienker, T.F.; Grohé, C. 2010: VEGF gene haplotypes are associated with sarcoidosis. Chest 137(1): 156-163

Amoli, M.M.; Amiri, P.; Alborzi, A.; Larijani, B.; Saba, S.; Tavakkoly-Bazzaz, J. 2012: VEGF gene mRNA expression in patients with coronary artery disease. Molecular Biology Reports 39(9): 8595-8599

Nakata, I.; Yamashiro, K.; Nakanishi, H.; Tsujikawa, A.; Otani, A.; Yoshimura, N. 2011: VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration. Japanese Journal of Ophthalmology 55(5): 435-443

Veloso, C.E.d.R.; de Almeida, L.N.ão.F.; Recchia, F.M.; Pelayes, D.; Nehemy, M.ár.B. 2014: VEGF gene polymorphism and response to intravitreal ranibizumab in neovascular age-related macular degeneration. Ophthalmic Research 51(1): 1-8

Tavakkoly-Bazzaz, J.; Amoli, M.M.; Pravica, V.; Chandrasecaran, R.; Boulton, A.J.M.; Larijani, B.; Hutchinson, I.V. 2010: VEGF gene polymorphism association with diabetic neuropathy. Molecular Biology Reports 37(7): 3625-3630

Maltese, P.; Canestrari, E.; Ruzzo, A.; Graziano, F.; Falcone, A.; Loupakis, F.; Tonini, G.; Santini, D.; Magnani, M. 2009: VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. International Journal of Colorectal Disease 24(2): 165-170

Formica, V.; Martano, L.; Palmirotta, R.; Ferroni, P.; Del Monte, G.; Guadagni, F.; Roselli, M. 2011: VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea. Annals of Oncology: Official Journal of the European Society for Medical Oncology 22(8): 1928-1929

Yang, S.L.; Yan, S.; Niu, R.L.; Lin, X.K. 2009: VEGF gene silencing by cytomegalovirus promoter driven shRNA expression vector results in vascular development defects in zebrafish. Genetika 45(9): 1187-1193

Enestvedt, C.K.; Hosack, L.; Winn, S.R.; Diggs, B.S.; Uchida, B.; O'Rourke, R.W.; Jobe, B.A. 2008: VEGF gene therapy augments localized angiogenesis and promotes anastomotic wound healing: a pilot study in a clinically relevant animal model. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 12(10): 1762-1770; Discussion: 1771-1772

Kalil, R.A.K.; Salles, F.B.d.; Giusti, I.I.ês.; Rodrigues, C.G.; Han, S.W.; Sant'Anna, R.T.; Ludwig, E.; Grossman, G.; Prates, P.R.L.; Sant'anna, J.ão.R.M.; Teixeira Filho, G.F.; Nardi, N.B.; Nesralla, I.A.ão. 2010: VEGF gene therapy for angiogenesis in refractory angina: phase I/Ii clinical trial. Revista Brasileira de Cirurgia Cardiovascular: Orgao Oficial da Sociedade Brasileira de Cirurgia Cardiovascular 25(3): 311-321

Sun, L.; Yuan, Q.; Cao, N.; Guo, W.; Yao, L.; Feng, J-Min.; Ma, J-Fei.; Wang, L-Ning. 2014: VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis. Thescientificworldjournal 2014: 624573

Fabre, P.J.; Charron, F.éd.ér. 2011: VEGF guides commissural axons: a classic blood vessel trophic factor on the nerve's service. Medecine Sciences: M/S 27(12): 1066-1068

Borroni, B.; Del Bo, R.; Goldwurm, S.; Archetti, S.; Bonvicini, C.; Agosti, C.; Bigni, B.; Papetti, A.; Ghezzi, S.; Sacilotto, G.; Pezzoli, G.; Gennarelli, M.; Bresolin, N.; Comi, G.P.; Padovani, A. 2010: VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome. Journal of Alzheimer's Disease: Jad 21(1): 87-94

Okuchi, Y.; Nagayama, S.; Mori, Y.; Kawamura, J.; Matsumoto, S.; Nishimura, T.; Yoshizawa, A.; Sakai, Y. 2010: VEGF hypersecretion as a plausible mechanism for pseudo-meigs' syndrome in advanced colorectal cancer. Japanese Journal of Clinical Oncology 40(5): 476-481

Pons, J.; Huang, Y.; Arakawa-Hoyt, J.; Washko, D.; Takagawa, J.; Ye, J.; Grossman, W.; Su, H. 2008: VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochemical and Biophysical Research Communications 376(2): 419-422

Wylegała, E.; Teper, S.ła.J. 2007: VEGF in age-related macular degeneration. Part I. Physiologic and pathologic role of VEGF. Klinika Oczna 109(1-3): 94-96

Wylegała, E.; Teper, S.ła.J. 2007: VEGF in age-related macular degeneration. Part II. VEGF inhibitors use in age-related macular degeneration treatment. Klinika Oczna 109(1-3): 97-100

Aguayo, A. 2013: VEGF in central nervous leukemia. Leukemia Research 37(4): 357-358

Aguayo, A. 2014: VEGF in chronic myeloid leukemia treated with interferon and imatinib. Leukemia Research 38(6): 660-661

Danese, S. 2008: VEGF in inflammatory bowel disease: a master regulator of mucosal immune-driven angiogenesis. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 40(8): 680-683

Chekhonin, V.P.; Shein, S.A.; Korchagina, A.A.; Gurina, O.I. 2012: VEGF in neoplastic angiogenesis. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2: 23-33

Shingyoji, M.; Ando, S.; Nishimura, H.; Nakajima, T.; Ishikawa, A.; Itakura, M.; Iizasa, T.; Kimura, H. 2009: VEGF in patients with non-small cell lung cancer during combination chemotherapy of carboplatin and paclitaxel. Anticancer Research 29(7): 2635-2639

Klein, M.; Catargi, B. 2007: VEGF in physiological process and thyroid disease. Annales d'Endocrinologie 68(6): 438-448

Schlich, R.; Willems, M.; Greulich, S.; Ruppe, F.; Knoefel, W.T.; Ouwens, D.M.; Maxhera, B.; Lichtenberg, A.; Eckel, J.ür.; Sell, H. 2013: VEGF in the crosstalk between human adipocytes and smooth muscle cells: depot-specific release from visceral and perivascular adipose tissue. Mediators of Inflammation 2013: 982458

Varet, J.; Douglas, S.K.; Gilmartin, L.; Medford, A.R.L.; Bates, D.O.; Harper, S.J.; Millar, A.B. 2010: VEGF in the lung: a role for novel isoforms. American Journal of Physiology. Lung Cellular and Molecular Physiology 298(6): L768-L774

Rosenstein, J.M.; Krum, J.M.; Ruhrberg, C. 2010: VEGF in the nervous system. Organogenesis 6(2): 107-114

Wernike, E.; Montjovent, M-O.; Liu, Y.; Wismeijer, D.; Hunziker, E.B.; Siebenrock, K-A.; Hofstetter, W.; Klenke, F.M. 2010: VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo. European Cells and Materials 19: 30-40

Ay, I.; Francis, J.W.; Brown, R.H. 2008: VEGF increases blood-brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice. Brain Research 1234: 198-205

Miao, Z.; Dong, Y.; Fang, W.; Shang, D.; Liu, D.; Zhang, K.; Li, B.; Chen, Y.-H. 2014: VEGF increases paracellular permeability in brain endothelial cells via upregulation of EphA2. Anatomical Record 297(5): 964-972

Peppa, V.I.; Arsenopoulou, Z.V.; Zarogiannis, S.G.; Deligiorgi, T.; Jagirdar, R.; Makantasis, I.; Stefanidis, I.; Liakopoulos, V.; Molyvdas, P.-A.; Gourgoulianis, K.I.; Hatzoglou, C. 2014: VEGF increases the permeability of sheep pleura ex vivo through VEGFR2 stimulation. Cytokine 69(2): 284-288

Yang, L.; Guan, H.; He, J.; Zeng, L.; Yuan, Z.; Xu, M.; Zhang, W.; Wu, X.; Guan, J. 2012: VEGF increases the proliferative capacity and eNOS/NO levels of endothelial progenitor cells through the calcineurin/NFAT signalling pathway. Cell Biology International 36(1): 21-27

Findley, C.M.; Cudmore, M.J.; Ahmed, A.; Kontos, C.D. 2007: VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arteriosclerosis Thrombosis and Vascular Biology 27(12): 2619-2626

Li, D.; Li, X.-P.; Wang, H.-X.; Shen, Q.-Y.; Li, X.-P.; Wen, L.; Qin, X.-J.; Jia, Q.-L.; Kung, H.-F.; Peng, Y. 2012: VEGF induces angiogenesis in a zebrafish embryo glioma model established by transplantation of human glioma cells. Oncology Reports 28(3): 937-942

Herr, D.; Sallmann, A.; Bekes, I.; Konrad, R.; Holzheu, I.; Kreienberg, R.; Wulff, C. 2012: VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5. Gynecologic Oncology 127(1): 210-216

Nourse, M.B.; Halpin, D.E.; Scatena, M.; Mortisen, D.J.; Tulloch, N.L.; Hauch, K.D.; Torok-Storb, B.; Ratner, B.D.; Pabon, L.; Murry, C.E. 2010: VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arteriosclerosis Thrombosis and Vascular Biology 30(1): 80-89

Sakai, Y.; Goodison, S.; Cao, W.; Urquidi, V.; Namiki, K.; Porvasnik, S.; Urbanek, C.; Rosser, C.J. 2009: VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model. World Journal of Urology 27(5): 659-666

English, B.C.; Price, D.K.; Figg, W.D. 2009: VEGF inhibition and metastasis: possible implications for antiangiogenic therapy. Cancer Biology and Therapy 8(13): 1214-1225

Nochy, D.; Lefaucheur, C.; Hill, G. 2008: VEGF inhibition and renal thrombotic microangiopathy. New England Journal of Medicine 359(2): 206; Author Reply 206-207

Grothey, A. 2013: VEGF inhibition beyond tumour progression. LANCET. Oncology 14(1): 2-3

Crawford, Y.; Ferrara, N. 2009: VEGF inhibition: insights from preclinical and clinical studies. Cell and Tissue Research 335(1): 261-269

Tak, Y.K.; Naoghare, P.K.; Han, E.; Song, J.M. 2011: VEGF inhibitor (Iressa) arrests histone deacetylase expression: single-cell cotransfection imaging cytometry for multi-target-multi-drug analysis. Journal of Cellular Physiology 226(8): 2115-2122

Jayson, G. 2011: VEGF inhibitors and advanced ovarian cancer. LANCET. Oncology 12(12): 1082-1083

Cury, C.E.; Rodrigues, E.B.; Meyer, C.H.; Farah, M.E. 2009: VEGF inhibitors and vitrectomy for diabetic vitreoretinopathy. Developments in Ophthalmology 44: 69-81

Barakat, M.R.; Kaiser, P.K. 2009: VEGF inhibitors for the treatment of neovascular age-related macular degeneration. Expert Opinion on Investigational Drugs 18(5): 637-646

Brastianos, P.K.; Batchelor, T.T. 2009: VEGF inhibitors in brain tumors. Clinical Advances in Hematology and Oncology: H&o 7(11): 753

Thys, J.; Dupont, G.; Rakic, J.M. 2009: VEGF inhibitors in ophthalmology. Revue Medicale de Liege 64(5-6): 323-326

Feltgen, N.; Stahl, A. 2013: VEGF inhibitors in vitreoretinal interventions. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 110(10): 926-934

Anderson, S.M.; Shergill, B.; Barry, Z.T.; Manousiouthakis, E.; Chen, T.T.; Botvinick, E.; Platt, M.O.; Iruela-Arispe, M.L.; Segura, T. 2011: VEGF internalization is not required for VEGFR-2 phosphorylation in bioengineered surfaces with covalently linked VEGF. Integrative Biology: Quantitative Biosciences from Nano to Macro 3(9): 887-896

Tögel, F.; Zhang, P.; Hu, Z.; Westenfelder, C. 2009: VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. Journal of Cellular and Molecular Medicine 13(8b): 2109-2114

Fushida, S.; Oyama, K.; Kinoshita, J.; Yagi, Y.; Okamoto, K.; Tajima, H.; Ninomiya, I.; Fujimura, T.; Ohta, T. 2013: VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody. Oncotargets and Therapy 6: 1445-1451

Coimbra, J.é C.-V. 2012: VEGF is clearly an exciting point of attack in the treatment of neovascular diseases of the retina and choroid. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 227(Suppl 1): 1

Markel, T.A.; Wang, Y.; Herrmann, J.L.; Crisostomo, P.R.; Wang, M.; Novotny, N.M.; Herring, C.M.; Tan, J.; Lahm, T.; Meldrum, D.R. 2008: VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. American Journal of Physiology. Heart and Circulatory Physiology 295(6): H2308-H2314

Oladipupo, S.; Hu, S.; Kovalski, J.; Yao, J.; Santeford, A.; Sohn, R.E.; Shohet, R.; Maslov, K.; Wang, L.V.; Arbeit, J.M. 2011: VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting. Proceedings of the National Academy of Sciences of the United States of America 108(32): 13264-13269

Siervo, M.; Tomatis, V.; Stephan, B.C.M.; Feelisch, M.; Bluck, L.J.C. 2012: VEGF is indirectly associated with NO production and acutely increases in response to hyperglycaemia(1). European Journal of Clinical Investigation 42(9): 967-973

Licht, T.; Eavri, R.; Goshen, I.; Shlomai, Y.; Mizrahi, A.; Keshet, E. 2010: VEGF is required for dendritogenesis of newly born olfactory bulb interneurons. Development 137(2): 261-271